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Sarcopenia is a characteristic of ageing where a substantial reduction of muscle tissue, 
strength and function are seen (Baumann et al, 2016). Previous reports have suggested that 
an age-related loss of stability of the neuromuscular junction can result in muscle fibre 
denervation, which in turn impacts on the capacity to activate muscles as well as altering 
muscle fibre architecture, composition, cross sectional area and number. Hence, muscle 
fibre denervation may play a fundamental role in sarcopenia.  
Previous studies (Muller et al, 2007; Bhattacharya et al, 2009; Pollock et al, 2017) have 
highlighted a significant increase in mitochondrial peroxide release in denervated muscle 
fibres but the physiological role of this increase is still unclear. Therefore, the main aim of 
this study was to determine the sources of peroxide in denervated muscle fibres and the 
physiological effect that this peroxide release has on skeletal muscle. A specific focus was 
given to the adaptive responses induced by the increased peroxide release and its effects 
on the metabolism and mitochondria of denervated muscle fibres.  
The main findings of this thesis are: 
 In response to surgically induced denervation of the Tibialis Anterior and Extensor 
Digitorum Longus muscles, a significant increase in peroxide release from 
mitochondria occurred from enzymes not involved in the electron transport chain. 
During prolonged denervation, muscles underwent significant atrophy accompanied 
by increased content of cytosolic enzymes such as phospholipase A2 and NADPH 
Oxidase 2 which may be responsible for the initiation of proteolysis.  
 In the experimental model of denervation, there was a significant increased content 
of mitochondrial fission markers with no apparent changes in fusion together with 
a progressive accumulation of p62 indicating mitophagy impairment. There was 
also a reduction of mitochondria content at 21 days post-denervation with the 
activation of pro-apoptotic pathways involving the Bcl-2 family.  
 Nuclear magnetic resonance metabolomics showed that prolonged denervation 
was associated with metabolic changes in pathways related to insulin resistance, 
increase of protein breakdown and activation of purine metabolism. 
 Given the extensive cellular alterations observed with prolonged, surgically induced 
denervation, similar measurements were performed in skeletal muscle from old 
mice to identify whether these changes were also evident during ageing. From 18 
months, mice exhibited an instability of the neuromuscular junction with progressive 
fragmentation and nerve sprouting. However, not all of the biochemical changes 
observed in skeletal muscle following surgically induced denervation were also 
seen in skeletal muscle during ageing.  
 
In conclusion, the results of the present work suggest that the increase in peroxide release 
in fully denervated muscle fibres triggers multiple responses resulting in impairment of 
mitophagy, insulin resistance, increased proteolysis and fibre atrophy.  
II 
 
Table of Contents 
Abstract .....................................................................................................I 
Table of Contents ................................................................................... II 
List of Figures ......................................................................................... X 
List of Tables ...................................................................................... XIX 
Abbreviations ....................................................................................... XX 
Acknowledgements ........................................................................ XXVII 
Chapter 1. Introduction .......................................................................... 1 
1.1 Skeletal muscle ................................................................................................... 2 
1.2 The Neuromuscular System ............................................................................. 5 
1.2.1 Neuromuscular system anatomy and physiology .......................................... 6 
1.3 Mitochondria ..................................................................................................... 7 
1.4 Reactive Oxygen Species ................................................................................. 10 
1.5 Reactive Oxygen Species production in skeletal muscle .............................. 13 
1.5.1 Superoxide anion ......................................................................................... 13 
1.5.2 Hydrogen peroxide ...................................................................................... 15 
1.5.3 Hydroxyl radical .......................................................................................... 16 
1.5.4 Alternative sources of H2O2 ........................................................................ 16 
1.5.5 Redox homeostasis and oxidative stress ..................................................... 22 
1.5.6 Redox signalling .......................................................................................... 23 
1.6 Adaptive responses in skeletal muscle ........................................................... 25 
1.6.1 Superoxide Dismutase ................................................................................. 27 
1.6.2 Catalase ....................................................................................................... 27 
1.6.3 Glutathione Peroxidase ................................................................................ 28 
1.6.4 Peroxiredoxins ............................................................................................. 29 
1.6.5 Thioredoxin ................................................................................................. 30 
III 
 
1.6.6 Heat Shock Proteins .................................................................................... 31 
1.7 Ageing ............................................................................................................... 32 
1.7.1 Skeletal muscle and Ageing ........................................................................ 33 
1.7.2 Neuromuscular junction during ageing ....................................................... 35 
1.7.3 Reactive oxygen species and ageing in skeletal muscle .............................. 38 
1.8 Mitochondrial dysfunction, reactive oxygen species and denervation .......... 39 
1.9 Aims of the work reported in this thesis ....................................................... 41 
Chapter 2. Materials and Methods ...................................................... 43 
2.1 Mouse models ................................................................................................... 44 
2.1.1 C57BL/6J mice ............................................................................................ 44 
2.1.2 B6.Cg-Tg(Thy1-YFP)16Jrs/J ...................................................................... 44 
2.2 Surgical transection of the peroneal and sciatic nerve to induce muscle 
denervation ............................................................................................................ 45 
2.3 Sample collection and preparation ................................................................ 46 
2.3.1 Sample preparation for SDS-PAGE western blot analysis ......................... 48 
2.3.2 Sample preparation for Oxyblot analysis .................................................... 48 
2.3.3 Sample preparation for GSH and GSSG assays .......................................... 48 
2.3.4 Sample preparation for morphological analysis .......................................... 49 
2.3.5 Sample preparation for the analysis of the neuromuscular junction ........... 49 
2.3.6 Sample preparation for analysis of mitochondrial peroxide generation ...... 49 
2.3.7 Sample preparation for TMRM analysis ..................................................... 49 
2.3.8 Sample preparation for NMR Metabolomics .............................................. 50 
2.3.9 Sample preparation for Citrate synthase assay ............................................ 50 
2.4 Biochemical assays .......................................................................................... 50 
2.4.1 Bicinchoninic Acid assay ............................................................................ 50 
2.4.2 Bradford Assay ............................................................................................ 52 
2.5 SDS-PAGE western blot analysis................................................................... 53 
IV 
 
2.5.1 Reagents ...................................................................................................... 53 
2.5.2 Sample preparation and gel electrophoresis ................................................ 56 
2.5.3 Western blotting of separated proteins ........................................................ 57 
2.6 Oxyblot analysis............................................................................................... 61 
2.6.1 Reagents ...................................................................................................... 61 
2.6.2 Protocol ....................................................................................................... 62 
2.7 Glutathione assay ............................................................................................ 63 
2.7.1 Reagents ...................................................................................................... 63 
2.7.2 Protocol ....................................................................................................... 64 
2.8 Oxidised glutathione assay ............................................................................. 65 
2.8.1 Reagents ...................................................................................................... 65 
2.8.2 Protocol ....................................................................................................... 66 
2.9 Haemotoxylin and Eosin staining (H&E) ...................................................... 66 
2.9.1 Reagents ...................................................................................................... 67 
2.9.2 Protocol ....................................................................................................... 67 
2.10 Wheat Germ Agglutinin staining ................................................................. 68 
2.10.1 Reagents .................................................................................................... 68 
2.10.2 Protocol ..................................................................................................... 68 
2.11 Analysis of the neuromuscular junction...................................................... 69 
2.11.1 Reagents .................................................................................................... 69 
2.11.2 Protocol ..................................................................................................... 69 
2.12 Immunofluorescence staining....................................................................... 70 
2.12.1 Reagents .................................................................................................... 70 
2.12.2 Protocol ..................................................................................................... 71 
2.13 Tetramethylrhodamine, methyl ester (TMRM) ......................................... 72 
2.13.1 Reagents .................................................................................................... 72 
2.13.2 Protocol ..................................................................................................... 74 
V 
 
2.14 Analysis of mitochondrial peroxide generation .......................................... 75 
2.14.1 Reagents .................................................................................................... 76 
2.14.2 Protocol ..................................................................................................... 77 
2.15 Citrate synthase assay ................................................................................... 77 
2.15.1 Reagents .................................................................................................... 78 
2.15.2 Protocol ..................................................................................................... 78 
2.16 Nuclear Magnetic Resonance-Based Metabolomics................................... 79 
2.16.1 Reagents .................................................................................................... 79 
2.16.2 Protocol ..................................................................................................... 79 
2.17 Statistical analysis ......................................................................................... 80 
2.17.1 Statistical analysis for NMR metabolomics .............................................. 81 
Chapter 3. Redox responses following skeletal muscle denervation 82 
3.1 Introduction ..................................................................................................... 83 
3.2 Materials and Methods ................................................................................... 85 
3.2.1 Mouse model ............................................................................................... 85 
3.2.2 Surgical denervation of the Tibialis Anterior and Extensor Digitorum Longus 
muscles ................................................................................................................. 85 
3.2.3 Haematoxylin and Eosin staining ................................................................ 85 
3.2.4 Imaging of neuromuscular junctions ........................................................... 85 
3.2.5 Analysis of mitochondrial peroxide generation .......................................... 86 
3.2.6 Total glutathione and oxidised glutathione assays ...................................... 86 
3.2.7 SDS-PAGE and western blot analysis ......................................................... 86 
3.2.8 Analysis of protein carbonylation ............................................................... 87 
3.3 Results .............................................................................................................. 88 
3.3.1 Anthropometric measurements .................................................................... 88 
3.3.2 Qualitative analysis of the neuromuscular junction following denervation 88 
3.3.3 Peroxide release from bundles of muscle fibres .......................................... 92 
VI 
 
3.3.4 Total glutathione and oxidised glutathione content..................................... 93 
3.3.5 Protein oxidation in TA muscles following denervation ............................. 95 
3.3.6 Content of NADPH oxidase subunits in denervated muscle ....................... 96 
3.3.7 Muscle protein content of Prx6, cPLA2 and Monoamine Oxidase A in 
denervated muscle .............................................................................................. 100 
3.3.8 Muscle content of mitochondria-localised regulatory enzymes post-denervation
 ............................................................................................................................ 102 
3.3.9 Heat Shock Proteins content of denervated muscle fibres ........................ 104 
3.4 Discussion ....................................................................................................... 107 
Chapter 4. Mitochondrial status following skeletal muscle 
denervation .......................................................................................... 115 
4.1 Introduction ................................................................................................... 116 
4.2 Materials and Methods ................................................................................. 119 
4.2.1 Mouse model ............................................................................................. 119 
4.2.2 Surgical denervation of the lower hind-limb ............................................. 119 
4.2.3 SDS-PAGE western Blot analysis ............................................................. 119 
4.2.7 Citrate synthase assay ................................................................................ 119 
4.2.8 Mitochondria membrane potential analysis............................................... 120 
4.3 Results ............................................................................................................ 121 
4.3.1 Anthropometric measurements .................................................................. 121 
4.3.2 Mitophagy markers .................................................................................... 123 
4.3.3 Apoptosis pathway activation.................................................................... 126 
4.3.4 Mitochondria content ................................................................................ 128 
4.3.5 Mitochondrial membrane potential ........................................................... 128 
4.4 Discussion ....................................................................................................... 130 
Chapter 5. Metabolic changes induced by skeletal muscle denervation
 ............................................................................................................... 137 
VII 
 
5.1 Introduction ................................................................................................... 138 
5.2 Materials and Methods ................................................................................. 141 
5.2.1 Nuclear Magnetic Resonance Metabolomics of denervated gastrocnemius
 ............................................................................................................................ 141 
5.2.2 Metabolite identification ........................................................................... 141 
5.3 Results ............................................................................................................ 142 
5.3.1 Anthropometric measurements .................................................................. 142 
5.3.2 NMR Metabolomics .................................................................................. 142 
5.4 Discussion ....................................................................................................... 154 
Chapter 6. Age-related skeletal muscle denervation and its effect on 
muscle structure .................................................................................. 160 
6.1 Introduction ................................................................................................... 161 
6.2 Materials and Methods ................................................................................. 163 
6.2.1 Mice strain ................................................................................................. 163 
6.2.2 Samples preparation for immunohistochemical analysis .......................... 163 
6.2.3 WGA Staining ........................................................................................... 163 
6.2.4 Myosin Heavy Chain immunostaining ...................................................... 163 
6.2.5 SDS-PAGE and western blot analysis ....................................................... 164 
6.2.6 Assessments of Neuromuscular junctions ................................................. 164 
6.2.7 Neuromuscular junction analysis with ImageJ .......................................... 165 
6.3 Results ............................................................................................................ 167 
6.3.1 Anthropometric measurements .................................................................. 167 
6.3.2 Age-related changes of the neuromuscular junction ................................. 169 
6.3.3 Analysis of changes of muscle structure and composition ........................ 174 
6.3.4 Age-related changes in neuromuscular junction markers ......................... 175 
6.3.5 Age-related changes in protein content of antioxidant enzymes ............... 176 
6.3.6 Age-related changes in autophagy/mitophagy and apoptosis markers...... 178 
VIII 
 
6.4 Discussion ....................................................................................................... 179 
Chapter 7. General discussion ........................................................... 187 
7.1 Discussion of the main findings .................................................................... 189 
7.1.1 Mitochondrial peroxide release following denervation is driven by enzymes 
not involved in the ETC and induces activation of NOX2, PLA2 and Prx6 in the 
cytosolic environment ........................................................................................ 189 
7.1.2 An initial adaptive response following denervation may be an attempt to protect 
mitochondria but is not sustained over long-term resulting in oxidative stress and 
possible activation of proteolytic pathways .......................................................... 190 
7.1.3 Mitophagy is significantly inhibited following denervation with an increase 
in fission, activation of pro-apoptotic pathways and reduction in mitochondria 
population ........................................................................................................... 190 
7.1.4 Activation of apoptosis in denervated skeletal muscle fibres ................... 191 
7.1.5 Denervation triggers significant metabolic changes in skeletal muscle .... 192 
7.1.6 During ageing there is a progressive instability of the NMJ, accompanied by 
nerve sprouting and post-synaptic receptor breakdown. These changes were 
accompanied by mild structural changes at muscular level ............................... 192 
7.2 Future perspectives ....................................................................................... 194 
7.2.1 Alternative methods for ROS detection .................................................... 194 
7.2.2 Analysis of the H2O2/lipid peroxide ratio .................................................. 194 
7.2.3 Activity of the 26 proteasome in denervated muscle fibres ...................... 195 
7.2.4 ATP production during oxidative phosphorylation in denervated skeletal 
muscle fibres ....................................................................................................... 195 
7.2.5 Muscle fibres contractility post-denervation ............................................. 196 
7.2.6 Redox proteomics ...................................................................................... 196 
7.2.7 Alternative mitophagy markers ................................................................. 196 
Bibliography ........................................................................................ 198 
Appendix 1. Western blot analysis and Ponceau normalisation .... A.1 
IX 
 
Appendix 2. Carbonyls blot analysis ................................................. A.2 
Appendix 3. Mitochondria isolation and NMR metabolomics of 
isolated mitochondria ......................................................................... A.3 





List of Figures 
Figure 1.1. Schematic representation of the skeletal muscle composition. Image 
adapted from Pearson Education, Inc.                                                                                  3                                   
Figure 1.2. Schematic representation of a myofibril and its contractile components. 
Image rom https://courses.lumenlearning.com                                                                4                      
Figure 1.3. Graphical representation of the ETC and its reactions resulting in the 
production of ATP and Reactive Oxygen Species. Image adapted from Zhao et al, 
2019.                                    10                              
Figure 1.4. Schematic representation of ROS production in eukaryotic cells. From 
Powers and Jackson, 2008.                                                                                          14 
Figure 1.5. Schematic representation of NOX2 and NOX4 localisation and ROS 
release sites in skeletal muscle. Image adapted from Ferreira and Laitano, 2016.     20 
Figure 1.6. Schematic representation of the NOX2 subunits assembly. Image adapted 
from Ferreira and Laitano, 2016.                                                                                  21 
Figure 1.7. Age-associated modifications at the neuromuscular level that culminate 
with sarcopenia. Adapted from Hepple and Rice, 2016.                                                37                    
Figure 2.1. Schematic overview of tissue utilisation for the experiments presented in 
Chapter 4 and 5 focused on determining the mitochondrial status and metabolic 
changes following skeletal muscle denervation.       46                                                                                                               
Figure 2.2. Schematic overview of tissue utilisation for the experiments presented in 
Chapter 3 focused on determining the redox response following skeletal muscle 
denervation.                                                           47         
Figure 2.3. Schematic overview of tissue utilisation for the experiments presented in 
Chapter 6 focused on determining the age-related changes of the NMJ, muscle 
morphology and the antioxidant enzymatic response.       47 
Figure 2.4. Graphical representation of the sandwich preparation for the transfer of 
proteins from the gel to the Nitrocellulose or PVDF membrane.                                    57 
Figure 3.1a. Total body weights from control mice (non-denervated) and mice at 1, 3, 
7, 14 and 21 days post-denervation. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).                  89 
Figure 3.1b. Tibialis Anterior muscle weights from control mice (non-denervated) and 
mice at 1, 3, 7, 14 and 21 days post-denervation. Histograms represent the mean and 
the standard error of the mean for each experimental group (n=4). ** p<0.01 - *** 
p<0.001 compared with the control group.                   89 
Figure 3.1c. Fibre number in Tibialis Anterior muscle from control mice (non-
denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. Histograms represent 
the mean and the standard error of the mean for each experimental group (n=4).     90                                                                                                                                                    
XI 
 
Figure 3.1d. Analysis of fibre CSA from Tibialis Anterior muscle in control mice 
(non-denervated) and mice at 7, 14 and 21 days post-denervation. Histograms 
represent the mean fibre percentage in each threshold and the standard error of the 
mean for each experimental group (n=4). * p<0.05 - ** p<0.01 - *** p<0.001 
compared with the control group.            90 
Figure 3.2a. Transverse sections of Tibialis Anterior muscles visualized by H&E 
staining from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation.             91 
Figure 3.2b. NMJs observed in whole EDL muscle from control mice (non-
denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. Images show the 
peripheral nerves (green) and acetylcholine receptors (red).     91 
Figure 3.3a. State 1 H2O2 production in mitochondria in permeablised Tibialis 
Anterior fibre determined by oxidation of amplex red from control (non-denervated) 
mice and mice at 1, 3, 7, 14 and 21 days post-denervation. Histograms represent the 
mean and standard error of the mean for each experimental group (n=4). *** p<0.001 
compared with the control group.                      92 
Figure 3.3b. State 1 mitochondrial H2O2 generation from permeabilised fibres of the 
Tibialis Anterior muscle in the presence of different enzyme inhibitors. Chlorgyline 
(Monoamine Oxidase A -100µM), parglyline (Monoamine Oxidase B - 100µM), 
apocynin (NADPH oxidase - 0.5mM), AACOCF3 (PLA2 - 20µM) resulted in 
significantly reduced H2O2 generation compared untreated fibre bundles at 14 and 21 
days post-denervation. Histograms represent the mean percentage of State 1 and 
standard error of the mean for each experimental group (n=4). * p<0.05 - ** p<0.01 - 
*** p<0.001 compared with its state 1 (fibres not exposed to any inhibitor).             93 
Figure 3.4a. Total glutathione (GSH) contents in Tibialis Anterior muscles from 
control (non-denervated) mice and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean and standard error of the mean for each experimental 
group (n=4).              94 
Figure 3.4b. Oxidised glutathione (GSSG) contents in Tibialis Anterior muscles from 
control (non-denervated) mice and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean and standard error of the mean for each experimental 
group (n=4).                                   94 
Figure 3.5. Quantification of protein carbonyls by densitometric analysis of the 
protein bands at different molecular weights.  A representative lane of an Oxyblot for 
control muscle showing the bands detected with approximate molecular weights 
indicated (kDa). Histograms represent the mean and standard error of the mean for 
each experimental group (n=4). * p<0.05 compared with the control group.                95  
Figure 3.6a. Quantification of western blots of NOX2/gp91phox in Tibialis Anterior 
muscle from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4). *** p<0.001 compared with the control 
group.             97 
XII 
 
Figure 3.6b. Quantification of western blots of p22phox in Tibialis Anterior muscle 
from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4). * p<0.05 - *** p<0.001 compared with the 
control group.             97 
Figure 3.6c. Representative western blots of p40phox in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
As shown in the figure the control group was not detectable when analysed together 
with the 14 and 21 days group making impossible to accurately quantify the relative 
content of this protein. Despite this it is clear the progressive increase in content of this 
protein observed from 7 days following denervation.            98 
Figure 3.6d. Quantification of western blots of p47phox in Tibialis Anterior muscle 
from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4). *** p<0.001 compared with the control 
group.              98 
Figure 3.6e. Quantification of western blots of p67phox in Tibialis Anterior muscle 
from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4). ** p<0.01 - *** p<0.001 compared with the 
control group.            99 
Figure 3.6f. Quantification of western blots of Rac-1 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean protein content and standard error of the mean for each 
experimental group (n=4). * p<0.05 compared with the control group.                       99 
Figure 3.6g. Quantification of western blots of NOX4 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean protein content and standard error of the mean for each 
experimental group (n=4).                     100 
Figure 3.7a. Representative western blots of Prx6 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 101 
Figure 3.7b. Quantification of western blots of cPLA2 in Tibialis Anterior muscle 
from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4). *** p<0.001 compared with the control 
group.                      101  
Figure 3.7c. Quantification of western blots of Monoamine Oxidase A in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 
days post-denervation. Histograms represent the mean protein content and standard 
error of the mean for each experimental group (n=4). * p<0.05 - ** p<0.01 - *** p<0.001 
compared with the control group.                    102 
XIII 
 
Figure 3.8a. Quantification of western blots of MnSOD in Tibialis Anterior muscle 
from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4).                  103 
Figure 3.8b. Quantification of western blots of TrxR2 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean protein content and standard error of the mean for each 
experimental group (n=4). ** p<0.01 - *** p<0.001 compared with the control group.     103 
Figure 3.8c. Quantification of western blots of GPx1 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean protein content and standard error of the mean for each 
experimental group (n=4). * p<0.05 - ** p<0.01 compared with the control group.   104 
Figure 3.9a. Quantification of western blots of Hsc70 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean protein content and standard error of the mean for each 
experimental group (n=4). ** p<0.01 - *** p<0.001 compared with the control group.     105   
Figure 3.9b. Quantification of western blots of Hsp25 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
Histograms represent the mean protein content and standard error of the mean for each 
experimental group (n=4). * p<0.05 - ** p<0.01 - *** p<0.001 compared with the 
control group.                      106 
Figure 3.9c. Representative western blots of Hsp70 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. 
As shown in the figure the control group was not detectable when analysed together 
with the 14 and 21 days group making relative quantification impossible.             106 
Figure 4.1a. Total body weights from control mice (non-denervated) and mice at 7 
and 21 days post-denervation. Histograms represent the mean and the standard error 
of the mean for each experimental group (n=4).                121 
Figure 4.1b. Tibialis Anterior muscle weights from control mice (non-denervated) and 
mice at 7 and 21 days post-denervation. Histograms represent the mean and the 
standard error of the mean for each experimental group (n=4). * p<0.05 -*** p<0.001 
compared with the control group.                              122 
Figure 4.1c. Extensor Digitorum Longus muscle weights from control mice (non-
denervated) and mice at 7 and 21 days post-denervation. Histograms represent the 
mean and the standard error of the mean for each experimental group (n=4). ** p<0.01 
compared with the control group.                               122 
Figure 4.1d. Soleus muscle weights from control mice (non-denervated) and mice at 
7 and 21 days post-denervation. Histograms represent the mean and the standard error 
of the mean for each experimental group (n=4). * p<0.05 compared with the control 
group.                                 123 
XIV 
 
Figure 4.2a. Representative western blot and quantification of the ratio between 
phosphorylated Drp1 and Drp1 protein content used as a marker of mitochondria 
fission in Tibialis Anterior muscle from Control (non-denervated) and mice at 7 and 
21 days post-denervation. Histograms represent the mean protein content and standard 
error of the mean for each experimental group (n=4). *** p<0.001 compared with the 
control group.                     124 
Figure 4.2b. Representative western blot and quantification of OPA1 protein content 
used as a marker of mitochondria fusion in Tibialis Anterior muscle from Control 
(non-denervated) and mice 7 and 21 days post-denervation. Histograms represent the 
mean protein content and standard error of the mean for each experimental group 
(n=4).                      124 
Figure 4.2c. Representative western blot and quantification of Mfn-2 protein content 
used as a marker of mitochondria fusion in Tibialis Anterior muscle from Control 
(non-denervated) and mice 7 and 21 days post-denervation. Histograms represent the 
mean protein content and standard error of the mean for each experimental group 
(n=4).                      125 
Figure 4.2d. Representative western blot and quantification of p62 protein content 
used as a marker mitophagy in Tibialis Anterior muscle from Control (non-denervated) 
and mice 7 and 21 days post-denervation. Histograms represent the mean protein 
content and standard error of the mean for each experimental group (n=4). *** p<0.001 
compared with the control group.                  125 
Figure 4.3a. Representative western blot and quantification of the ratio between BAX 
and Bcl-2 proteins content used as a marker of activation of apoptosis in Tibialis 
Anterior muscle from Control (non-denervated) and mice 7 and 21 days post-
denervation. Histograms represent the mean protein content and standard error of the 
mean for each experimental group (n=4). *** p<0.001 compared with the control 
group.                      126 
Figure 4.3b. Representative western blot and quantification of caspase-3 protein 
content used as a marker of activation of apoptosis in Tibialis Anterior muscle from 
Control (non-denervated) and mice 7 and 21 days post-denervation. Histograms 
represent the mean protein content and standard error of the mean for each 
experimental group (n=4). *** p<0.001 compared with the control group.                    127 
Figure 4.3c. Representative western blot and quantification of cleaved caspase-3 protein 
content used as a marker of activation of caspase-3 and apoptosis in Tibialis Anterior muscle 
from Control (non-denervated) and mice 7 and 21 days post-denervation. Histograms 
represent the mean protein content and standard error of the mean for each experimental 
group (n=4). * p<0.05 compared with the control group.                127 
Figure 4.4. Citrate synthase activity expressed as mean µM/min/proteins and standard 
error of the mean for each experimental group (n=4). The assays were performed in 
duplicate for each sample. Histograms represent the mean activity and standard error 
of the mean for each experimental group (n=4). *** p<0.001 compared with the 
control group.                    128 
XV 
 
Figure 4.5. A) Measurement of ΔΨm in intact mitochondria of isolated EDL muscle 
fibres from control (non-denervated) and mice at 7 and 21 post-denervation, assessed 
by changes in TMRM (30nM) fluorescence in response to oligomycin (Olm, 2.5μM) 
and FCCP (4μM), added at the indicated time points. B) Representative images of an 
isolated muscle fibres in bright-field and fluorescent image following loading with 
TMRM (scale bar 50μm).                   129 
Figure 5.1. Representative NMR metabolomics spectra and its component metabolites 
as presented by Soininen et al, (2009).                                        139 
Figure 5.2. Gastrocnemius muscle weights from control mice (non-denervated) and 
mice at 7 and 21 days post-denervation. Histograms represent the mean and the 
standard error of the mean for each experimental group (n=4). *** p<0.001 compared 
with the control group.                               142 
Figure 5.3. 1H 1D NMR spectra (700MHz) of murine gastrocnemius muscle tissue 
extract for Control (non-denervated), 7 day and 21 days post-denervation groups 
(n=4). Inset spectra (Blue squares) represent 4x magnification of specific spectral 
regions: 10-7ppm (aromatic including NAD+ and ATP) and 2.8-3.8ppm polar amino 
acids (glutamine and glutamate).                  143 
Figure 5.4. A) Results of the principal component analysis. Figure shows the first 5 
components able to explain more than 95% of the variance seen between the Control 
(Δ - non-denervated), 7 days post-denervation (+) and 21 days post-denervation (X) 
groups. B) Results of the Principal Component Analysis of the first 2 Principal 
Components able to explain 75.5% of the variance seen between the control (Black - 
non-denervated), 7 days post-denervation (light grey) and 21 days post-denervation 
(dark grey) groups.                     144 
Figure 5.5. Heatmap representing the results of the statistically significant metabolites 
(p<0.05) identified from NMR metabolomics (shown on the right of the figure). 
Groups are indicated at the top of the figure in black (Control), light grey (7 days post-
denervation) and dark grey (21 days post denervation). Individual samples IDs are 
indicated at the bottom of the figure.                  147 
Figure 5.6. Box plot presenting the mean-centered relative abundance of Glucose in 
control (non-denervated), 7 days and 21 days post-denervation groups. Dots represent 
individual samples (n=4 per group) while asterisks show the statistical differences 
between 7 and 21 days post-denervation groups and the control group (non-
denervated) as follows: *** p<0.001.                 148 
Figure 5.7. Box plot presenting the mean-centered relative abundance of NAD+ in 
control (non-denervated), 7 days and 21 days post-denervation groups. Dots represent 
individual samples (n=4 per group) while asterisks show the statistical differences 
between 7 and 21 days post-denervation groups and the control group (non-
denervated) as follows: ** p<0.01.                  148 
Figure 5.8. Box plot presenting the mean-centered relative abundance of A) Glucose 
6 phosphate, B) Pyruvate and C) Lactate in control (non-denervated), 7 days and 21 
days post-denervation groups. Dots represent individual samples (n=4 per group) 
XVI 
 
while asterisks show the statistical differences between 7 and 21 days post-denervation 
groups and the control group (non-denervated)                                               149 
Figure 5.9. Box plot presenting the mean-centered relative abundance of A) GTP, B) 
IMP and C) Xanthine in control (non-denervated), 7 days and 21 days post-
denervation groups. Dots represent individual samples (n=4 per group) while asterisks 
show the statistical differences between 7 and 21 days post-denervation groups and the 
control group (non-denervated).                                                 150 
Figure 5.10. Box plot presenting the mean-centered relative abundance of A) Valine, B) 
Isoleucine and C) Phenylalanine and D) Glutamate in control (non-denervated), 7 days and 
21 days post-denervation groups. Dots represent individual samples (n=4 per group) while 
asterisks show the statistical differences between 7 and 21 days post-denervation groups and 
the control group (non-denervated).                 151 
Figure 5.11. Box plot presenting the mean-centered relative abundance of Methionine 
in control (non-denervated), 7 days and 21 days post-denervation groups. Dots 
represent individual samples (n=4 per group) while asterisks show the statistical 
differences between 7 and 21 days post-denervation groups and the control group (non-
denervated) as follows: *** p<0.001.                                       152 
Figure 5.12. Box plot presenting the mean-centered relative abundance of 3-
Methylhistidine in control (non-denervated), 7 days and 21 days post-denervation 
groups. Dots represent individual samples (n=4 per group) while asterisks show the 
statistical differences between 7 and 21 days post-denervation groups and the control 
group (non-denervated) as follows: *** p<0.001.                152 
Figure 5.13. Box plot presenting the mean-centered relative abundance of 
Acetylcholine in control (non-denervated), 7 days and 21 days post-denervation 
groups. Dots represent individual samples (n=4 per group) while asterisks show the 
statistical differences between 7 and 21 days post-denervation groups and the control 
group (non-denervated) as follows: ** p<0.01 - *** p<0.001.              153 
Figure 6.1. Schematic representation of the steps necessary to analyse the NMJ 
structure using the ImageJ extension Binary connectivity. (Image adapted from Jones 
et al, 2016).                     166 
Figure 6.2a. Total body weights from mice sacrified at different ages: 6, 12, 15, 18, 
21, 24 and 27 months. Histograms represent the mean and the standard error of the 
mean for each experimental group (n=4).                 167 
Figure 6.2b. Tibialis Anterior muscle weights from mice sacrified at different ages: 6, 
12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).               168 
Figure 6.2c. Extensor Digitorum Longus muscle weights from mice sacrified at 
different ages: 6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and 
the standard error of the mean for each experimental group (n=4).              168 
Figure 6.2d. Muscle fibre minimum Feret’s diameter. Histograms represent the mean 
and standard error of the mean of the percentage of fibres counted in each threshold 
XVII 
 
(10-20, 20.1-30, 30.1-40, 40.1-50, 50.1-60, 60.1+) for each experimental group: 6, 12, 
15, 18, 21, 24 and 27 months.                   169 
Figure 6.3a. Percentage of fully innervated (Black - 100-80% overlap), partially 
innervated (Light grey - 79-15% overlap) and denervated (Dark grey - <15% overlap) 
acetylcholine receptors together with representative NMJs. Histogram represent the 
percentage of overlap of the NMJs for each experimental group: 6, 12, 15, 18, 21, 24 
and 27 months. * p<0.05 - ** p<0.01 compared with the 6 months group.             170 
Figure 6.3b. Average overlap between the motor neuron and the post-synaptic 
receptors from mice sacrified at different ages: 6, 12, 15, 18, 21, 24 and 27 months. 
Histograms represent the mean and the standard error of the mean for each 
experimental group (n=4). * p<0.05 - ** p<0.01 - *** p<0.001 compared with the 6 
months group.                    171 
Figure 6.3c. Analysis of the Area of synaptic contact between motor neurons and post-
synaptic receptors from mice sacrified at different ages: 6, 12, 15, 18, 21, 24 and 27 months. 
Histograms represent the mean and the standard error of the mean for each experimental 
group (n=4). * p<0.05 - ** p<0.01 compared with the 6 months group.              171 
Figure 6.3d. Analysis of the post-synaptic receptors area from mice sacrified at 
different ages: 6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and 
the standard error of the mean for each experimental group (n=4). * p<0.05 compared 
with the 6 months group.                    172 
Figure 6.3e. Analysis of the post-synaptic receptors diameter of acetylcholine 
receptors from mice sacrified at different ages: 6, 12, 15, 18, 21, 24 and 27 months. 
Histograms represent the mean and the standard error of the mean for each 
experimental group (n=4). * p<0.05 compared with the 6 months group.               172 
Figure 6.4a. Representative image of muscle innervation obtained from a 27 months 
old mouse. Axon branches (green), acetylcholine receptors (red) and NMJs (yellow) 
formed by the overlap between the pre-synaptic terminal and the acetylcholine 
receptors.                     173 
Figure 6.5. Representative image of a TA muscle (scale bar 100μm) stained for the four 
myosin heavy chain isoforms present in murine muscle: MyHC-I (Blue), MyHC-IIa (Red), 
MyHC-IIb (Green) and MyHC-IIx (Black). Histograms represent the mean percentage of 
fibres expressing one of the 4 myosin heavy chain isoforms in tibialis anterior muscle and 
the standard error of the mean for each experimental group: 6, 12, 15, 18, 21, 24 and 27 
months. * p<0.05 - ** p<0.01 compared with the 6 months group.              174 
Figure 6.6a. Agrin protein content of Tibialis Anterior muscle from mice sacrified at 
6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).               175 
Figure 6.6b. MuSK protein content of Tibialis Anterior muscle from mice sacrified at 
6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).               175 
XVIII 
 
Figure 6.7a. CuZnSOD protein content of Tibialis Anterior muscle from mice 
sacrified at 6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and 
the standard error of the mean for each experimental group (n=4).               176 
Figure 6.7b. MnSOD protein content of Tibialis Anterior muscle from mice sacrified 
at 6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).                176 
Figure 6.7c. GPx1 protein content of Tibialis Anterior muscle from mice sacrified at 
6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).               177 
Figure 6.7d. Catalase protein content of Tibialis Anterior muscle from mice sacrified 
at 6, 12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).               177 
Figure 6.8a. p62 protein content of  Tibialis Anterior muscle from mice sacrified at 6, 
12, 15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).                178 
Figure 6.8b. BAX/Bcl-2 ratio of Tibialis Anterior muscle from mice sacrified at 6, 12, 
15, 18, 21, 24 and 27 months. Histograms represent the mean and the standard error 






List of Tables 
Table 1.1. Classification of fibre types in skeletal muscles. Adapted from Powers and 
Howley, 1994.                                                                                                                  5  
Table 1.2. Overview of the main NADPH Oxidase isoforms, their expression in 
different tissues, cell localisation, functions and regulatory components. Table was 
adapted from Panday et al, 2014; Breitenbach et al, 2018.                                          19 
Table 2.1. Protocol recommended by Thermo Fisher for the preparation of a protein 
standard using a Bovine Serum Albumin stock with concentration 2mg/ml.               52      
Table 2.2. Recipes used for the preparation of the poly-acrylamide gels. The units 
presented in the table are millilitres (ml).         56 
Table 2.3. List of the antibodies used for SDS-PAGE western blot analysis.             60 
Table 2.4. List of the secondary antibodies used for SDS-PAGE western blotting 
analysis.                                                                                                                       61 
Table 2.5. Cocktail recipe based on the analysis of different number of samples.         65 
Table 2.6. List of primary antibodies used for the immunofluorescence staining.         71 
Table 2.7. List of secondary antibodies used for the immunofluorescence staining.  71 
Table 3.1. List of the main transcription factors regulated by ROS in developed 
skeletal muscle. Adapted from Espinosa-Diez et al, 2015.                                          83 
Table 5.1. List of significant peaks identified using NMR Metabolomics. In the table 
are reported the metabolite(s) identified for a specific bin, the bin number, the 
statistical F value, with the original and adjusted p value.        145-146 
Table 5.2. List of the pathways identified using MSEA in order from the most mapped 
to the least mapped. The table shows the pathways, the pathways size, the number of 
metabolites mapped together with the raw p value, the adjusted p value and the 





µg Micro grams 
µl Micro liters 
µM Micro moles 
ν Frequency (expressed in Hertz) 
1H Proton as referred to in NMR Metabolomics 
1D One dimensional 
2H2O Deuterated water 
4-HNE 4-hydroxynonenal  
AACOCF3 Arachidonyl trifluoromethyl ketone 
ACh Acetylcholine 
AChR Acetylcholine Receptors  
ADP Adenosine Diphosphate 
AGEs  Advanced Glycation End Products  
Akt Protein Kinase B 
AMP Adenosine Monophosphate  
Apaf-1 Apoptotic protease activating factor 1 
APS Ammonium Persulfate  
ATP Adenosine Triphosphate 
AU Arbitrary Unit 
BAX Bcl-2-associated X protein  
BCA Bicinchoninic Acid Assay 
Bcl-2 B-cell lymphoma 2  
BSU Biomedical Service Unit 
Ca2+ Calcium ions 
XXI 
 
CMA Chaperone-Mediated Autophagy  
CO2 Carbon Dioxide 
Complex-I NADH-coenzyme Q oxidoreductase  
Complex-II Succinate-Q oxidoreductase  
Complex-III Q-cytochrome c oxidoreductase  
Complex-IV Cytochrome c oxidase  
COX Cyclooxygenases 
cPLA2 Calcium-dependent phospholipase A2 
CSA Cross Sectional Area 
CuZnSOD Copper-zinc Superoxide Dismutase  
Cyto Cytosolic extract 
DAPI 4′,6-diamidino-2-phenylindole 
ddH2O Double distilled water 
DOK7 Downstream of tyrosine kinase 7 
Drp1 Dynamin-1-like protein  
DTNB Elleman’s solution or 5,5-dithio-bis-(2-nitrobenzoic acid)  
DUOX gp91phosphorylated homologues distinguishing DUAL Oxidase isoforms 
E Energy (expressed in Joules) 
ECL  Enhanced Chemiluminescence  
EcSOD Extracellular Superoxide dismutase 
EDL Extensor Digitorum Longus muscle 
EDTA Ethylenediaminetetraacetic acid  
EGTA Ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid 
EWGSOP European Working Group on Sarcopenia  
EPR Electron Paramagnetic Resonance 
XXII 
 
FAD Flavin adenine dinucleotide 
FADH2 Flavin Adenine Dinucleotide 
FCCP Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone  
FMN  Flavin mononucleotide 
FMNH2 Reduced Flavin mononucleotide 
g Grams 
GADPH Glyceraldehyde 3-phosphate dehydrogenase 
GC Gastrocnemius muscle 
gp91phox gp91 phosphorylated  
G Proteins Guanine nucleotide-binding proteins 
GPx Glutathione Peroxidase 
GSH  Reduced Glutathione 
GSSG Oxidised Glutathione 
GTP Guanosine Triphosphate  
h Planck’s constant 
H&E Haemotoxylin and Eosin staining  
H2O2  Hydrogen Peroxide 
Hepes buffer 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HO• Hydroxyl radical 
Hsp Heat Shock Proteins 
IMP Inosine-5’-Monophosphate  
iPLA2 Calcium-independent phospholipase A2 isoform 
IRS1 Insulin receptor substrate 1 
K2HPO4 Dipotassium hydrogen phosphate trihydrate 




Keap-1 Kelch-like ECH-associated protein 1 
K-MES MES Potassium salt  
LAMP-2A Lysosome-Associated Membrane Protein 2 
LC3 Microtubule-associated proteins 1A/1B light chain 3B 
LOX Lipoxygenases  
M Molar 
M.O.M Mouse On Mouse 
MAPK Mitogenactivated protein kinases  
MCAT Mouse strain overxepressing the catalase enzyme 
Mff Mitochondrial fission factor  
Mfn-2 Mitofusin 2 
mg Milligrams 
Mg2ATP Adenosine 5′-triphosphate magnesium salt 
MgCl2 Magnesium Chloride 
MgCl2·6H2O  Magnesium Chloride, Hexahydrate 
Mito Mitochondrial extract 
ml Millilitre 
MnSOD Manganese-dependent Superoxide Dismutase 
M.O.M Mouse On Mouse blocking 
MOPS 3-(N-Morpholino)propane sulfonic acid 
MSEA Metabolite Set Enrichment Analysis 
MuSK Muscle-Specific Kinase 
MyHC Myosin Heavy Chain isoform 
Na2HPO4 Disodium hydrogen phosphate trihydrate 
XXIV 
 
NAD+ Nicotinamide Adenine Dinucleotide oxidised 
NADH Nicotinamide Adenine Dinucleotide + Hydrogen - reduced 
NF-ĸB Nuclear factor kappa-light-chain-enhancer of activated B cells  
NMJ Neuromuscular junction 
NMJs Neuromuscular junctions 
NMR Nuclear Magnetic Resonance  
NO Nitric Oxide 
NOS Nitric Oxide Synthase 
NOX  gp91phosphorylated homologues  distinguishing NADPH Oxidase isoforms 
NOX1 NADPH Oxidase 1 
NOX2  NADPH Oxidase 2 
NOX4 NADPH Oxidase 4 
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells 
Nrf2 Nuclear factor erythroid 2-related factor 2 
O2•- Superoxide  anion 
O2  Oxygen 
OCT Optimal cutting temperature compound 
ONOO- Peroxynitrite 
OPA1 Optic Atrophy 1  
p22phox p22 phosphorylated  
p40phox p40 phosphorylated  
p47phox p47 phosphorylated  
p67phox p67 phosphorylated  
PBS Phosphate Buffer Saline 
pDRP1 Phosphorylated Dynamin-1-Like Protein 
XXV 
 
Pi Inorganic Phosphate 
ppm Parts Per Million 
Prx Peroxiredoxin 
Prx6 Peroxiredoxin 6 
PVDF Polyvinylidene difluoride 
QH2 Reduced Ubiquinone  
Qi Coenzyme Q oxidised 
Qo Centre of complex III 
Rac Ras-related C3 botulinum toxin substrate 
RLRs RIG-1-like receptors  
ROMO1 Reactive Oxygen Species Modulator 1 
ROS Reactive Oxygen Species 
rpm Round per Minute 
SDS Sodium dodecyl sulphate  
SO2H Sulfinic acid  
SO3H Sulfonic acid  
SOH Sulfenic acid  
SOL Soleus muscle 
sPLA2 Secretory phospholipase A2 isoform 
SSA  5-Sulfasalicylic  
TA Tibialis Anterior muscle 
TBS Tris Buffer Saline  
TBS-T20 Tris Buffer Saline - Tween 20  
TEA Triethanolamine  
Temed NNN’N’-tetramethylethylene-diamine  
XXVI 
 
TMRM Tetramethylrhodamine, methyl ester  
TSP Selectively deuterated TrimethylSilyl Propionate 
TNF-α Tumour necrosis factor alpha 
Trx Thioredoxin Reductase 
TrxR Thioredoxin 
Vi Initial volume 
XMP Xanthosine Monophosphate 
YFP Yellow Fluorescent Protein 
δ Chemical shift 






The past 3 years have been among the most exciting and demanding of my life so far. 
I sincerely express my gratitude to my supervisory team: Dr Aphrodite Vasilaki, Prof 
Malcolm Jackson and Dr Natalie Pollock. They were always there to support and motivate 
me doing everything they could to allow me to reach my full potential encouraging me to 
elaborate my own thoughts and interpret every result independently.  
A special mention goes also to all the other members of the group: Anne, Caroline, 
Clare, Jamie, Sam, Kay but in particular to Euan, Shah, Lorenzo and Wasu for having 
been such a help, support and distraction in the past 3 years. It is also impossible not 
to mention Dr Marie Phelan for having been so helpful and patient during the NMR 
metabolomics experiments and my advisors Dr Kasia Whysall and Professor John 
Wilding having been an important additional support and guidance. Furthermore, I would 
like to thank the Institute of Ageing and Chronic Disease and the U.S. National Institutes 
of Health for the financial support and The University of Liverpool and the Biomedical 
Service Unit for providing all the necessary support in order to complete this project.  
Outside my PhD, a special thank goes to Melissa who, since she became part of my 
life, always made me feel loved, appreciated and proud of who I am. Thank you also 
to my best friend Andrea who has always been there to support me although living in 
another country and to Stan and Natasha for welcoming in their family with open arms 
and for making me feel at home since the very beginning.  
And last (but not least) thank you to my family, in particular my parents and two 
brothers, whom by setting the right example and making a lot of sacrifices allowed me 














Dedicato a mamma e papá 














1.1 Skeletal muscle 
In mammals 3 major types of muscles can be identified: smooth, cardiac and skeletal.  
Smooth muscle is an involuntary, non-striated muscle found in many organs such as 
stomach, intestines, urinary bladder, uterus and that can also be found in arteries and 
veins. Cardiac muscle, as the name suggests, constitutes the main tissue of the heart 
walls. It is an involuntary, striated muscle, whose activity is regulated by special 
pacemaker cells. Skeletal muscle is a voluntary, striated muscle whose contraction is 
tightly regulated by the somatic nervous system. This very dynamic and plastic tissue 
accounts for 30-40% of total body mass (Janseen et al, 2000) and contains 50-75% of 
the proteins of our body (Frontera and Ochala, 2015).   
 The majority of skeletal muscle (75%) is composed of water, 20% proteins (which 
80% is represented by contractile, regulatory and cytoskeletal proteins), salts, minerals, 
carbohydrates and lipids that all together represent the remaining 5% (Frontera and 
Ochala, 2015). Skeletal muscle has multiple important functions including the conversion 
of chemical energy into mechanical energy in order to generate force and power 
necessary for posture maintenance and movement. In addition, skeletal muscle exerts 
important metabolic roles including: storage of amino acids and carbohydrates, 
production of heat and it is accountable for consumption of the majority of oxygen 
(O2) and fuel used during physical activity and exercise (Frontera and Ochala, 2015).   
Figure 1.1 demonstrates the multilevel structure of skeletal muscle which is composed 
of different tissues including: muscle tissue, nerves, blood vessels and connective 





Figure 1.1 . Schematic representation of the skeletal muscle composition. 
Image from Pearson Education, Inc.  
 
Muscle fibres are long multinucleated cells whose plasma membrane is known as the 
sarcolemma and is developed from the fusion of single nucleated cells known as 
myoblasts. Each muscle fibre is formed by around 1,000 small structures (1 to 2 µm 
in diameter) that represent the main contractile elements and are known as myofibrils.  
Myofibrils are composed mainly of two proteins called myosin and actin. Actin, 
together with troponin and tropomyosin, forms the thin filament which functions as 
anchorage for myosin. Myosin is formed of 6 polypeptides: 2 heavy chains and 4 light 
chains (2 regulatory and 2 alkali) with the heavy chain that contains the heads capable 
to interact with the actin binding site and possess an adenosine triphosphate (ATP) 
binding site responsible for hydrolysing ATP into ADP and Pi releasing the energy 
necessary for contraction (Lodish, 2000). Myosin is responsible for binding the anchorage 
site and pull the thick filament with it (Saladin and Kenneth, 2012). Following a stimulus 
capable of releasing calcium ions (Ca2+) from the endoplasmic reticulum, Ca2+ binds 
to troponin C exposing specific sites present on the actin filaments. At this stage, actin 
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and myosin are almost ready to interact but another step is necessary to initiate the 
contraction (Saladin and Kenneth, 2012). Actin and myosin can be found in two 
different structural states, strong and weak, coupled with ATP (Baumann et al, 2016). 
The link between ATP and myosin is a weak structural state and ATP hydrolysis is 
necessary to induce a change of the myosin structural status allowing cross bridging 
between actin and myosin. The ATP binding and hydrolysis cycle allows the 
interaction of actin and myosin that result in the sliding of the actin filaments toward 
the M-Line (Figure 1.2) (Baumann et al, 2016). 
 
 
Figure 1.2.  Schematic representation of a myofibril and its contractile 
components.  Image from https://courses.lumenlearning.com  
 
Four different Myosin Heavy Chains (MyHC) isoforms have been discovered in 
skeletal muscle: MyHC-I, MyHC-IIa, MyHC-IIb and MyHC-IIx. These isoforms have 
significant differences (in metabolism, characteristics and functioning) but they also 
share a lot of similarities. They all encode between 1935-1942 amino acids and have 
a molecular weight between 200-220 kDa (Sawano et al, 2016). In addition, these 
isoforms share a very high level of similarity in amino acid sequence; however, one of 
the main differences among these is that in the 19th position of the N-Terminus, 
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MyHC-I contains the amino acid leucine, MyHC-IIa methionine, MyHC-IIb valine 
and MyHC-IIx isoleucine (Sawano et al, 2016). 
Differences in muscle fibres contractile and metabolic properties are due to their 
Myosin Heavy Chain isoform composition (Harridge et al, 1996) and are presented in 
Table 1.1. 
 
Table 1.1 .  Classification of fibre types in skeletal muscles. Adapted from Powers and 
Howley, 1994.  
 
 
Skeletal muscle has a high plasticity and it is able to modify its fibre size and fibre 
composition according to need (Scott et al, 2001). In addition, some age-related 
structural and physiological “abnormalities” are commonly seen including variations 
in size, shape and organization of muscle fibres (Lexell and Taylor, 1991) that will be 
further discussed later in this chapter.  
1.2 The Neuromuscular System 
The neuromuscular system is composed of motor units and every motor unit comprises 
a motor neuron and all the muscle fibres innervated by it. The core system of every 
motor unit is the neuromuscular junction which represents one of the major subclass 
of synapses and that plays a central role in the network that connects the brain with the 
skeletal muscles (Jones et al, 2017).  
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1.2.1 Neuromuscular system anatomy and physiology 
The neuromuscular system is a complex network of different types of cells: motor 
neurons, Schwann cells, muscle fibres and kranocytes (Sugiura and Lin, 2011). The 
core structure of this system, the neuromuscular junction (NMJ), is a chemical synapse 
that connects a motor neuron and a muscle fibre (Rygiel et al, 2016). Due to the activity 
of docking protein downstream-of-tyrosine-kinase 7 (DOK7), NMJs show a 
characteristic “pretzel” conformation that is shared among mammals and allows the 
link of the axon terminal to the post-synaptic receptors (Hepple and Rice, 2016).  
The main role played by the NMJ is the conversion of the action potential from the 
nerve into muscle contraction (Tintignac et al, 2015). This task requires control, 
coordination and the signal must be transmitted quickly and reliably. To generate a 
contraction, a neurotransmitter, acetylcholine (ACh), is released by the presynaptic 
terminal of the motor neurons. Once released, ACh binds to nicotinic acetylcholine 
receptors present on the post-synaptic receptors on the muscle fibre surface. The link 
between ACh and nicotinic receptors generates an action potential that is distributed 
across the surface of the sarcolemma penetrating within the muscle fibre through the 
transverse tubules. This depolarization stimulates the voltage-sensitive dihydropyridine 
receptors present in the transverse tubules that in turn activate the ryanodine receptors 
(calcium channels composed of four monomers embedded in the sarcolemma membrane). 
The activation of ryanodine receptors leads to an increase in cytoplasmic levels of 
calcium initiating the contraction process described above (Baumann et al, 2016).  
Several proteins cooperate to maintain the stability of the NMJ, activating a cascade 
of signals that involves the entire neuromuscular system (Hepple and Rice, 2016). An 
important role in this signalling event is played by agrin, a large heparin sulphate 
proteoglycan generated in the cell bodies of motor neurons and transported alongside 
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the axons to the motor neuron terminal. Agrin is then released in the post-synaptic cleft 
and sequestered by the agrin receptors present on the myotube surface (McMahan, 
1990). Once incorporated in the muscle this large heparin sulphate proteoglycan of 
220kDa is able to link and activate an important muscle-specific tyrosine kinase known 
as Muscle-Specific Kinase (MuSK) (McMahan, 1990; Tsen et al, 1995). Once 
activated, MuSK interacts with DOK7 leading to clustering of the acetylcholine receptors 
in the classic pretzel configuration (Koneczny et al, 2014). 
1.3 Mitochondria 
Mitochondria are small structures of 1-2 micron in length and ~0.2-0.7 micron in 
diameter that play a primary role in most eukaryote systems. Mitochondria occupy 
approximately 25% of a normal eukaryote cell (Lodish et al, 2004) and approximately 
10-15% of the total muscle volume (Eisenberg, 1983). These structures were firstly 
observed in 1890 by Richard Altmann who named them “bioblasts”. Subsequently, 
Carl Brenda renamed them “mitochondria” but it was only in 1954 that the important 
role played by mitochondria was recognized by Philip Siekevitz who defined these 
structures as “the powerhouse of the cell” (McBride et al, 2006). Since 1954, mitochondria 
have been well known for their primary role in energy production generating ATP utilizing 
nutrient substrates and O2 (Porter and Wall, 2012). Nevertheless, this is not the only role 
played by these structures as they also play a role in cellular signalling, cell growth, 
differentiation and death (McBride et al, 2006). 
Mitochondria are formed by an inner and an outer membrane of phospholipids and 
proteins with different characteristics and functions. These membranes create 4 
different compartments:  
 Outer mitochondrial membrane; 
 Intermembrane space (the space between the outer and inner membranes); 
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 Inner mitochondrial membrane (in which the complexes of the ETC and ATP 
synthase are found); 
 Matrix (space within the inner membrane) (Alberts et al, 2002; McBride et al, 
2006). 
Cells are able to produce ATP through different pathways such as: glycolysis, citric 
acid cycle/oxidative phosphorylation (the combination is known as cellular respiration) 
and β-oxidation (Alberts et al, 2002). 
Glycolysis, a ten enzyme-catalysed reaction, is an oxygen-independent pathway that 
occurs in the cytosol and that yields pyruvate as its main product (Voet et al, 2006). 
Once pyruvate molecules are generated by glycolysis, these are actively transported 
into the mitochondrial matrix where they are oxidised and combined with coenzyme 
A producing CO2, acetyl-CoA, and Nicotinamide Adenine Dinucleotide + Hydrogen 
(NADH) (Voet et al, 2006). 
Once Acetyl-CoA is formed within the mitochondria, the second step of cellular 
respiration begins. The citric acid cycle, also known as the Krebs cycle, is a series of 
chemical reactions that requires 8 enzymes involved in the conversion of Acetyl-CoA in 
2 molecules of water and carbon dioxide and the production of guanosine triphosphate, 3 
NADH molecules, 1 FADH2 and 1 ATP (Wagner, 2014).  
The third stage of cellular respiration is known as oxidative phosphorylation, a metabolic 
pathway where several enzymes are used to oxidise nutrients releasing energy that is 
then used to generate ATP. To release the energy necessary to generate ATP, a series of 
redox reactions take place where electrons are transferred from donors to acceptors. In 
eukaryotic cells, this series of reactions takes place within the mitochondria and is 
carried out by a set of proteins that together form the Electron Transport Chain (ETC). 
Four main protein complexes are involved in this process and the energy generated is 
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used to transport protons through the mitochondrial membrane. The potential energy 
produced in the form of pH gradient and electrical potential across the membrane 
induces a rotational movement of a part of the ATP synthase enzyme which converts 
the adenosine diphosphate (ADP) into ATP.  
The 4 protein complexes are (Figure 1.3):   
 NADH-coenzyme Q oxidoreductase (complex I); 
 Succinate-Q oxidoreductase (complex II);  
 Q-cytochrome c oxidoreductase (complex III);  
 Cytochrome c oxidase (complex IV) (Guo et al, 2018). 
Following all the reactions of the ETC, for each NADH molecule that enters the 
transport chain, a total of 10 protons are pumped into the mitochondrial inter-
membrane space:  
 Complex I pumps 4 protons;  
 Complex II reduces 2 protons but none of them is pumped outside the matrix; 
 Complex III pumps 4 protons (two of them obtained from complex II);  
 Complex IV pumps 2 protons (Guo et al, 2018).  
The pumping of protons across the mitochondrial matrix into the intermembrane space 
generates an accumulation of positive charge in the intermembrane space and an 
accumulation of negative charges within the matrix (Li et al, 2013). This charge 
misbalance between the matrix and the inner membrane generates a mitochondrial 
membrane potential (Δψm) necessary to activate the final step of oxidative phosphorylation 
(Li et al, 2013).   
The final step of cellular respiration is carried out by ATP synthase, a protein complex 
composed of sixteen subunits (Rubinstein et al, 2003). The increased mitochondrial 
membrane potential induces a flux of protons through the channel at the base of ATP 
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synthase activating this complex inducing conformational changes and generating the 
energy necessary to couple ADP with inorganic phosphate (Pi) forming ATP. Three 
to four protons are required to synthesise one ATP molecule; this ratio can vary 




Figure 1.3.  Graphical representation of the ETC and its reactions resul ting in the 
production of ATP and Reactive Oxygen Species . Image adapted from Zhao et al,  
2019. 
 
The process described above involving glycolysis, citric acid cycle and oxidative 
phosphorylation is able to form 38 molecules of ATP (2 from glycolysis, 2 from citric 
acid cycle and 34 from ETC) from a single molecule of glucose (Bonora et al, 2012). 
Although mitochondria play fundamental roles within the cell, they are also major 
contributors to intracellular oxidant production (Holmstron and Finkel, 2010). 
Mitochondrial oxidants, also known as mitochondrial reactive oxygen species, are 
mainly generated during oxidative phosphorylation. 
1.4 Reactive Oxygen Species 
Reactive Oxygen Species (ROS) is a general term used to refer to reactive molecules 
generated as by-product of normal aerobic metabolism and are commonly produced in 
the mitochondrion (Rahal et al, 2014). Nevertheless, ROS can also be formed during 
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reactions involving cytochrome P-450 enzymes, peroxisomal oxidase, NADPH Oxidase 
and xanthine oxidase (Rahal et al, 2014).  
In the mitochondrion the leakage of electrons from complex I and III induces a one-
electron reductions of an O2 molecule generating superoxide anion (Sakellariou et al, 
2014a; Rahal et al, 2014). Recent data indicate that a maximum of approximately 
0.15% of the total electron flow in the mitochondria gives origin to ROS (Jackson et 
al, 2016a). Among the complexes of the ETC, complex I and complex III are mainly 
involved in the production and release of superoxide (Figure 1.3) with complex I being 
the main producer of superoxide both in vivo and in vitro (Sakellariou et al, 2014a). 
Two mechanisms are involved in the superoxide production within complex I:  
 NADH-FMN interaction and NADH/NAD+ ratio 
Complex I can produce superoxide through the reaction of O2 with reduced 
Flavin mononucleotide produced during the process that transfer electrons 
from NADH to ubiquinone. The reduced state of Flavin mononucleotide is 
determined by the NADH/NAD+ ratio which increase can be induced by 
several factors such as mitochondrial damages, ischemia, low ATP request or 
various mutations. The increase of NADH/NAD+ ratio has been linked with 
increased superoxide production by complex I in the ETC (Kussmaul and Hirst, 
2006; Murphy, 2009).  
 Reverse electron transport 
It is also possible that along the ETC, electrons are driven backwards from 
reduced coenzyme Q (CoQH2) into complex I with subsequent reduction of 
NAD+ into NADH. This pathway occurs when the electrons supply is elevated 
and there is a reduction in the concentration of coenzyme Q available. 
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Although the role played by complex III in superoxide production during normal 
conditions is small compared to complex I, it is important to not underestimate the role 
of this complex in the production of ROS (Murphy, 2009). Complex III ROS production 
can be triggered by two events:  
 Increased supplementation of reduced coenzyme Q;  
 Inhibition of oxidised coenzyme Q (Qi - one of the two centres of the complex 
III) by antimycin (a secondary metabolite produced by Streptomyces bacteria) 
enhancing the reaction between O2 with an ubisemiquinone bound to the other 
centre of the complex III (Qo) (Neft and Farley, 1972; Cadenas et al, 1977; 
Bleier and Drose, 2013). 
Another important factor associated with mitochondrial ROS production and release 
is the O2 concentration. The increase of O2 flux within mitochondria is associated with 
increased mitochondrial ROS production (Stowe and Camara, 2009). Paradoxically, 
this increase is registered also during hypoxia where the complex III ROS production 
is increased (Bell et al, 2007). The theories proposed to explain this increased 
mitochondrial ROS production in both hyperoxia and hypoxia still remain controversial. 
A state of hyperoxia could induce an increase of mitochondrial ROS production given 
the increased O2
 concentration within the mitochondria with more chances of interaction 
of an electron and an O2
 molecule. On the other hand, the increase of mitochondrial ROS 
production during hypoxia is still not fully understood. Nevertheless, as proposed by 
Aon and colleagues (2010), a hypoxic state seems to increase mitochondrial membrane 
potential explaining the increase in ROS production. 
ROS can be divided into free radicals (atom/molecules presenting one or more unpaired 
electrons such as superoxide) or non-radical derivate of O2 (such as hydrogen peroxide) 
(Powers et al, 2011). Both free radical and non-radical ROS have the ability to interact 
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with other molecules altering their structure and inducing damage to nucleic acids, 
proteins and lipids (Duan and Kasper, 2011). The uncontrolled accumulation of ROS, 
a condition known as “oxidative stress” has been associated with carcinogenesis, 
neurodegeneration, atherosclerosis, diabetes and ageing (Ray et al, 2012). Nevertheless, 
several studies have also highlighted the capacity of the cells to restrict and control 
ROS utilising these molecules for the activation of important signalling pathways (Li 
et al, 2013).  
ROS production in skeletal muscle holds a particular relevance as during contraction 
a high ROS flow has been reported (Barbieri and Sestili, 2012). Furthermore, in 
muscles, ROS may trigger different signalling pathways able to induce different 
responses from adaptation to cell death (Barbieri and Sestili, 2012). 
1.5 Reactive Oxygen Species production in skeletal muscle 
Different ROS can be found in skeletal muscle including the free radical superoxide 
and the non-radical hydrogen peroxide (H2O2) (Powers and Jackson, 2008). As shown 
in Figure 1.4, within the skeletal muscle different enzymes and metabolic processes 
can induce the production of ROS (Powers and Jackson, 2008).  
1.5.1 Superoxide anion 
Superoxide is the product of the incomplete reduction of an O2 molecule by a single 
electron that results in the formation of a reactive molecule with a relatively long half-
life and limited radical character (Sakellariou et al, 2014a). Given the negative charge, 
superoxide cannot easily diffuse across the cell membranes (it can only do this by 
exploiting voltage-dependent anion channels), therefore the production site of superoxide 
is of major relevance (Han et al, 2003). Increasing evidence suggests that superoxide 
produced by complex I is released into the matrix while superoxide produced by 
complex III is released both in the matrix and in the intermembrane space (Szeto, 
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2008). In addition, in skeletal muscles, superoxide can be generated also by NADPH 
oxidase (present in the mitochondrion, sarcoplasmic reticulum and transverse tubules) 
and by xanthine oxidase in the endothelium (Powers et al, 2011). As mentioned 
previously, superoxide possess a limited radical character as it does not directly react 
with polypeptides, sugars, or nucleic acids but can be quickly converted onto secondary 
ROS such as H2O2 or peroxynitrite. It has been calculated that in aqueous solution, 
superoxide is dismutated to H2O2 at a rate of approximately 2 x 10
9 M-1s-1 (Beckman 
and Koppenol, 1996) mainly by the activity of two enzymes: Copper-zinc superoxide 













Figure 1.4.  Schematic representation of ROS production in eukaryotic 
cells. Superoxide (O2· -) mainly generated in mitochondria during the 
electron transport chain is quickly converted into  a more stable 
compound known as Hydrogen peroxide (H2O2) by enzymes belonging to 
the superoxide dismutase family (MnSOD and CuZnSOD) . Alternatively, 
superoxide can also be converted into peroxyn itrite (ONOO -) following 
the interaction with nitric oxide (NO) a reactive nitrogen species 
generated by the activity of the Nitric Oxide Synthase (NOS) family .  
Generation of ONOO - is harmful for the cell since this free radical can 
damage a wide array of molecules including DNA and proteins . Image 




1.5.2 Hydrogen peroxide 
Hydrogen peroxide is a non-radical ROS mainly generated through the dismutation of 
superoxide by the superoxide dismutase enzymes (Fukai and Fukai, 2011). As explained 
by Go and colleagues (2015), H2O2 can also be generated as a consequence of several 
one- or two-electron reduction reactions by 31 different enzymes. Among these 31 
enzymes, a primary role in skeletal muscle is played by NADPH Oxidase, Phospholipase 
A2, Monoamine Oxidase A and Monoamine oxidase B (Sies, 2017, Go et al, 2015). 
H2O2 is involved in a large series of signalling pathways such as cell shape changes, 
inflammatory response, immune cell proliferation and recruitment. Together with 
calcium ions and ATP, H2O2 is recognised as one of the main transcription-independent 
signalling molecule within the cell (Sies, 2017; Flohe et al, 2011). Hydrogen peroxide’s 
main role in redox regulation is played through thiol peroxidases and the involvement 
of the reversible oxidation of cysteine residues and the formation of disulphide bonds 
(Sies, 2017; Flohe et al, 2011). Once generated, H2O2 is quite stable with a long half-
life (1ms) compared to superoxide (1μs) (Bienert et al, 2006) and in skeletal muscle, 
during resting conditions, its levels have been estimated to be around 10-100 nM 
(Jackson et al, 2016a). Furthermore, H2O2 can also move through the different muscle 
cell compartments exploiting specific aquaporin channels, also identified as peroxiporins 
for their specificity for H2O2 (Bienert et al, 2006; Sies, 2017).   
H2O2 is rapidly produced within the cell but despite its weak reactivity its accumulation 
can by cytotoxic (Lennicke et al, 2015). Therefore, within the cell, antioxidant enzymes 
such as glutathione peroxidase, catalase and peroxiredoxins are present and capable of 
catalysing the reduction of H2O2 (Lubos et al, 2011). 
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1.5.3 Hydroxyl radical 
Hydroxyl radical (HO•) is a highly reactive and short-lived molecule generated by the 
reaction of H2O2 and active copper or iron atoms (Vatansever et al, 2013). The generation 
of H2O2 in close proximity of these metals creates the conditions for the initiation of a 
Fenton reaction that leads to the production of hydroxyl radical (Halliwell, 1989). 
Hydroxyl radical plays a role in DNA damage. Indeed, this molecule is a strong 
mutagen that targets DNA, in particular the 5-methyl group on the thymine base 
forming a 5-formyluracil base that can induce pyrimidine transitions like G:C to A:T 
(and vice versa) seriously affecting DNA replication (Tsunoda et al, 2010). Furthermore, 
hydroxyl radical compared to other ROS such as H2O2 is more prone to inactivate most 
of mitochondrial enzyme proteins seriously affecting mitochondrial survival (Zhang et 
al, 1990).   
1.5.4 Alternative sources of H2O2 
1.5.4.1 Monoamine Oxidase 
Monoamine Oxidases is a family of enzymes that in mammals is composed by 2 
isoforms: Monoamine Oxidase A and Monoamine Oxidase B. The two Flavin isoforms 
found in mammals share approximately 70% of sequence homology and present some 
overlap in functions despite using different substrates and being inhibited by different 
inhibitors (Duicu et al, 2016). During normal physiological conditions Monoamine 
Oxidase A shows a particular preference for serotonin and norepinephrine while 
Monoamine Oxidase B appears to be more active in processing phenethylamine. In 
addition both isoforms oxidise (at a similar rate) tyramine and dopamine (Edmondson, 
2014). These enzymes are present in the mitochondrial outer membrane and their 
primary functions are the regulation of neurotransmitter levels and the degradation of 
amines produced from important neurotransmitters such as serotonin, dopamine and 
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norepinephrine that could function as false neurotransmitters (Edmondson, 2014; 
Duicu et al, 2016). Both Monoamine Oxidase A and B play an important role in H2O2 
production being capable of producing a large amount of this ROS, increasing its 
steady state concentration both in the mitochondrial matrix and the cytosol through the 
following reaction (Cadenas and Davies, 2000; Duicu et al, 2016): 
 
R- CH2-NH2 + O2 + H2O → R-CHO + NH3 + H2O2 
 
1.5.4.2 Phospholipase A2 
The phospholipase A2 family of enzymes is involved in the hydrolysis of sn-2 fatty 
acyl chains of phospholipids generating fatty acid such as arachidonic acid 
(Sakellariou et al, 2014a). This family of enzymes is found in mammalian tissues, in 
arachnid, insects and snake venom (Nicolas et al, 1997). Arachidonic acid is an important 
substrate for cyclooxygenases (COX) and lipoxygenases (LOX) both involved in the 
generation of ROS playing a role in different physiological processes such as 
inflammation, apoptosis or cell injury (Sun et al, 2010). 
Three different major isoforms of PLA2 have been identified:  
 The secretory PLA2 located prevalently in the sarcolemma and mitochondria;  
 The calcium-dependent PLA2 (cPLA2) mainly found in the cytosol but with 
the capacity to translocate within the mitochondria during stress conditions; 
 The calcium-independent PLA2 (iPLA2) found in mitochondria even during 
non-stress conditions (Sun et al, 2010). 
Particularly involved in the production of arachidonic acid is the cPLA2 isoform that 
plays a role in the modulation of several processes (Sun et al, 2010). It also plays an 
important physiological role during skeletal muscle contraction influencing contracting 
properties and fatigue characteristics of the muscle (Sakellariou et al, 2014a). Calcium-
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dependent PLA2 activity is influenced by different factors such as the intracellular 
levels of calcium, the phosphorylation state and the exposure to ROS such as H2O2 
(Sakellariou et al, 2014a). For instance, an increase of calcium flux induces the 
activation and movement of cPLA2 to the endoplasmic reticulum and perinuclear 
membrane allowing it to release arachidonic acid using the membrane phospholipids 
as substrate (Sun et al, 2010). 
Arachidonic acid produced by cPLA2 is involved in enhancing ETC ROS production 
(Sakellariou et al, 2014a) and an increase in cPLA2 expression and content is 
indicative of an increased production of fatty acid hydroperoxides concentration in 
skeletal muscle (Abruzzo et al, 2010). Additionally, arachidonic acid produced by 
cPLA2 can be used by Mitogen-activated protein kinase (MAPK) as substrate to induce the 
phosphorylation and translocation of p40 phosphorylated, p47 phosphorylated and p67 
phosphorylated to the membrane, allowing the assembling of NADPH Oxidase 2 
(Zhao et al, 2002).  
1.5.4.3 NADPH Oxidase 
NADPH Oxidase is a family of multi-subunit enzymes mainly localized on the cell 
membrane (Sun et al, 2010). NADPH Oxidase, which was firstly described in 
phagocytes, plays an important role in the immune system being responsible of the 
initiation of the respiratory burst (Nguyen et al, 2017), a very quick release of ROS 
from different cells (in particular from immune system cells following exposure to 
infections) (Inoguchi et al, 2003).  
As shown in table 1.2, NADPH Oxidase isoforms are expressed in different tissues 
where they play several different functions. 
In skeletal muscle 2 main NADPH Oxidases are expressed (Figure 1.5):  




 NADPH Oxidase 4 (NOX4) expressed in the sarcolemma, sarcoplasmic reticulum, 
transverse tubules but also in the inner mitochondrial membrane (Ferreira and 
Laitano, 2016; Loureiro et al, 2016).  
 
Table 1.2.  Overview of the main NADPH Oxidase isoforms, their expression in 
different tissues, cell localisation, functions and regulatory components. Table was 
adapted from Panday et al, 2014; Breitenbach  et al, 2018. 
 
 
NOX4 is associated with the regulatory subunit p22 and its activity is normally 
regulated by its own level of expression (Loureiro et al, 2016). In contrast, NOX2 
needs specific agonists for its activation (e.g. cytokines, growth factors or mechanical 
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stress) able to induce the association of all the regulatory subunits that compose this 
enzyme (Konior et al, 2014). 
 
 
Figure 1.5.  Schematic representation of NOX2 and NOX4 localisation and ROS 
release sites in skeletal muscle. Image adapted from Ferreira and Laitano , 2016. 
 
NOX2 is composed of different proteins whose content, location and function are 
required for the correct functioning of this enzyme. The NOX2 components shown in 
Figure 1.6 are: 
 gp91 phosphorylated (gp91phox) - several homologues of gp91phox have been 
identified (NOX 1-5, DUOX 1-2); 
 p22 phosphorylated (p22phox); 
 p40 phosphorylated (p40phox); 
 p47 phosphorylated (p47phox); 
 p67 phosphorylated (p67phox). 
The large glycosylated protein gp91phox and the smaller adapter protein p22phox 
compose the membrane-bound part of this protein (Panday et al, 2015). p22phox contains 
a SRC Homology 3 Domain site which is fundamental for the link of the triumvirate of 
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soluble oxidase component p40phox, p47phox and p67phox linked together by the 






Figure 1.6.  Schematic representation of the NOX2  (A) and NOX4 (B) structures and 
subunits. Image adapted from Ferreira and Laitano, 2016.  
 
p40phox plays an important role in the recruitment of p47phox and p67phox and it 
appears to have an important regulatory effect on this complex assembly (Holmstron 
and Finkel, 2010). The phosphorylation of p47 results in protein shape modification, 
translocation to the membrane and binding to p22phox (Holmstron and Finkel, 2010). 
The phosphorylation of p67 is another important step in the correct functioning of 
NOX2. Indeed, p67phox is involved in the transfer of electrons from NADPH to FAD. 
Lastly, a small protein called Ras-related C3 botulinum toxin substrate (Rac) is 
necessary for activation of this complex (Holmstron and Finkel, 2010). This protein 
switches between inactive (when it is bound to Guanosine Diphosphate) and active 
forms (when it binds Guanosine Triphosphate) (Holmstron and Finkel, 2010). Once 
Rac is activated and linked with p67phox, the electron flow from NADPH to FAD 
begins resulting in the formation of superoxide and the release of NADH-dissociated 
protons that become available to interact with superoxide and generate H2O2 (Nisimoto 
et al, 2014).  
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NOX2 activation results in a significant increase of H2O2 that can have important 
physiological implications, playing an important role in signalling (Sun et al, 2010).  
For instance, H2O2 generated by NOX2 appears to play an important role during 
contraction (Ward et al, 2014) alongside a lot of other fundamental functions such as 
insulin resistance or activation of atrophy pathways (Ferreira and Laitano 2016). 
NOX4 is an O2 sensor able to regulate the KCNK3/TASK-1 potassium channel and 
the activity of Hypoxia Inducible Factor 1 Alpha (Lee et al, 2006). In addition, recent 
evidences suggests that NOX4 may also play a role in angiotensin II-induced muscle 
wasting regulating the activity of Nuclear factor erythroid 2-related factor 2 (Nrf2) 
protein (Kadoguchi et al, 2018).  
1.5.5 Redox homeostasis and oxidative stress 
Redox homeostasis is: “the capacity of the cells to continuously deal with challenges 
that generate electrophiles. Challenges brought by different stressors are the result of 
metabolic or environmentally non-injurious temporary movement toward the edge of 
the normal physiological range. Maintenance of redox homeostasis is achieved 
through feedback mechanisms operating at different level of complexity such as relief 
of the inhibition of an enzyme or transcriptional up-regulation” (Ursini et al, 2016). 
In simpler terms, redox homeostasis can be described as a balance between ROS 
production and the ability of the body to detoxify these reactive compounds. Both an 
increase in ROS production and an alteration in the functionality of the detoxifying 
systems can lead to an alteration of redox homeostasis and to an increased accumulation 
of ROS-related damage (Gaschler and Stockwell, 2017). The accumulation of ROS and 
ROS-related damage result in a condition known as “oxidative stress”, a potential 
trigger of ageing and other different pathologies such as diabetes (Paravicini and 
Touyz, 2006), neurodegeneration (Andersen, 2004; Shukla et al, 2011) and is also able 
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to promote tumour metastasis through the direct interaction with specific genes 
(Ishikawa et al, 2008; Trachootham et al, 2009). Oxidative stress can be defined as a 
physiological chronic misbalance between pro-oxidant/antioxidant concentrations that 
leads to alterations of homeostasis and accumulation of high levels of ROS (Uttara et 
al, 2009).  
The accumulation of ROS that has been registered during ageing has been reported to 
trigger an increase of proteolysis that can explain the correlation between oxidative 
stress and sarcopenia (Baumann et al, 2016). The mechanisms that connect the 
accumulation of ROS during ageing and muscle wasting are still not completely clear. 
As suggested by Powers and colleagues (2011), the mechanism behind ROS-related 
muscle wasting can be compared to the one observed during prolonged periods of 
physical inactivity. Indeed, during ageing as well as during immobilisation, ROS 
accumulation stimulate protein breakdown enhancing the activity of protease systems 
such as ubiquitin-proteasome, caspase or calpains (Baumann et al, 2016).  
Recent evidence suggests that ROS might play a crucial role also in regulating lifespan. 
To understand this, it is necessary to introduce a concept that dates back to the end of 
XIX century and that was proposed by the German pharmacologist Hugo Schulz. The 
concept of “hormesis” suggests that a little stress at cell level is able to protect the cells 
from a larger stress (Mattson and Calabrese, 2010). Bearing this in mind, the mitochondrial 
release of oxidants can trigger the activation of a series of protective pathways able to 
extend the lifespan of the cells reinforcing the idea that ROS, under certain circumstances, 
might play a beneficial role in the organism (Holmstrom and Finkel, 2014).  
1.5.6 Redox signalling 
For many years ROS production was seen as an unregulated process where the target 
of these molecules were completely random. Through the years, several studies have 
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revealed that some oxidant species (in particular H2O2) might play an important 
signalling role (Holmstrom and Finkel, 2014).  
The reduction-oxidation signalling mechanism (also known as redox-dependent signalling 
mechanism) it is a highly conserved mechanism that triggers different responses (including 
increased expression of repair and protective enzymes) following changes in redox of 
homeostasis (Holmstrom and Finkel, 2014). This process mainly alters structures 
through the interaction with different amino acids, in particular the amino acid cysteine 
(Ray et al, 2012). Cysteine is a semi-essential amino acid with formula C3H7NO2S, it 
is one of the least abundant and one of the most conserved amino acids in nature 
(Poole, 2015). This amino acid contains a low pKa sulfhydryl group (-SH) in his side 
chain that is very susceptible to oxidation and is able to form a disulphide bonds with 
another sulfhydryl group making it the main target of oxidants (Janssen-Heininger et 
al, 2008; Miki and Funato, 2012). Its characteristics and the tendency to be clustered 
make this amino acid the perfect mediator of ROS-induced post-translations 
modifications (Poole, 2015; Wood et al, 2016). However, other amino acids such as 
methionine, tryptophan, and tyrosine can also be targeted by ROS (Janssen-Heininger 
et al, 2008). The pKa of an amino acid is fundamental for its susceptibility to oxidation 
and depends on the charge of the neighbouring amino acid. Therefore, the 3-
dimensional arrangement of a protein is fundamental for determining ROS-derived 
modifications (Janssen-Heininger et al, 2008).  
Once oxidised, an amino acid can experience a series of different modifications some 
of which are reversible such as: S-nitrosylation, S-glutathionylation, S-sulfhydration, 
formation of sulfenic acid and of inter-/intra-molecular disulphide bonds (Murray and 
Van Eyk, 2012). In addition, amino acids targeted by ROS can also undergo irreversible 
modifications such as the formation of sulfinic or sulfonic acids (Murray and Van Eyk, 
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2012). Sulfenic acid (-SOH) is a short-lived species that can form disulphide bonds with 
nearby cysteines. When sulfenic acid oxidises further, it can form sulfinic acid (-SO2H) 
or sulfonic acid (-SO3H) (Nagy and Winterbourn, 2010). Both sulfinic and sulfonic 
acid are less reactive than sulfenic acid and therefore their capacity to form disulphide 
bonds is much lower (Nagy and Winterbourn, 2010). The formation of disulphide 
bonds induced by ROS is a fundamental step in redox signalling as it is able to alter 
the protein structure producing stable dimers, polymers, or complexes with the 
potential to induce different functional outcomes in the targeted proteins (Janssen-
Heininger et al, 2008; Trivedi et al, 2009).  
ROS can induce several other modifications at protein level such as carbonylation and 
glycation that are currently used as markers of oxidative change. Carbonylation is the 
most common type of alteration during oxidative stress and during this process carbonyl 
groups are introduced into proteins by a metal-catalysed oxidation of specific amino 
acids or indirectly by the reaction with species derived from lipid peroxidation (Lyons 
et al, 1997). Another marker of oxidative stress generally used is 4-hydroxynonenal (4-
HNE), one of the aldehydic products of lipid peroxidation that is a key mediator of 
oxidative stress-induced cell death (Lyons et al, 1997). Furthermore, the addition of a 
sugar molecule to a protein (known as glycation) results in the formation of Advanced 
Glycation End Products (AGEs). The levels of AGEs significantly increase during 
exposure to ROS and, therefore, it has been used as a marker of oxidative stress (Lyons 
et al, 1997).  
1.6 Adaptive responses in skeletal muscle 
As already mentioned, antioxidants are the primary mechanism of defence against 
ROS stress. These molecules are involved in the termination of radical propagation 
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donating electrons to ROS without becoming a radical themselves (Gaschler et al, 
2017).  
The accumulation of ROS induces changes in the redox-status of the cell triggering a 
series of post-translational signals that allow the cell to develop an appropriate cellular 
response. Important transcription factors activated by changes of the muscle redox-
status are nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and 
Nuclear factor erythroid 2-related factor 2 (Nrf2) (Kurutas et al, 2014).  
NF-κB is a dimeric transcription factor composed of p50 and p65 subunits mainly 
located in the cytoplasm of the cell where it is associated with a transcriptional 
repressor IκB (Sadi and Sadi, 2010). Activating factors such as cytokines, radiation 
and exposure to oxidative stress induce activation of the IκB kinase (IKK) complex 
inducing phosphorylation and subsequent degradation of IκBs (Wan and Lenardo, 
2010). The now liberated NF-κB is free to translocate to the nucleus where binding to 
regulatory DNA sequences known as κB sites is able to regulate gene expression. 
Similarly to NF-κB, during normal conditions, Nrf2 is located in the cytosol where it 
is associated with Kelch-like ECH-associated protein 1 (Keap1), a cytoskeletal protein 
responsible for the ubiquitination and proteolysis of Nrf2. Keap1 is rich in cysteine 
residues making it a very sensitive detector of redox-balance changes. Once oxidised 
Keap1 goes through some conformational changes that result in Nrf2 accumulation 
and translocation to the nucleus (Sadi and Sadi, 2010). Once in the nucleus, Nrf2 plays 
an important role as master regulator of cytoprotective genes through the coordination 
of antioxidant response elements, cis-regulatory elements able to regulate genes 
transcription following alteration of the redox balance of the cell (Raghunath et al, 
2018; Kasai et al, 2020). 
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Previous studies have shown that in skeletal muscle, in response to changes of redox 
homeostasis, the contents of several antioxidants enzymes are increased including: 
superoxide dismutase, catalase, thioredoxins, glutathione peroxidase and Peroxiredoxins 
(Kurutas et al, 2014).  
1.6.1 Superoxide Dismutase 
Superoxide dismutase (SOD) is a family of metalloenzymes that plays a fundamental 
role within the cell generating H2O2 through the dismutation of superoxide according 
the following reaction: 
2O2
•- + 2H+ → H2O2+O2 
In skeletal muscle, three different isoform of superoxide dismutase have been 
identified:  
 Copper-zinc SOD (CuZnSOD) a homodimer primarily located in the cytosol 
(but a small portion is also found in the mitochondrial intermembrane space 
and in the nucleus) with a molecular weight of 32 kDa (Fukai and Fukai, 2011).  
 Manganese SOD (MnSOD) a homotetramer with a molecular weight of 88 kDa 
that is expressed in the mitochondria (Fukai and Fukai, 2011; Becuwe et al, 
2015).  
 Extracellular SOD (EcSOD) a homotetramer located outside the muscle cell 
with a molecular weight of 135 kDa (Fukai and Fukai, 2011). 
In skeletal muscle the majority of SOD is located in the cytosol (65-85%) while the 
remaining 15-35% is found in the mitochondria (Powers et al, 2011).  
1.6.2 Catalase  
Catalase is a highly efficient tetramer of four polypeptide chains containing heme and 
is ubiquitously expressed in different compartments of the muscle cell (Powers et al, 
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2011). Catalase is involved in the reduction of 2 H2O2 molecules into water and O2 
following a two-step reaction (Heck et al, 2010): 
 
2 H2O2 → 2 H2O + O2 
 
Once the catalase active site interacts with H2O2, it induces proton transfer between 
the O2 atom of H2O2 and the amino acids asparagine 148 and histidine 75. At this stage 
a H2O molecule and Fe
(IV)=O are released and the iron can interact with the second 
molecule of H2O2 to form Fe
(III), H2O and O2 (Zamocky et al, 2008). Catalase has been 
reported to have a lower affinity for H2O2 at low concentrations compared to glutathione 
peroxidase. Its steady concentration in muscle cells is relatively low but it is 
significantly increased in response to a rise in H2O2 levels (Lubos et al, 2018).  
1.6.3 Glutathione Peroxidase 
The Glutathione Peroxidase (GPx) family is a selenium-containing enzyme family 
composed of five different isoforms expressed in mammalian cells (GPx 1-5) (Lubos 
et al, 2011). These five isoforms differ in localization and substrate specificity. GPx1 
and GPx4 are mainly expressed in the mitochondria, GPx3 is mainly found in the 
extracellular space, GPx2 in the gastrointestinal system and GPx5 is mainly expressed 
in the male reproductive tract (Jiao et al, 2017).  
GPx is responsible for the reduction of H2O2 with the assistance of reduced glutathione 
(GSH - a tripeptide with glutamate, cysteine and glycine residues) used as electron donor 
(Li et al, 2003): 
2GSH + H2O2 → GSSG + 2H2O 
 
The inactivation of H2O2 by GPx causes oxidation of reduced glutathione generating 
oxidised glutathione (GSSG) which is then recycled back to GSH by Glutathione 
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Reductase that uses NADPH as substrate for this reaction. The bioavailability of 
NADPH guarantees the correct maintenance of reduced glutathione and the correct 
functionality of this antioxidant system (Li et al, 2003).  
Compared to Catalase, GPx shows a great affinity for H2O2 when the levels of this 
ROS are low (Lubos et al, 2018). 
1.6.4 Peroxiredoxins  
Peroxiredoxins (Prxs), also known as thiol-specific antioxidants, are a family of 
cysteine- dependent enzymes involved in the reduction of H2O2 using electrons from 
the thioredoxin enzymes (Rhee et al, 2005). In skeletal muscle, six different isoforms 
are found distributed in different compartments (Rhee et al, 2005). Prxs I, II and VI are 
found mainly in the cytosol, III is mainly expressed within the mitochondria and IV can 
be found both in the endoplasmic reticulum and the extracellular space (Sakellariou et 
al, 2014a). 
Peroxiredoxins can be divided in three different main categories:  
 Typical 2-Cys Prxs (Prxs 1-4); 
 Atypical 2-Cys Prxs (Prxs 5); 
 1-Cys Prx (Prx6). 
As described by Chae and colleagues (1994), all Prxs conserve a cysteine residue 
known as “required peroxidatic cysteine”. Nevertheless, in the case of 2-Cys Prxs (the 
largest class of Prxs) another semi-conserved cysteine is present and it is known as 
“resolving cysteine” placed near residue 170 and being able to form a disulphide bond 
with the required peroxidatic cysteine (Wood et al, 2003). Among all the Prxs, those 
mainly involved in the reduction of H2O2 are the 2-Cys Prxs that are also involved in 
the reduction of peroxynitrite and in the regulation of peroxide-mediated signalling 
pathways (Wood et al, 2003). Among all the Prxs, the 1-Cys Prx6, found in all 
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mammals, presents unique characteristics. This Prx shows bi-functional capacities due 
to two different active sites: 
 Cys47, Arg132 and His39 allow this protein to perform its normal peroxidatic 
activity;  
 Ser32, His26 and Asp140 allow this protein to exert PLA2 activity (Fisher, 
2011). 
The switching of Prx6 activity between peroxidatic and PLA2 can be determined both 
by pH and hyperoxidation (Fisher, 2011). If the pH is neutral (around 7-8), peroxidatic 
activity is acquired.  In contrast, if the pH is more acidic (between 3 and 5 with a peak 
at 4) PLA2 activity appears to be activated (Chen et al, 2000). Conversely, when 
hyperoxidation of Prx6 occurs, phospholipase activity is enhanced and the 3 amino 
acids play a pivotal role in the functionality of this enzyme. His26 only has binding 
functions, Ser32 both binds and hydrolyses the liposome while Asp140 is involved in 
the catalytic processes that generates arachidonic acid and lipid peroxides (Kim et al, 
2016). As described by Wu and colleagues (2009), His26 and Asp140 are significantly 
more distant in Prx6 compared to cPLA2 and a structural rearrangement is required 
for the correct functioning of Prx6 as PLA2. The phosphorylation of Thr177 (located 
in the C-terminal domain) induces the conformational changes necessary to allow Prx6 
to execute the hydrolysis of sn-2 fatty acyl chains of phospholipids (Wu et al, 2009). 
1.6.5 Thioredoxin 
Thioredoxins (Trx) are proteins encoded by the genes TXN and TXN2 and are 
expressed in the majority of the organisms (Wollman et al, 1988). They play an 
important role as antioxidants but also play an important role in redox signalling. These 
small proteins of 12kD contain two vicinal cysteines in their amino acid sequence that 
allow these proteins to reduce the disulphide bonds present in other proteins using the 
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electrons released by NADPH Oxidase (Cheng et al, 2010). Thioredoxins are maintained 
in their reduced state by the activity of thioredoxin reductase (TrxR) (Nordberg and 
Arnér, 2001). Among the three isoforms of TrxR discovered in mammalians cells, two 
are expressed in skeletal muscle:  
 Thioredoxin Reductase 1 (TrxR1) found both in the cytosol and in the extracellular 
space; 
 Thioredoxin Reductase 2 (TrxR2) expressed in mitochondria.  
1.6.6 Heat Shock Proteins 
Heat Shock Proteins (Hsp) are a family of proteins that plays a primary role in response 
to various stress conditions and are named according to their molecular weight. Some 
of them are also known as chaperonin proteins because they are involved in stabilising 
the newly formed and refolding proteins that have been damaged by cellular stress 
(Jee, 2016).  
Hsps are found in different compartments within the cell and their location is important 
considering that the cytosol is a reducing environment while the endoplasmic reticulum 
is more oxidising (Jee, 2016). These compartmental differences mean that each 
environment requires a specific chaperone network (Janssen-Heininger et al, 2008). 
Hsp10, Hsp60, Hsp75 are found in the mitochondria and are mainly involved in ensuring 
correct protein folding. Hsp40 and Hsp110 are mainly found in the cytosol, Hsp70, 
Hsp90, Hsp100 are found in the cytoplasm and Hsp47 and GRP78 are found in the 
endoplasmic reticulum (Jee, 2016).  
Hsps also play an important role in redox-signalling (Shigeoka and Maruta, 2014). For 
example, mammalian Hsp25, 60, 70 and 90 present a redox-active cysteine in their 
structure which, following an increase in oxidative stress, is oxidised generating the 
formation of a disulphide bond (Janssen-Heininger et al, 2008). This oxidative stress-
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related modification of the Hsps induces modifications in the functionality of these 
proteins. However, not only disulphide formation is able to induce modifications in 
the Hsp activity; nitrosylation and glutathionylation are also able to induce alteration 
of Hsp activity (Janssen-Heininger et al, 2008). 
1.7 Ageing 
Ageing is a natural process that occurs in all the living organisms and is influenced by 




 Environmental factors (Bulla and Shafwe, 2011).  
Ageing can be defined as a complex pattern of physiological and pathophysiological 
modifications that occur during lifetime and that lead to deterioration of the entire organism 
and its functions (Bulla and Shafwe, 2011). Given the complexity of the ageing process, 
an interdisciplinary approach is required by scientists for its study (Dillin et al, 2014) 
and several theories have tried to explain how the interaction of environmental, genetic 
and epigenetic variables lead ageing of an organism.  
Ageing theories can be divided in two main categories:  
 Programmed theories; 
 Damage-related theories.  
While programmed theories suggest that the same factors able to influence our development 
are able to direct our senescence, damage-related theories identify the accumulation of 
damage at different levels as the main cause of ageing. 
Among the damage-related theories of ageing, the oxidative stress theory stands out. 
Indeed, during ageing and several other conditions, the levels of oxidative stress tend 
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to increase with the potential of causing disturbance of homeostasis with severe impact 
on health inducing tissue degeneration and system dysfunctions (Bouzid et al, 2014; 
Fulco et al, 2003). 
1.7.1 Skeletal muscle and Ageing 
Skeletal muscle is seriously affected by the ageing process showing different variations in 
size, shape and organisation (Cruz-Jentoft et al, 2019). Several studies have highlighted 
that the peak in muscle mass is reached around the age of 24 followed by a decrease 
of approximately 10% in the next 25 years (Keller et al, 2013; Kalyani et al, 2014). 
After the age of 50, muscle wasting accelerates with a loss of 10% per decade (Lexell 
et al, 1988). The age-related loss of muscle mass, together with the decline of muscle 
function is defined as “sarcopenia”. 
1.7.1.1 Sarcopenia  
Sarcopenia is a disease (Diagnosis Code ICD-10-MC) where a substantial reduction 
of muscle tissue (substituted by intramuscular fat and connective tissue) and muscle 
strength occurs (Baumann et al, 2016). Several internal and external components are 
involved in the development of this disease and, according to the European Working 
Group on Sarcopenia (EWGSOP), in order to diagnose it, different factors must be 
taken into consideration (Vellas et al, 2018; Cruz-Jentoft et al, 2019). In the recently 
released guidelines, the attention is focused more on muscle strength rather than 
muscle mass (in particular lower limb muscle strength). As explained by Cruz-Jentoft 
and colleagues (2019), the diagnosis of sarcopenia is confirmed by the simultaneous 
presence of low muscle quantity and poor muscle quality. In addition, when low muscle 
quantity and strength are present together resulting in low physical performance, sarcopenia 
can be considered severe (Cruz-Jentoft et al, 2019). 
1.7.1.2 Age-related structural changes in skeletal muscle 
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Sarcopenia is characterised by significant changes in muscle structure that results in 
the loss of muscle mass with two main factors contributing to it: 
 Loss of muscle fibres; 
 Muscle fibres atrophy.  
While the loss of muscle fibres appears to be non-specific and can only partially 
explain the age-related loss of muscle mass, muscle fibre atrophy appears to be driven 
by more specific factors playing an important role in sarcopenia (Deschenes, 2004). 
Previous reports have suggested that fast-twitch glycolytic fibres appear more vulnerable to 
age-related atrophy compared to slow-twitch fibres (Wang and Pessin, 2013). Indeed, type 
I fibre cross sectional area does not differ from young and old adults while type IIa, 
type IIb and type IIx fibres of older adults show, respectively, a 13%, 22% and 26% 
reduction of cross sectional area (Lexell et al, 1988; Deschenes, 2004). These fibre-
specific differences can be attributed to how different signalling pathways are able to 
trigger protein degradation regulating the activity of a series of genes identified as 
“atrogins” in the different fibre types (Wang and Pessin, 2013; Lang et al, 2017).  
Researchers have also demonstrated that, in addition to the decrease in skeletal muscle 
cross sectional area, older adults’ fibers present myopathic modifications including 
necrotic or hyalinised myofibres, split or fragmented myofibers and accumulation in 
degenerative inclusion bodies, lipofuscin, and lipid droplets that significantly impair 
the contractility of these fibers (Williams et al, 2002; Dumitru et al, 2018, McCormick 
and Vasilaki, 2018). Furthermore, previous studies showed that in older adults’ muscles 
there is an increase in MURF1 activity. This protein can regulate the proteasomal 
degradation of sarcomeric related proteins resulting in the breakdown of myosin 




1.7.1.3 Age-related functional changes in skeletal muscle 
The loss of muscle mass has a tremendous impact on muscle strength (the maximal 
force that a muscle or a muscle group can exert during a contraction) (Cheatham, 
2013). During ageing, the force per unit area, the velocity of contraction and the motor 
neuron firing rate appear to be reduced with a major impact on absolute strength and 
power (Powers et al, 2013, Connelly et al, 1999). Longitudinal studies have reported 
that the loss of muscle function is not linear with the loss of muscle mass (Baumann 
et al, 2016). As mentioned earlier, after the age of 50 the loss of muscle mass in the 
lower limbs is around 1-2% per year while the loss of muscle strength is more 
prominent with a 1.5-5% loss per year (Cruz-Jentoft et al, 2019).  
A characteristic of ageing and some chronic diseases associated with muscle wasting 
is the reduction of neurological properties, including changes at the nervous system level 
that have a direct impact on the voluntary capacity to activate muscles. This has also a direct 
impact on fibre architecture/composition, the excitation-contraction coupling processes and 
cross bridge mechanics (Baumann et al, 2016). These results open the possibility that 
denervation may play a primary role in the characteristic age-related loss of muscle 
mass and strength. 
1.7.2 Neuromuscular junction during ageing 
The efficacy and mass of the neuromuscular system tends to deteriorate during ageing 
and early reports described this phenomenon in rats (Gutman and Hanzlikova, 1966) 
and few years later also in humans (Oda, 1984). Previous reports have also shown that 
between the age of 25 and the age of 65, the number of motor units declines 
approximately 40% (McNeil et al, 2005). Nevertheless, from the age of 65 to the age 
of 80, there is an acceleration that results in the loss of a further 33% of motor units 
(McNeil et al, 2005). The reasons behind this age-related loss of motor units are still 
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unclear but several studies have suggested that during ageing there is a progressive 
degeneration at different levels of the spinal cord (starting from the ventral horn) that 
are able to trigger different consequences at peripheral level (Deschenes, 2004). 
Impairments at the spinal cord level seem to be able to induce loss of motoneurons and 
reduced axonal transport that might affect the availability of important trophic factors 
and the movement of organelles (e.g. Mitochondria) necessary for the survival of the 
NMJ (Jang and Van Remmen, 2011; McDonagh et al, 2016). A study performed by 
Balice-Gordon (1997) demonstrates that in mice, the NMJs are very stable until they reach 
12-18 months when some loss of motor terminal branches begins. These modifications 
have been seen in experimental denervation models suggesting that, most likely, this 
progressive instability is the result of the loss of efficacy of the denervation-reinnervation 
cycles (McDonagh et al, 2016). The process of denervation-reinnervation, induces a 
transient disconnection between the muscle and the motor neuron followed by the 
subsequent reinnervation from the same motor neuron or the sprouting of a nearby 
axon (Hepple and Rice, 2016). This process is cyclically repeated in adult life (Jang 
and Van Remmen, 2011; Aare et al, 2016). Nevertheless, with ageing its efficacy tends 
to decrease leading to loss of terminal branches and nerve sprouting able to induce 
motor unit remodelling, progressive reduction of the motor units number spatial 
domain (Larsson et al, 1999) and loss of NMJs (Aare et al, 2016; Jang and Van 
Remmen, 2011). Impairment and failure of the denervation-reinnervation process can 
impact muscle health triggering a series of consequences (shown in Figure 1.5) that 
culminate in the loss of muscle mass, loss of muscle strength and loss of muscle 
functions characteristic of sarcopenia (Jang and Van Remmen, 2011). 
Following the loss of terminal branches, in the attempt to compensate, axonal sprouting 
occurs where a healthy motoneuron sprouts to form additional synapses with non-
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overlapped acetylcholine receptors (Son and Thompson, 1995; Jang and Van 
Remmen, 2011). Several studies through the years have tried to determine the stimuli 
able to drive a healthy motoneuron to a non-overlapped acetylcholine receptor. Early 
evidence suggests that the lack of contractile activity may be responsible for this 
phenomenon (Son and Thompson, 1995). More recent evidence suggests that the 
increased peroxide release from denervated muscle fibres may be aimed at stimulating 
re-innervation through sprouting (Pollock et al, 2017).  
 
 
As a consequence of nerve sprouting, surviving muscle fibres tend to organise themselves 
in a way that a single motor neuron can innervate a higher number of fibres at the same 
time. The formation of bigger clusters is seen following denervation and is aimed to 
increase the chances of clustered muscle fibres to remain innervated for their 
remaining lifespan (Aare et al, 2016). Fibre grouping is also widely observed during 
sarcopenia reinforcing the idea that denervation plays a primary role in age-related 
muscle wasting (Hepple and Rice, 2016). Nevertheless, with ageing even the 
efficiency of this process is dramatically reduced and the newly formed branches are 
 
Figure 1.7. Age-associated modifications at the neuromuscular level that culminate with 
sarcopenia. Adapted from Hepple and Rice, 2016. 
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more vulnerable to neurodegenerative processes and usually they disappear within 
weeks (Jang and Van Remmen, 2011). 
A study performed by Aare and colleagues (2016) on rats, showed that in old animals, 
denervated fibres are on average 35-50% smaller than innervated fibres while this 
difference is less marked in young animals (approximately 7%). This denervation-
related reduction in fibre size seems to confirm the role played by denervation in muscle 
wasting. Indeed, impairments of the NMJs are able to activate atrophy pathways in 
denervated fibres resulting in fibre atrophy and increase number of angular fibres, two 
main characteristics of skeletal muscle ageing (Baloh et al, 2007; Hepple and Rice, 
2016). 
Several studies also demonstrated that the age-related changes in the morphology of 
the NMJ differ between muscle fibre types suggesting that these changes can be related 
to the fibre metabolism. For instance, further studies conducted both in old rats and 
humans demonstrated that with ageing there is a preferential loss of fast motor units 
compared to slow motor units (Jang and Van Remmen, 2011). 
1.7.3 Reactive oxygen species and ageing in skeletal muscle 
An increase in skeletal muscle contractile activity induces an increase in O2 consumption 
and an increase in intracellular generation of superoxide and nitric oxide (Jackson and 
McArdle, 2016; Gomes et al, 2017). As discussed previously, physiological concentrations 
of ROS play an essential role in redox signalling and cell survival, playing a central 
role also in muscle contraction (Jackson and McArdle, 2016; Gomes et al, 2017).  
During ageing a significant accumulation of ROS is seen in skeletal muscle and, 
although their role remain controversial, evidence suggests that their accumulation can 
result in mitochondrial DNA damage, together with oxidative damage to lipids and 
proteins, playing a central role in sarcopenia (Jang and Van Remmen, 2011; Jackson 
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and McArdle, 2016). In addition, other reports suggest that during ageing, the 
accumulation of ROS in skeletal muscle can also be associated with contractile 
dysfunction and fatigue (Powers et al, 2011).  
During ageing most tissues also show a progressive decrease in antioxidant defences, 
but in skeletal muscle the activity of superoxide dismutase isoforms, catalase and 
glutathione peroxidase isoforms increases (Vasilaki et al, 2006a; Steinbacher and Eckl, 
2015). This increase in antioxidant defences seems to be muscle type-specific with 
type I fibres showing the most prominent increase (Steinbacher and Eckl, 2015) while 
type II showing a lower increase in antioxidant enzymes and a higher rate of oxidative 
injury, making them more prone to denervation and muscle fibre atrophy (Jang and 
Van Remmen, 2011; Gomes et al, 2017). In addition, ageing skeletal muscle shows a 
significantly higher mitochondrial iron content that exposes the muscle to the 
generation of the highly reactive HO• from H2O2 (Szentesi et al, 2019).  
1.8 Mitochondrial dysfunction, reactive oxygen species and denervation 
As previously mentioned, mitochondria play several important roles within the muscle 
cell from energy production to cell signalling. At pre-synaptic level, mitochondria can 
be found in the nerve terminals (they usually travel along the microtubules using the 
axonal transport system) while in the post synaptic region of the muscle fibre can be 
found in the sub sarcolemma region (Jang and Van Remmen, 2011). The role that these 
mitochondria play are different: energy support, regulation of calcium, support of 
synaptic transmission, and apoptosis. Several studies have highlighted that mitochondria 
located in proximity of the NMJ can be responsible of the transportation of calcium 
ions in the endoplasmic reticulum, nucleus and plasma membrane of cells (including 
skeletal muscle cells) (Karam et al, 2017). Following denervation, the loss of overlap 
between the motoneuron and the acetylcholine receptor present in the post-synaptic 
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receptors induces alterations in calcium metabolism (Baumann et al, 2016). Calcium 
levels significantly increase in the cytosol, overloading mitochondria and, consequently, 
inducing increased ROS production. Mitochondrial dysfunction and increased levels 
of cytosolic calcium seem to have an impact not only in the activation of atrophy 
patterns, they also appear to be associated with lower levels of neurotransmitters released 
by the presynaptic terminal of surrounding fibres, with reduced capability of the motor 
unit to generate an action potential (Baumann et al, 2016). In addition as Jang and Van 
Remmen (2011) suggested, it is reasonable to believe that dysfunction of the mitochondria 
present in the NMJ region can have a negative impact on the motor unit survival 
inducing alterations of key proteins involved in the maintenance of the NMJ. Indeed, 
an increase in calcium ion flux can polarize the mitochondria in proximity of the Ach 
receptors inducing the activation of proteases such as calpain, whose physiological 
role is still controversial but interacting with rapsyn (involved in the stabilization of the 
acetylcholine receptors) can induce the disruption of the acetylcholine receptors complex 
(Jang and Van Remmen, 2011). 
As initially demonstrated by Muller and colleagues (2007a), following surgically induced 
denervation there is a significant increase in mitochondrial ROS production. In the 
following years, other studies (Bhattacharya et al, 2009; Abruzzo et al, 2010; Pollock 
et al, 2017) demonstrated that ROS production is significantly increased following 
denervation and that mitochondria appear to be the main source of peroxide 
production. The increase in peroxides release from mitochondria of denervated muscle 
fibres is induced only marginally by the ETC while other enzymes such as NADPH 
Oxidase, PLA2, Monoamine Oxidase A and Monoamine oxidase B seem playing a 
predominant role (Pollock et al, 2017). Nevertheless, the causes and the physiological 
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meanings and consequences of this increased peroxide release are still poorly 
understood.  
A study from Giniatullin and collagues (2006) has also highlighted how the increase 
in H2O2 released from mitochondria can significantly inhibit the release of the 
acetylcholine from the pre-synaptic terminals as well as the activity of Synaptosomal 
associated protein 25 which plays an important role in the NMJ regulating the 
neurotransmitter release (Ramakrishnan et al, 2012). Furthermore, the increased peroxide 
release following denervation appears to also induce the activation of NF-κB and/or 
Tumor Necrosis Factor alpha (TNF-α) inflammatory pathways which could lead to the 
upregulation of atrophy patterns such as Atrogin-1/MAFbx and 26S protease system 
(Abruzzo et al, 2010). These alterations result in disruption of the balance between 
protein synthesis and protein degradation with muscle fibre atrophy and loss of muscle 
mass (Sun et al, 2006). Evidence suggests that denervation-induced atrophy can be 
highly attributable to mitochondrial dysfunctions (Karam et al, 2017).  
1.9 Aims of the work reported in this thesis 
Recent studies have highlighted significant age-related changes in the innervation of 
skeletal muscle with loss of integrity of the NMJ accompanied by a significant loss of 
muscle mass. Recent evidence from our group (Pollock et al, 2017) also highlighted 
that one of the main consequences of the loss of integrity of the NMJ is the significant 
increase in peroxide release in denervated muscle fibres. Nevertheless, the physiological 
meaning and impact of this increase in peroxide release is still poorly understood.  
The aims of the present thesis are:  
 Examine the effects of skeletal muscle denervation on redox homeostasis in 
skeletal muscle focusing on the content of proteins that may contribute to peroxide 
generation and other adaptive and regulatory proteins.  
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 Examine the effects of skeletal muscle denervation on mitochondria with a specific 
focus on: mitophagy, activation of apoptosis and mitochondrial number.  
 Determine the metabolic changes induced by denervation in skeletal muscle.  
 Investigate whether the redox-related changes observed in our denervation model 
also occur during skeletal muscle ageing since muscle denervation appears to be a 
key characteristic of sarcopenia.  
 Evaluate the age-related changes occurring between the nerve-muscle interactions 
and to examine whether the age-related loss in the stability of the NMJs results in 















2.1 Mouse models 
All mice were kept in the Biomedical Service Unit (BSU) facilities fed on a standard 
laboratory diet and subjected to a 12-h light/dark cycle. All the experiments were 
performed in accordance with UK Home Office guidelines under the UK Animals 
(Scientific Procedures) Act 1986 and received ethical approval from the University of 
Liverpool Animal Welfare Ethical Review Body. Two main strains were used in the 
present thesis C57BL/6J and B6.Cg-Tg(Thy1-YFP)16Jrs/J mice. For experiment 4 
mice in each experimental group were used. 
2.1.1 C57BL/6J mice 
Also known as Black 6, C57BL/6J mice present a high resistance to tumours and are 
often used in the production of transgenic models as this strain allows researchers to 
induce specific mutations. They present a relatively low bone density and during 
ageing can develop hair loss (https://www.jax.org). They can also develop diet-related 
obesity, type II diabetes and atherosclerosis.  
2.1.2 B6.Cg-Tg(Thy1-YFP)16Jrs/J 
These mice, also known as Thy-1 YFP (Yellow Fluorescent Protein), express high 
levels of a yellow fluorescent protein in their motor and sensory neurons only. YFP 
expression is present since gestation and allows detailed visualisation of the nervous 
system and skeletal muscle innervation using fluorescent microscopy. The mutation 
was generated by injecting into fertilized B6CBAF1 mouse eggs a transgenic construct 
containing YFP gene derived from a mouse Thy1gene. Subsequently, mice were 
backcrossed with wild type C57BL/6J mice for at least five generations. Previous 
unpublished data from our group and our collaborators failed to detect differences in 
the muscle phenotype of C57BL/6J and B6.Cg-Tg(Thy1-YFP)16Jrs/J mice. 
45 
 
2.2 Surgical transection of the peroneal and sciatic nerve to induce 
muscle denervation 
To induce denervation in different muscles of the lower hind limb, mice underwent 
two different types of surgical procedure:  
 The complete removal of a small section of the peroneal nerve in the right 
lower limb (peroneal nerve transection) to induce denervation in the Tibialis 
Anterior (TA) and Extensor Digitorum Longus (EDL) muscles; 
 The complete removal of a small section of the sciatic nerve in the right lower 
limb (sciatic nerve transection) to induce complete denervation of all the 
muscles in the lower hind limb.   
Both surgical procedures were performed in a sterile environment using specific 
instruments for microsurgical procedures adequately sterilised before use and between 
surgeries of different mice. Before surgery, each mouse was put into an induction 
chamber where a mix of O2 and isofluorane (97:3 ratio) was used to initially 
anesthetise the mouse. The mouse was then moved on the pre-surgery station where it 
was weighted, placed in a nose cone connected to a vaporiser supplying a mix of O2 
and isofluorane 0.2% and ophthalmic lubricant was applied to the eyes in order to 
prevent cornea drying during surgery. Following the removal of hair from the surgical 
area, Buprenorphine (an analgesic; 1mg/kg, SC 0.1ml) and Baytril (an antibiotic; 2.5% 
1 in 10 dilution, SC 0.07ml) were injected and the mouse moved to the surgery theatre 
where, still connected to the vaporizer supplying gas anaesthetic, the surgical 
procedure was carried out.  
A small incision was performed at the level of the sciatic notch which was identified 
through palpation of the knee. At this level the sciatic nerve splits in three different 
branches: the tibialis, the peroneal and the sural nerves. 
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For the sciatic nerve transection, a section of the sciatic nerve was removed before the 
trifurcation described above, whereas for the peroneal nerve transection, once the 
peroneal nerve was identified a tiny section was removed. The wound was then sutured 
using CliniSorb Q 6/0, Super Glide (Reverse Cutting), Undyed, 13mm needle 
(International Medical Supplies, Stockport, UK).  
After surgery, mice were maintained in isolation cages until the complete recovery of 
movement and then placed back in their original cages. Mice were checked regularly 
to identify any post-surgical pain, discomfort or stress conditions.  
2.3 Sample collection and preparation 
For each project, mice were sacrificed by cervical dislocation and muscles were 
dissected and treated differently according to the analysis performed (see Figures 2.1, 
2.2 and 2.3).  
 
 
Figure 2.1 .  Schematic overview of tissue utilisation for the experiments presented in 






Figure 2.2.  Schematic overview of tissue utilisation for the experiments present ed in 
Chapter 4 and 5 focused on determining the mitochondrial  status and metabolic 




Figure 2.3.  Schematic overview of tissue  utilisation for the experiments presented in 
Chapter 6 focused on determining the age-related changes of the NMJ, muscle 




2.3.1 Sample preparation for SDS-PAGE western blot analysis  
Frozen muscles were cryopulverised in liquid nitrogen using a mortar and pestle. The 
resulting powder was added to 1% Sodium Dodecyl Sulphate (SDS) containing 
Pierce™ Protease and Phosphatase Inhibitor Mini Tablets, Ethylenediaminetetraacetic 
acid (EDTA) Free. Samples were then homogenised for 30-60 seconds maintaining 
the tube on ice to avoid overheating. Following homogenisation, samples were collected 
in 1.5ml polypropylene Eppendorf tubes (Thermo Fisher Scientific, Waltham, MA, 
USA) and centrifuged for 10 minutes at 14,000g at a constant temperature of 4ºC. 
Following centrifugation, the supernatant was collected and stored at -20ºC for further 
analysis while the pellet containing insoluble proteins and cell debris was discarded.   
2.3.2 Sample preparation for Oxyblot analysis 
For the analysis of protein carbonylation, the powder collected after cryopulverisation was 
added to 180µl of Hepes Buffer (20mM of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid pH7.4, 150mM NaCl, 1mM EDTA and protease and phosphatase inhibitors). Samples 
were homogenised for 30-60 seconds while kept on ice during the entire process, the 
homogenate was collected in 1.5ml polypropylene Eppendorf tubes and centrifuged 
for 10 minutes at 14,000rpm at a constant temperature of 4ºC. 
After centrifugation, the supernatant solution containing proteins was collected and 
stored at -20ºC for further analysis while the pellet containing insoluble proteins and 
cell debris discarded. 
2.3.3 Sample preparation for GSH and GSSG assays 
Following cryopulverisation, 1% 5-Sulfasalicylic acid (SSA) was added to the samples. 
Samples were homogenised for 30-60 seconds on ice, transferred to 1.5ml polypropylene 
Eppendorf tubes, centrifuged for 10 minutes at 14,000rpm at a constant temperature of 
4ºC. After centrifugation, the supernatant containing reduced and oxidised glutathione 
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was collected, placed in a different Eppendorf tubes and stored at -20ºC until further 
analysis. 
2.3.4 Sample preparation for morphological analysis 
Samples for histoimmunochemical analysis were placed perpendicularly on a cork for 
cryosectionning, embedded in Optimal Cutting Temperature (OCT – Sigma-Aldrich 
Ltd, Gillingham, Dorset, United Kingdom) and submerged in isopentane cooled in 
liquid nitrogen. Once the OCT was set, samples were covered with aluminium foil and 
kept in liquid nitrogen until used or stored at -80ºC for further analysis.  
For immunohistochemical analysis, 12µm thick sections were obtained by cryosectionning 
performed on a Leica 1900 (Leica, Wetzlar, Germany). Samples were collected on 
Superfrost Plus glass slides (Thermo Fisher Scientific, Waltham, MA, USA) and 
stored at -20⁰C until analysis.  
2.3.5 Sample preparation for the analysis of the neuromuscular junction  
Muscles were dissected and fixed in 10% Neutral Buffer Formalin (Genta Medical, 
York, United Kingdom) for 1 hour at room temperature. Following incubation in 
formalin, samples were kept in 1% PBS-Sodium Azide at 4⁰C until usage.  
2.3.6 Sample preparation for analysis of mitochondrial peroxide generation  
Immediately following dissection, muscles were submerged in ice-cold relaxing 
solution (4.5µM Mg2ATP, 10mM Imidazole, 2mM EGTA, 100mM KCl, 1mM MgCl2) 
containing saponin from quillaja bark (200µM - Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom) and dissected into small bundles for analysis.   
2.3.7 Sample preparation for TMRM analysis 
Following dissection, muscles were pinned on a sylgard dish and submerged in ice-
cold relaxing solution (Section 2.3.6) while fibres were manually teased out of the 
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muscle under a dissecting microscope. Isolated fibres were incubated for 30 minutes 
at room temperature in relaxing solution containing Saponin (0.164mM - Sigma-
Aldrich Ltd, Gillingham, Dorset, United Kingdom). Following permeabilisation fibres 
were used for analysis. 
2.3.8 Sample preparation for NMR Metabolomics 
Following dissection, samples were stored at -80⁰C until utilisation. Samples were 
ground in liquid nitrogen and the powder accurately weighted to determine the amount 
of tissue available.  
2.3.9 Sample preparation for Citrate synthase assay 
Following dissection, muscles were immediately frozen in liquid nitrogen and stored 
at -80⁰C until further analysis. Samples were cryopulverised in liquid nitrogen and the 
resulting powder was added to 120µl of extraction buffer (250mM Sucrose, 10mM 
Trizma Base, 1mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic 
acid - EGTA). Samples were sonicated for 15 seconds in ice and centrifuged at 12,000g 
for 10 minutes at 4⁰C. Supernatants were collected for the analysis.  
2.4 Biochemical assays 
For most of the experiments performed, protein quantification was necessary and 2 
specific protocols were chosen for their compatibility with the chemicals used to extract 
proteins.  
2.4.1 Bicinchoninic Acid assay 
The bicinchoninic acid assay (BCA assay), is a copper-based protein assay used to 
measure the amount of proteins present in a solution. It provides a good range of 
detection from 0.5µg/ml to 1.5µg/ml. This method analyses the colour change, from 
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light green to purple through which is possible to estimate the amount of proteins 
present (Smith et al, 1985).  
2.4.1.1 Reagents 
For this analysis a kit purchased from Thermo Fisher Scientific was used 
(Waltham, MA, USA) containing: 
 BCA Reagent A 
o Sodium carbonate, 
o Sodium Bicarbonate, 
o Bicinchoninic Acid, 
o Sodium tartrate; 
 BCA Reagent B 
o 4% Copper(II); 
 2mg/ml Bovine Serum Albumin (Thermo Fisher Scientific, Waltham, MA, 
USA). 
2.4.1.2 Protocol 
Samples were removed from the -20ºC freezer and slowly defrosted on ice. A standard 
curve was prepared following the protocol recommended by Thermo Fisher as 
presented in Table 2.1. The protein standard was left on ice while a fraction of the 
sample was diluted 1:60 and 1:120. Twenty microlitres of both samples and protein 
standards were added to a 96 well plate (Costar, Corning Incorporated, New York, 
USA). 
Immediately before use, 1 part of BCA Reagent B was mixed with 49 parts of BCA 
Reagent A and 180µl added to the each well. The plate was then incubated for 30 
minutes at 36ºC in a dark environment and, following incubation, it was read on the 
plate reader Spectro Star Nano (BMG LabTech, Offenburg, Germany) set at 562nm 




Table 2.1  Protocol recommended by Thermo Fisher for the preparation of protein 
standards using Bovine Serum Albumin stock with concentration  of 2mg/ml.  
 
 
2.4.2 Bradford Assay 
This is a slightly different method for the quantification of proteins compared with the 
BCA assay. The proteins, present in an acidic environment, link with Coomassie Dye 
to induce a change of colour from the green-anthracite to blue which is recorded at a 
wavelength of 595nm. This method is able to detect peptides or proteins over 3kDa 
(Bradford, 1976) with no risk of interference from protein fragments, free amino acids 
and dye.  
2.4.2.1 Reagents 
 Bradford Ultra (Expedeon, San Diego, Ca, USA); 
 2mg/ml Bovine Serum Albumin (Thermo Fisher Scientific, Waltham, MA, 
USA). 
2.4.2.2 Protocol 
Samples were removed from the -20ºC freezer and slowly defrosted on ice. A standard 
curve was prepared following the protocol described for the BCA assay. The protein 
standard was left on ice while a small fraction of the sample was diluted 1:60 and 
1:120. Twenty microliters of both samples and protein standard were added to a 96 
well plate (Costar, Corning Incorporated, New York, USA) and 180µl of Bradford 
Ultra was added to each well. 
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The plate was left at room temperature for 5 minutes in a dark environment and then 
analysed on the Spectro Star Nano plate reader (BMG LabTech, Offenburg, Germany) 
set at 595nm wavelength. The mean absorbance was recorded and used for protein 
quantification. 
2.5 SDS-PAGE western blot analysis  
SDS-PAGE western blot analysis, also known as protein blotting, immunoblot or 
simply western blot, is a technique which uses synthetic or animal-derived antibodies 
for the detection of specific proteins.  
This method allows a semi-quantitative analysis of the content of specific proteins in 
a sample through the analysis of the colour intensity of a signal generated on a blotting 
membrane by the interaction between a protein and its specific antibody.  
2.5.1 Reagents 
 1% SDS (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom);  
 Pierce™ Protease and Phosphatase Inhibitor Mini Tablets, EDTA Free 
(Thermo Fisher Scientific, Waltham, MA, USA); 
 BLU 4x  
o 1M Tris/Hcl (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o Glycerol (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 20% SDS (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 




o Distilled water (ddH2O); 
 ddH2O; 
 Acrylagel (30% w/v Acrylamide Stock Solution) (Geneflow Ltd., 
Staffordshire, UK); 
 ProtoGel Resolving Buffer (Tris/SDS) (Geneflow Ltd., Staffordshire, UK); 
 ProtoGel Stacking Buffer (Tris/SDS) (Geneflow Ltd., Staffordshire, UK); 
 10% Ammonium Persulphate (APS) (Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom); 
 NNN’N’-tetramethylethylene-diamine (Temed); 
 Ethanol 99.9% chemical gradient (Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom); 
 Running Buffer 
o 100mL Tris-Glycine (Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom), 
o 10mL SDS 10% (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 890mL ddH2O; 
 PageRuler™ Plus Prestained Protein Ladder, 10 to 250 kDa (Thermo 
Fisher Scientific, Waltham, MA, USA); 
 Anode 1 (pH 10.4) 
o 36.34g Trizma Base (Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom), 
o 200ml Methanol HPLC (Thermo Fisher Scientific, Waltham, MA, 
USA), 
o 800mL ddH2O; 
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 Anode 2 (pH 10.4) 
o 3.02g Trizma Base (Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom), 
o 200ml Methanol HPLC (Thermo Fisher Scientific, Waltham, MA, 
USA), 
o 800mL ddH2O; 
 Cathode (pH 7.6) 
o 5.24g 6-amino n hexanoic acid (Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom), 
o 200ml Methanol HPLC (Thermo Fisher Scientific, Waltham, MA, 
USA), 
o 800mL ddH2O; 
 Ponceau S solution (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Tris Buffer Saline - Tween 20 (TBS-T20)  
o Tris Buffer Saline (TBS 1x - Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom), 
o Tween 20 (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 5% non-fatty milk  
o Milk powder (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o TBS-T20; 
 Primary antibody (see table 2.5 for further information); 
 Secondary antibody (see table 2.6 for further information); 
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 SuperSignal™ West Dura Extended Duration Substrate (Thermo Fisher 
Scientific, Waltham, MA, USA). 
2.5.2 Sample preparation and gel electrophoresis 
After protein quantification using either the BCA or Bradford assays, 30μg of protein 
(unless differently stated) for each sample was added to ddH2O and 4μL of BLU 4x 
(diluted 1:4) to achieve an equal final volume for each sample.  
Samples were boiled at 95⁰C for 5 minutes on a thermo-block (Falc, Bergamo, Italy) 
to allow proteins to acquire the random-coil aspect required for the separation of the 
proteins, exclusively, according their molecular weight. Following boiling, samples 
were left at room temperature for 2 minutes before being centrifuged at 4ºC for another 
2 minutes at 13,000rpm. For most of the experiments, gels were prepared using Mini-
PROTEAN® Tetra Handcast Systems (Bio-Rad, Hercules, CA, USA). Poly-
acrylamide gels with different poly-acrylamide percentages were prepared following 
the recipe presented in Table 2.2. Once the gels had set, samples were loaded on gels 
together with a protein ladder. In the last well of the gel, a control sample was also 
added to verify the specificity of the secondary antibody excluding any risk of non-
specific binding. 
 
Table 2.2. Recipes used for the preparation of the poly -acrylamide gels. The units 






One dimensional electrophoresis was carried out to separate the proteins contained in 
each sample according their molecular weight. The process was carried in a wet 
environment submerging the slides and the cassette in a running buffer containing 
glycine and 10% SDS. The initial voltage was set at 60V and maintained constant until 
the samples had run through the stacking gel. The voltage was then increased to 80V 
until the bromophenol dye had reached the bottom of the gel (approximately 1.5-2 hr).  
2.5.3 Western blotting of separated proteins 
During this stage, samples are transferred from the gel to a membrane following the 
same principles described above. As proteins migrate through a gel in an electrical 
field, proteins can also be transferred, by an electrical field, from the gel onto a 
membrane that “blots” the proteins from the gel onto the membrane. 
Two different types of membrane are commercially available: nitrocellulose and 
Polyvinylidene difluoride (PVDF). Unless differently specified, Amersham™ 
Protran® western blotting nitrocellulose membrane (GE Healthcare Bio-Sciences, 
Pittsburgh, USA) was used. The semi-dry transfer was chosen and a “sandwich” was 
created using 6 chromatography papers 1.5mm thick (Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom), nitrocellulose and gel as shown in Figure 2.5.  
 
 
Figure 2.4.  Graphical representation of the sandwich preparation for the transfer of 





A constant current of 45mA per gel was applied for 90 minutes and following transfer, 
the membrane was kept and stained using Ponceau S (Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom). Ponceau S solution binds to the proteins present on the 
membrane generating a red signal that was detected with the use of ChemidocTM 
imaging system (Bio-Rad, Hercules, CA, USA). Ponceau was used to verify the 
effectiveness of the transfer and to normalise the results of the western blot as 
suggested by Romero-Calvo and colleagues (2010) and Thacker and colleagues 
(2015). These independent studies found that total protein membrane staining methods 
such as Ponceau and Comassie Blu optimally balance accuracy and precision and 
represent a more accurate alternative to GADPH and -actin. These high-abundance 
proteins not only can be affected by the experimental conditions but also their signal 
gets quickly saturated possibly leading to mistake in the normalisation process 
(Romero-Calvo et al, 2010; Thacker et al, 2015).  
Ponceau S solution was washed away from the membrane using TBS-T20 and the 
membrane was blocked in 5% non-fatty milk at room temperature for 1 hour with 
gentle shacking. At this point the “secondary only” lane was cut from the membrane 
and incubated overnight at 4ºC in TBS-T20 while the rest of the membrane was 
incubated overnight at 4ºC in the primary antibody diluted in 5% non-fatty milk 
according to the manufacturer’s recommendation (see Table 2.4 for further details) 
while the “secondary only” membranes were kept in TBS-T20. 
After incubation, the membranes (including the “secondary only” membranes) were 
repeatedly washed in TBST-T20 and incubated for 1 hour at room temperature with a 
secondary antibody diluted in 5% non-fatty milk according to the manufacturer’s 
recommendation (see Table 2.4 for further details). After incubation with the 
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secondary antibody the membrane was repeatedly washed to eliminate any trace of 
secondary antibody not linked to the primary antibody.  
Where a ChemidocTM imaging system (Bio-Rad, Hercules, CA, USA) was used, 
enhanced chemiluminescence (ECL) solution was prepared by mixing an equal 
amount of SuperSignal™ West Dura Extended Duration Substrate solution A with 




































The ECL solution was added to the membranes that were then analysed using the 
ChemiDocTX. If LICOR Cx (Licor, Bad Homburg, Germany) was chosen for the 
analysis, a fluorescent conjugated secondary antibody was used and the membrane was 
analysed without the addition of other chemicals. The images obtained from 
ChemidocTM imaging system and LICOR Cx were analysed using the ImageJ 
software following the protocol by McLean (2011) and the results normalised using 
Ponceau as presented in Appendix 1.  
2.6 Oxyblot analysis 
Oxyblot analysis is a procedure to analyse the levels of carbonylation formed in 
proteins by interaction with ROS. The MERK Millipore kit (S7150 - Merk, Darmstadt, 
Germany) was used for this analysis. 
2.6.1 Reagents 
 1x DNPH solution (Kit component); 
 1x Derivitalization solution (Kit component); 
 Neutralization solution (Kit component); 
 12% SDS (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
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 Phosphate Buffer Saline (PBS 1x, Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom); 
 Tween 20 (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Blocking dilution buffer 0.01% 
o PBS-T20, 
o BSA; 
 BLU 1x  
o 1M Tris/Hcl (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o Glycerol (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 20% SDS (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o β-Mercaptolethanol (Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom), 
o Distilled water. 
2.6.2 Protocol 
Following protein quantification using the Bradford assay, 30µg of proteins (Vi) were 
added to an equivalent volume of 12% SDS to ensure protein denaturation. Samples 
were then vortexed for few seconds and derivatised by adding 2 times Vi of DNPH 1x 
solution (the same volume of 1x Derivitisation-control was also added to a positive 
control). Samples were incubated for 15 minutes at room temperature and 1.5 times Vi 
Neutraliser solution was added to stop the derivitisation. Samples were then added to 
a polyacrylamide gel and run as described for the SDS-PAGE western blot analysis 
(section 2.5.2) using the same transfer method described in section 2.5.3. The only 
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difference was the use of PVDF Membrane (GE Healthcare Bio-Sciences, Pittsburgh, 
USA) which was activated in 95% ethanol for 15 seconds prior to adding it to the 
transfer apparatus. Following transfer, the membrane was blocked with the blocking 
buffer provided with the kit for 1 hour at room temperature. After blocking, the 
primary antibody was diluted 1:150 in the blocking buffer and the membrane incubated 
at room temperature for 1 hour. The membrane was then washed with PBS-T20 and 
incubated in the secondary antibody (diluted 1:300) at room temperature for 1 hour 
before washing with PBS-T20. At this point the ECL solution was prepared by mixing 
an equal amount of SuperSignal™ West Dura Extended Duration Substrate solution 
A with SuperSignal™ West Dura Extended Duration Substrate solution B. The ECL 
solution was then added to the membranes and they were immediately exposed in the 
ChemiDocTX (Bio-Rad, Hercules, CA, USA) set with the chemiluminescence 
protocol. The images recorded were collected for densitometry analysis that was 
performed using the ImageJ software as previously described (section 2.5.3). 
2.7 Glutathione assay 
The levels of total glutathione in samples was measured using glutathione reductase to 
induce the formation of sulfhydryl groups. The interaction between the sulfhydryl 
groups with the Elleman’s reagent generates a yellow change of colour in the samples 
which is recorded by a spectroscopic plate reader set at 37ºC and 415nm wavelength. 
The plate reader provides information about the rate at which each sample change 
colour (slope) and the average slope is used to indirectly measure the levels of 
glutathione contained in the sample (Baker et al, 1990).  
2.7.1 Reagents 




 Glutathione reductase (1346 units/ml Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom); 
 Oxidised glutathione (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Reduced glutathione (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Stock Buffer (pH 7.5) 
o 143mM of sodium phosphate (Na2HPO4 - Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom), 
o 6.3mM of Tetrasodium EDTA (Na4EDTA - Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom); 
 NADPH (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Elleman’s solution or 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB - Sigma-
Aldrich Ltd, Gillingham, Dor-set, United Kingdom). 
2.7.2 Protocol 
Samples were taken from the -20ºC freezer and slowly defrosted on ice. Reagent 
solutions were prepared as follow: the daily buffer was prepared adding 3.5mg of 
NADPH in 14ml of stock buffer and placed immediately on ice. In addition, 6mM of 
DTNB were dissolved in stock buffer and placed in ice. 
A standard curve was prepared dissolving 16mg of reduced glutathione and 16mg of 
oxidised glutathione in 10ml of 1%SSA and a range of dilutions was prepared to obtain 
different concentrations ranging from 10.4µM to 0.081 µM plus a blank (1%SSA 
only). 
Once defrosted, samples were diluted 1:20 in 1%SSA and 20µl of diluted sample or 
standard added to a 96-well plate (Costar, Corning Incorporated, New York, USA). A 
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“cocktail” solution was then prepared as presented in Table 2.5. Glutathione reductase 
was added immediately before analysis. 
 




200µl of cocktail solution were added to each well while the plate reader Spectro Star 
Nano (BMG LabTech, Offenburg, Germany) was set at 37ºC and 415nm wavelength 
with readings taken every 20 seconds for a total duration of 10 minutes (300 cycles). 
The average slope of the absorbance change was collected for data analysis.  
2.8 Oxidised glutathione assay 
2.8.1 Reagents 
 1% SSA  (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Glutathione reductase (1346 units/ml Sigma-Aldrich Ltd, Gillingham, Dorset, 
United Kingdom); 
 Oxidised glutathione (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Reduced glutathione (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Stock Buffer (pH 7.5) 
o 143mM of Sodium Phosphate dibasic (Na2HPO4 - Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom), 
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o 6.3mM of Na2EDTA (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 2-Vynylpyridine (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Triethanolamine (TEA - Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom).  
2.8.2 Protocol 
Samples were taken from the -20ºC freezer and slowly defrosted in ice. Once 
defrosted, samples were diluted 1:20 in 1% SSA reaching a final volume of 200µl. The 
standard curve was prepared as for the glutathione assay (section 2.7.2). Two 
microlitres of 2-vynilpyridine were added to the samples and the standards and each 
was vortexed immediately for one minute. To verify if the sample pH was between 6 
and 7, 1µl of sample was removed and applied to a pH strip (pH range 1-11, Thermo 
Fisher Scientific, Waltham, MA, USA). If the pH was higher than 7, 2µl of 2-
vynilpyridine were added. In contrast, if the pH was lower than 6, 3µl of TEA (diluted 
1:1 in distilled water) were added to the sample to neutralise the excess 2-vynilpyridine. 
Samples and standards were left at room temperature for 1 hour and subsequently 
loaded on a 96 well plate (Costar®, Corning Incorporated, New York, USA). Samples 
were then analysed as described for the glutathione assay (section 2.7.2).  
2.9 Haemotoxylin and Eosin staining (H&E) 
The Haemotoxylin and Eosin staining takes its name after the two different dyes used 
to perform this analysis: haemotoxylin (a basic dye able to stain acidic structures with 
a purple/blue staining) and eosin (an acidic dye, negatively charged able to stain basic 





o PBS 1x (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
o Tween 20  (0.04% - Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Harry’s Haemotoxylin (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Acid Alcohol (Thermo Fisher Scientific, Waltham, MA, USA); 
 Eosin (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Ethanol 70% (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Ethanol 90% (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Ethanol 100% (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 DPX Mountant (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom). 
2.9.2 Protocol 
Prior to start the H&E staining, slides with samples sections were defrosted at room 
temperature for at least 30 minutes and submerged in PBS-T20 for 5 minutes to remove 
any excess OCT and any bubbles present between the sample and the slide.  
Slides were then submerged in haemotoxylin for 6 minutes after which the slides were 
washed with water. At this point, slides were dipped into acid alcohol and immediately 
submerged in Eosin for 10 seconds. Slides were then washed with 70% ethanol for 1 
minute, 90% ethanol for another minute and 100% ethanol for another 2 minutes.  
The slides were left to air dry before 2 drops of DPX mounting media were added to a 
cover glass before placing it on the slide carefully avoiding bubble formation. Slides 
were visualised on the Nikon Ci (Nikon, Kingston, UK) using 4x and 20x magnifications. 
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2.10 Wheat Germ Agglutinin staining 
2.10.1 Reagents 
 PBS (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 PBS-T20  
o PBS (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
o Tween 20 (0.05% - Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Methanol (Thermo Fisher Scientific, Waltham, MA, USA); 
 Rhodamine, Wheat germ agglutinin (WGA - Vector Lab, Burlingame, 
California, USA); 
 4′,6-diamidino-2-phenylindole (DAPI - Vector Lab, Burlingame, California, 
USA); 
 Mounting media (Leica, Wetzlar, Germany); 
 Cover slips (Leica, Wetzlar, Germany). 
2.10.2 Protocol 
Following cryosectionning, slides were left to dry at room temperature for 15-20 
minutes. Once dried, an area was drawn around the sections using a hydrophobic 
marker pen (Vector Lab, Burlingame, CA, USA) and the sections were left to dry for 
further 10 minutes.  Sections were rehydrated with ice cold PBS for 5 minutes, fixed 
with ice cold methanol for 10 minutes at room temperature and washed 3 times with 
PBS-T20 for 5 minutes. 
Wheat germ agglutinin was diluted 1:1000 in PBS and added to the slides for 10 
minutes at room temperature. Slides where washed once in PBS-T20 for 5 minutes and 
1 time in distilled water to remove any salt residue that could interfere with the 
analysis. Slides were then left to dry at room temperature in a dark environment before 
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adding the cover slips using a mounting media containing DAPI staining (Vector Lab, 
Burlingame, CA, USA). Slides were analysed on the Zeiss LSM 800 confocal 
microscope (Zeiss, Oberkochen, Germany). 
2.11 Analysis of the neuromuscular junction 
Alpha-Bungarotoxin is a 74 amino acid neurotoxin component of the venom of some 
snakes. It is able to bind in an irreversible manner with the nicotinic ACh receptors 
found at the NMJ level (Moise et al, 2002). When conjugated with Alexa FluorTM 647, 
this neurotoxin can be used to stain the ACh receptors of the NMJ to visualise their 
structure. 
2.11.1 Reagents 
 Neutral Buffer Formalin (Genta Medical, York, United Kingdom); 
 1% PBS-Sodium Azide  
o PBS  (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
o Sodium Azide (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 α-Bungarotoxin, Alexa FluorTM 647 conjugate (Thermo Fisher Scientific, 
Waltham, MA, USA). 
2.11.2 Protocol 
Samples were removed from 1% PBS-Sodium Azide, washed in PBS for 5 minutes 
and then stained with α-Bungarotoxin, Alexa FluorTM 647 conjugate (Invitrogen, 
Paisley, United Kingdom) diluted 1:500 in PBS for at least 30 minutes, in a dark 
environment at room temperature.  
Samples were kept in a dark environment until analysed with a Nikon A1 confocal 
microscope (Nikon, Kingston, UK). A Z-stack analysis was performed and the 
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resulting images were analysed in ImageJ and the NMJ-morph Extension following 
the protocol published by Jones and colleagues (2016).  
2.12 Immunofluorescence staining 
Immunofluorescence is a light microscopy technique that uses fluorescence to 
visualise the distribution of a specific target within a cell or tissue. Similar to western 
blot analysis, the use of primary and fluorescent secondary antibodies is necessary to 
detect the target of interest. If the primary antibody is already conjugated with a 
fluorescent probe, the secondary antibody is not needed. When the fluorescent probe 
tagged to the antibody is excited (at a specific wavelength) it generates a fluorescent 
signal which allows a detailed qualitative analysis of the distribution of a specific 
protein or structure within the cell or a tissue. 
2.12.1 Reagents 
 PBS (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 PBS-T20 
o PBS (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
o Tween 20 (0.05 - Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Goat serum (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Various antibodies; 
 Rhodamine, WGA (Vector Lab, Burlingame, California, USA); 
 DAPI (Vector Lab, Burlingame, California, USA); 
 Mouse On Mouse (M.O.M) blocking (Vector Lab, Burlingame, California, 
USA); 
 Mounting media (Leica, Wetzlar, Germany); 
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 Cover slips (Leica, Wetzlar, Germany). 
2.12.2 Protocol 
Following cryosectioning, the slides were left to dry at room temperature for 30 
minutes. With a hydrophobic marker pen (Vector Lab, Burlingame, CA, USA) an area 
around the sections was drawn and the samples were left to dry for another 10 minutes. 
Samples were rehydrated with PBS for 5 minutes. Following rehydration, samples 
were blocked for 1 hour at room temperature using 5% goat serum in PBS containing 
Mouse On Mouse (M.O.M) blocking. The primary antibody was prepared by diluting 
it in PBS with 5% goat serum and slides were incubated overnight at 4°C. Following 
incubation, slides were washed 3 times for 5 minutes in PBS-T20. The secondary 
antibody was prepared in PBS with 12% goat serum and slides were incubated at room 
temperature for 1 hour before they were washed 3 times in PBS-T20 for 5 minutes. 
Slides were then stained using the Rhodamine wheat germ agglutinin protocol 
described before (section 2.11). Once dry, coverslips were mounted and the slides were 
visualised using the Zeiss LSM 800 confocal microscope (Zeiss, Oberkochen, 
Germany).  
 









2.13 Tetramethylrhodamine, methyl ester (TMRM) 
TMRM is a cell-permeant cationic dye that is quickly sequestered by mitochondria 
generating a fluorescent signal able to provide information regarding the mitochondrial 
membrane potential in isolated and permeabilised muscle fibres.  
In physiological conditions, mitochondria show a membrane potential of -150mV (Perry 
et al, 2011). Being TMRM a cationic dye (with positive charge), it is able to accumulate 
within the negatively charged mitochondria in inverse proportion to the mitochondrial 
membrane following the principle described by the Nernst equation: 




Where E is the cell potential, E° the cell potential in standard condition, R the ideal gas 
constant (8.314 J/mol-K), T the temperature in Kelvins, n the number of moles of dye 
transferred, F the Faraday constant (95,484.56 C/mol) and lnQc the natural log of 
quotient content at the moment in time (Perry et al, 2011).  
Separation of muscle fibres is usually carried out in a relaxing solution where single 
muscle fibres are teased out from the muscle using fine forceps (Fine Science Tools 
GmbH, Heidelberg, Germany). For this protocol, a relaxing solution consisting of 
EDTA and Magnesium was used to prevent rigor mortis and induce muscle relaxation 
following dissection (Bozler, 1954).  
Permeabilisation of the muscle fibres allows the study of important functional 
parameters of the mitochondria that would not be possible in normal cells as some 
probes and effectors cannot reach the mitochondria in non-permeabilised cells (Brand 
and Nicholls, 2011). 
2.13.1 Reagents 
 Relaxing solution 
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o 4.5µM Adenosine 5′-triphosphate magnesium salt (Mg2ATP - Sigma-
Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
o 10mM Imidazole (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 2mM EGTA (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 100mM Potassium Chloride (KCl - Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom), 
o 1mM Magnesium Chloride (MgCl2 - Sigma-Aldrich Ltd, Gillingham, 
Dorset, United Kingdom); 
 Saponin (0.025g/500µl) (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 TMRM (Invitrogen, Paisley United Kingdom); 
 Buffer Z 
o 110mM MES Potassium salt (K-MES - Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom), 
o 35mM KCl (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 1mM EGTA (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 5.3mM Na2ATP (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 10mM Dipotassium hydrogen phosphate trihydrate (K2HPO4 - Sigma-
Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
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o 3mM Magnesium Chloride, Hexahydrate (MgCl2·6H2O - Sigma-
Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Oligomycin A (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom); 
 Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP - Sigma-
Aldrich Ltd, Gillingham, Dorset, United Kingdom). 
2.13.2 Protocol 
Saponin solution was prepared fresh by adding 0.025g of saponin to 500µl of relaxing 
solution. Eight microlitres of saponin were diluted in 1000µl of relaxing solution 
(Dilution A) and 500µl of Dilution A was added to 1000µl of relaxing solution 
(working dilution).  
Immediately following dissection, muscles were added into ice-cold relaxing solution 
and muscle fibres were manually teased out from the muscle under a microscope 
(Nikon, Kensington, UK). Following isolation, fibres were incubated for 30 minutes 
in saponin and left at room temperature to induce permeabilisation of the sarcolemma.  
Following permeabilization, fibres were transferred in a glass bottom 35mm petri dish 
(MatTek, Ashland, MA, USA) and submerged with 30nM of TMRM solution prepared 
by diluting 1.5µl of TMRM stock solution in 5ml of Buffer Z. The dish was then placed 
on an inverted confocal microscope (Nikon, Kensington, UK) and a time course 
experiment was set using 60x magnification objective at an excitation/emission 
wavelength of 543/605. A single image was captured every 3 minutes for a total of 90 
minutes. Following 45 minutes, oligomycin was added to the dish at a concentration of 
2.5µM. Olygomycin interferes with ATP Synthase of the ETC inducing accumulation of 
protons in the mitochondrial intermembrane space consequently increasing mitochondrial 
membrane potential. As TMRM was used in a non-quenching way, this increase in 
mitochondrial potential corresponds to an increase in fluorescent signal that was 
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recorded every 3 minutes. After 72 minutes, FCCP was added to the solution to reach a 
final concentration of 4µM. FCCP is a photonophore able to induce depolarization of the 
mitochondrial inner-membrane inducing an increase proton flux into the mitochondrial 
matrix and therefore significantly depolarising the mitochondrial membrane inducing a 
significant reduction of the fluorescent signal. Following addition of FCCP, the signal 
was recorded every 3 minutes until the end of the protocol (90 minutes total).   
2.14 Analysis of mitochondrial peroxide generation 
The Amplex Red assay allows the detection of mitochondrial peroxide release. This 
technique is based on the activity of a reagent (Amplex Red) that, reacting with H2O2 
in a 1:1 stoichiometry manner, generates a resorufin fluorescent signal with a maximal 
emission of 585nm. 
This very straightforward assay is able to detect levels of H2O2 as low as 10 picomoles 
in 100µl of volume. Furthermore, this technique allows the analysis of the H2O2 
production both under normal mitochondrial respiratory conditions and following the 
addition of specific inhibitors of ETC enzymes or other enzymes involved in the 
production of H2O2 in the mitochondria. 
As for the TMRM analysis, muscle bundles were permeabilised using saponin. This 
compound allows the permeabilisation of muscle fibres by interacting with the cholesterol 
molecules forming pores on the cell membrane bilayers inducing the dispersion of all 
cytosolic components (Jacob et al, 1991). Previous studies (Casas et al, 2008; 
Kuznetson et al, 2009; Mathers and Staples, 2015) have demonstrated the efficacy of 
this permeabilisation protocol to study mitochondrial functions in skeletal muscles. 
Furthermore, previous studies in denervated muscles carried out independently by our 
collaborators (Muller et al, 2007) and our laboratory (Pollock et al, 2017) have shown 
76 
 
no major differences in the analysis of peroxides release using Amplex Red in isolated 
mitochondria and permeabilised muscle bundles. 
2.14.1 Reagents 
 ROS buffer 
o 125mM KCl (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 10mM Hepes (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 5mM MgCl2 (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
o 2mM K2HPO4 (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom), 
 Amplex Red Solution (in 50ml of ROS buffer) 
o 50µl SOD from bovine erythrocytes (at 37.5U/mg, Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom) 
o 19.44mM Amplex Red solution (Thermo Fisher Scientific, Waltham, 
MA, USA) 
o 10µl Horseradish peroxidase (5U/mg Sigma, Aldrich Ltd, Gillingham, 
Dorset, United Kingdom) 
 Saponin (0.025g/500µl) (Sigma-Aldrich Ltd, Gillingham, Dorset, United 
Kingdom); 
 Specific ETC substrates 
o Glutamate/Malate – Complex I substrate, 0.25M in dH2O (Sigma-
Aldrich Ltd, Gillingham, Dorset, United Kingdom), 
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o Succinate – Complex II substrate, 0.5M in dH2O (Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom), 
o Rotenone – ETC inhibitor, 200µM in Ethanol (Sigma-Aldrich Ltd, 
Gillingham, Dorset, United Kingdom); 
 Specific enzymes inhibitors  
o Arachidonyl trifluoromethyl ketone (AACOCF3), PLA2 inhibitor, 
20µM;  
o Apocynin – NADPH Oxidase inhibitor, 0.5mM; 
o Chlorgyline - Monoamine Oxidase A inhibitor, 100µM; 
o Pargyline – Monoamine Oxidase B inhibitor, 100µM. 
2.14.2 Protocol 
Following permeabilisation of the muscle bundles using the same protocol as for the 
TMRM analysis (section 2.13), the fluostar plate reader (BMG labtech Ltd, Aylesbury, 
United Kingdom) was set a 37°C. Individual muscle bundles were placed in a black 
96 well plate (Corning, Wiesbaden, Germany) and incubated with 100µl of Amplex 
Red solution with specific substrates or inhibitors. The plate was then placed in the 
plate reader set at 590nm and incubated at 37°C for 5 minutes before analysis that was 
performed using a kinetic protocol collecting readings every 2 seconds for 10 minutes. 
At the end of the protocol, the muscle bundles were removed from the wells and frozen 
at -80°C for cryopulverisation, homogenisation and protein quantification using the 
Bradford Assay (section 2.4.3) and the results used to normalise the results obtained 
during this analysis.  
2.15 Citrate synthase assay 
Citrate synthase is an enzyme localised within the mitochondrial matrix responsible of 
the condensation of dicarboxylate oxaloacetate and acetyl CoA to tricarboxylate. The 
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activity of this enzyme can be used to indirectly determine the mitochondria number 
within a tissue homogenate. A kit from Cayman Scientific (Cayman Scientific, Ann 
Arbor, MI, USA) was used and the samples were treated following the instructions 
provided with the kit. 
2.15.1 Reagents 
 Extraction buffer 
o  250mM Sucrose (Sigma-Aldrich, Gillingham, Dorset, UK),  
o 10mM Trizma Base (Sigma-Aldrich, Gillingham, Dorset, UK),  
o 1mM EGTA (Sigma-Aldrich, Gillingham, Dorset, UK); 
 Buffer assay (Cayman Scientific, Ann Arbor, MI, USA); 
 Acetyl-CoA (Cayman Scientific, Ann Arbor, MI, USA); 
 Developer reagent (Cayman Scientific, Ann Arbor, MI, USA); 
 Oxaloacetate (Cayman Scientific, Ann Arbor, MI, USA). 
2.15.2 Protocol 
Samples were ground in liquid nitrogen and the resulting powder was mixed with 
120µl of extraction buffer. Samples were sonicated for 15 seconds on ice and 
centrifuged at 12,000g for 10 minutes at 4⁰C. Supernatants were then collected and 
quantified using the Bradford assay.  
An equal amount of protein from each sample was diluted 1:50 in the Buffer Assay 
provided with the kit and the samples stored on ice until use. A solution (Solution A) 
containing Acetyl-CoA and a developer reagent was prepared according to the kit 
guidelines and 50µl added to each well. Thirty microlitres of diluted sample and 20µl 
of a solution (Solution B) containing Oxaloacetate diluted in buffer assay were mixed 
according to the manufacturer instructions and added to the wells immediately before 
starting the reading. The plate was read using the Spectro Star Nano (BMG LabTech, 
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Offenburg, Germany) set at 412nm with readings every 30 seconds for a total of 20 
minutes. Readings from the plate reader were plotted as absorbance (y-axis) versus 
time in minutes (x-axis). The slope of the linear portion of the curve was calculated 







 x Sample dilution = µmols/min/ml 
 
2.16 Nuclear Magnetic Resonance-Based Metabolomics  
Nuclear Magnetic Resonance (NMR) Metabolomics is a technique developed in 1974 
by Wilson and Burlingame. NMR is a reliable and highly reproducible technique that 
allows the investigation of metabolites in different tissues.  
2.16.1 Reagents 
 Solvent solution 
o 50% HPLC grade acetonitrile (Thermo Fisher Scientific, Waltham, 
MA, USA), 
o  50 % ultra-pure water; 
 Selectively deuterated TrimethylSilyl Propionate (TSP); 
 Rehydration buffer  
o 100mM Sodium phosphate pH 7.4, 
o 100% deuterated water (2H2O). 
2.16.2 Protocol 
Following weighting, a variable volume (depending on sample amount) of solvent 
solution was added and samples were sonicated twice in an ice bath using an exponential 
micro probe for 30 seconds at 23kHz of frequency.  
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Following sonication, samples were vortexed for 60 seconds at maximum speed and 
centrifuged at 21,500g for 10 minutes at 4⁰C. Supernatants were collected and centrifuged 
again using the same settings before being collected and lyophilised overnight at -80⁰C.  
The following day, lyophilised samples were rehydrated in 200µl of rehydration 
buffer, centrifuged at 21,500g for 10 minutes at 4⁰C and the resulting supernatant 
added to NMR glass tubes that were then analysed on a 700MHz spectrometers 
(Bruker, Coventry, United Kingdom) fitted with Samplejet auto-samples and a proton-
optimised triple resonance NMR “inverse” probe to simultaneously decouple multiple 
nuclei and optimise for 1H observations (http://bruker.com). Samples were run 
overnight and the resulting spectra obtained were analysed with TopSpin 3.5 (Bruker, 
Coventry, United Kingdom) and ChenomX 8.2 (Edmonton, Alberta, Canada) for the 
correct “annotation” of the metabolites present in the tissue. The pattern file was 
verified using tameNMR on Galaxy.liv.ac.uk as suggested by Afgan and colleagues 
(2016) and formatted for the analysis and quantification of the metabolites using 
MetaboAnalyst 4.0 and R studio.  
2.17 Statistical analysis 
Statistical analysis was performed using IBM SPSS statistic version 22 software (IBM 
analytics, New York, USA). All tests were carried out with a 95% confidence interval 
and the level of significance was set at 0.05. Normal distribution was checked using 
the Shapiro-Wilk test and the data were expressed as the mean ± standard error mean. 
One-way ANOVA was chosen to analyse most of the variables that were showing a 
normal distribution using Bonferroni’s correction in the post-hoc analysis to find 
eventual differences between the control group and the other time points. For those 
variables where the assumption of normality was violated, differences within and 
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between groups were determined by Kruskal-Wallis test followed by Mann-Witney U 
test for post-hoc analysis applying Bonferroni’s correction. 
Furthermore, when required, the Multivariate ANalysis Of VAriance (MANOVA) was 
performed using the Wilk’s Lambda model and using Bonferroni’s correction to find 
eventual crude differences between the experimental groups.  
2.17.1 Statistical analysis for NMR metabolomics 
For NMR metabolomics, an initial analysis was performed using the online software 
MetaboAnalyst and the analysis was implemented using R studio as recommended by 
Chong and Xia (2018). For the statistical analysis, spectra were normalised to total 
area and scaled using the Pareto method. This scaling method use the √𝑆𝐷 as scaling 
factor maintaining the data structure intact while allowing a close analysis of the 
original measurements (van den Berg et al, 2016). Following normalisation and 
scaling, a Principal Component Analysis was performed to verify the eventual 
presence of differences between groups. This statistical procedure uses an orthogonal 
transformation to convert a set of possibly correlated variables into a set of values of 
linearly uncorrelated variables (Principal Components) (Patel, 2016). One-way 
ANOVA was performed to verify any crude differences between the groups for each 
metabolite applying Tuckey’s correction to avoid the risk of Type II errors.  
A heatmap was also generated using all metabolites showing significant differences 
between groups to facilitate the interpretation of the results. Pathway analysis using 
the KEGG reference was performed using Metabolite Set Enrichment Analysis 
(MSEA) to identify eventual effects of denervation on specific metabolic pathways 



















Loss of muscle mass and strength has a severe impact on the quality of life and survival 
of older adults and is referred as sarcopenia. One of the main factors responsible for 
driving the loss of muscle mass and strength during ageing is skeletal muscle 
denervation. As described by several authors (Aare et al, 2006; Jang and Van Remmen, 
2011, McDonagh et al, 2016) denervated muscle fibres show a significant reduction in 
size of approximately 35-50% compared to innervated fibres. The main causes of 
denervation in ageing are still unclear, but evidence shows that failure of the denervation-
reinnervation cycle may play a fundamental role. The denervation-reinnervation cycle is 
an important mechanism that occurs throughout life and that, when efficient, gives the 
neuromuscular system great plasticity and adaptability to external stimuli. When 
impaired, it initiates a cascade of events that result in denervation and loss of muscle 
mass, strength and power (Hepple and Rice, 2016).  
 
Table 3.1.  List of the main transcription factors regulated by ROS in developed 




Another notable characteristic of ageing is an increase in ROS levels that, if not 
adequately counteracted, can result in oxidative stress (McDonagh et al, 2016). As 
discussed earlier in this thesis, several studies have highlighted how ROS play an 
important role also in signalling. Oxidants can activate and inactivate transcription 
factors (Table 3.1 for further information), membrane channels, metabolic enzymes in 
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addition to modulating calcium-dependent and phosphorylation signalling pathways 
(Winterbourn et al, 2008). 
Hydrogen peroxide, a non-radical ROS, plays a key role in cell signalling and is 
usually generated within the mitochondria by the dismutation of superoxide (section 
1.5.3). Besides the mitochondrial ETC, 31 other enzymes have been implicated in the 
generation of H2O2 including NADPH oxidase, PLA2 and the Monoamine oxidase 
isoforms (Go et al, 2016). 
Nerve transection models have been used to examine the mechanisms leading to reduction 
in muscle mass and function following the loss of innervation. Studies using these 
denervation models in rodents also highlighted a role of mitochondrial oxidative stress 
in the mechanisms of denervation-induced muscle atrophy. In 2007, a study by Dr. 
Van Remmen’s group (Muller et al, 2007) highlighted a significant increase in 
mitochondrial ROS production (nearly 30 fold after 7 days) while a more recent study 
from our group (Pollock et al, 2017) highlighted that the increased release of mitochondrial 
peroxide is induced by the activity of several enzymes not involved in the ETC. 
The goal of the present chapter was to examine the effects of prolonged skeletal muscle 
denervation on redox homeostasis of the muscle. Specifically, our aim was to determine 
the effect of prolonged denervation on the muscle content of proteins that may 




3.2 Materials and Methods 
3.2.1 Mouse model 
Twenty-four wild type C57BL/6 and B6.Cg-Tg(Thy1-YFP)16Jrs/J adult male mice (8 
to 10 months old) were purchased from The Charles Rivers Laboratory (Bar Harbor, 
ME, USA) and kept in the Biomedical Service Unit (BSU) facilities in accordance 
with the UK Home Office guidelines under the UK Animals (Scientific Procedures) 
Act 1986. 
3.2.2 Surgical denervation of the Tibialis Anterior and Extensor Digitorum 
Longus muscles 
 To induce full denervation of the TA and EDL muscles, mice underwent a surgical 
procedure to remove a small section of the peroneal nerve in the right limb as 
previously described by Pollock et al (2017) and explained in section 2.2. Mice were 
sacrificed at different time points after denervation (1, 3, 7, 14, 21 days) through cervical 
dislocation and TA and EDL muscles collected and prepared for further analysis. 
3.2.3 Haematoxylin and Eosin staining  
TA muscles were prepared as presented in section 2.3.4, stained following the standard 
protocol for H&E staining (section 2.9) and each slide was examined using Nikon Ci 
microscope at 4x and 20x magnifications. 
3.2.4 Imaging of neuromuscular junctions  
Following dissection, muscles were fixed in 10% Neutral Buffer Formalin (Genta 
Medical, York, United Kingdom) as explained in section 2.3.5, stained with α-
Bungarotoxin-Alexa FluorTM 647 conjugate (Invitrogen, Paisley, United Kingdom) 
diluted 1:500 in PBS and analysed as stated in section 2.11. 
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3.2.5 Analysis of mitochondrial peroxide generation 
Amplex-Red analysis was used to determine the mitochondrial release of H2O2 and 
other peroxides from the TA muscle. Immediately following dissection fibres were 
separated in small bundles and permeabilised as presented in section 2.3.6. 
Approximately 15-20 bundles per sample were placed in a black 96 well plate 
(Corning, Wiesbaden, Germany) with Amplex Red solution without added substrates 
to assess State 1 ROS production, or ROS production in the presence of specific 
enzymes inhibitors (see section 2.14.1 for further information) and the signal analysed 
as explained in section 2.14.2. 
3.2.6 Total glutathione and oxidised glutathione assays 
Tibialis Anterior muscles were ground in liquid nitrogen and the resulting powder was 
added to 1% SSA (Sigma-Aldrich Ltd, Gillingham, Dorset, United Kingdom) and 
treated as shown in section 2.3.3. Total glutathione was assessed using the recycling 
method described in section 2.7. To analyse GSSG content, before the analysis, 
samples prepared as for the GSH assay were derivatised by the addition of 2µl of 2-
Vinylpyridine as presented in section 2.8. 
3.2.7 SDS-PAGE and western blot analysis 
For SDS-PAGE and western blot analysis TA muscles were ground in liquid nitrogen 
and treated as explained in section 2.3.1. For each SDS-PAGE analysis, 30μg of total 
protein were added to a polyacrylamide gel and electrophoresis performed as presented 
in section 2.5. Following transfer of the proteins onto a membrane, Ponceau red 
(Sigma-Aldrich, St. Louis, MI, USA) was used to to normalise the results as described 
by Romero-Calvo and colleagues (2010). 
Chemiluminescence signal was detected using the ChemiDocTM imaging system 
(Bio-Rad, Hercules, CA, USA) after the addition of ECL to each membrane (Bio-Rad, 
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Hercules, CA, USA). Densitometric analysis was performed using the ImageJ software 
(McLean, 2011). Most of the subunits analysed in this chapter showed changes within 
the dynamic range of western blots that could be quantified by densitometry. However, 
some proteins were undetectable, or barely detectable in the baseline (non-denervated) 
and, therefore, in these cases only example blots are presented to show the changes 
observed. 
3.2.8 Analysis of protein carbonylation 
Tibialis Anterior muscles were homogenised in Hepes buffer and processed using the 
OxyBlot Protein Oxidation Detection Kit (Merk, Darmstadt, Germany) (sections 2.3.2 and 
2.6). Samples were separated on 12% polyacrylamide using a protocol similar to the 
one used for the SDS-PAGE (section 2.6). Densitometry analysis of the bands at 





3.3.1 Anthropometric measurements  
The statistical analysis identified no significant differences in total body weight between 
the control and denervation groups (Figure 3.1a). Analysis of the denervated TA mass 
showed a significant reduction in muscle weight starting at 7 and proceeding up to 21 
days when compared with the control group F(5,19)=33.204 p<0.01 (Figure 3.1b). 
Statistical analysis also showed that there were no significant differences between the 
control and the other groups in total fibre numbers (Figure 3.1c) although there were 
significant differences in muscle fibres CSA. As shown in Figure 3.1d, 7 days following 
denervation there is a significant decrease of large muscle fibres (>2001μm) with a 
related increase of small/medium muscle fibres. 
The H&E staining (Figure 3.2a) was undertaken to determine potential infiltration of 
the muscle with immune cells. No significant accumulation of immune cells was seen 
in skeletal muscle following denervation (Figure 3.2a).  
3.3.2 Qualitative analysis of the neuromuscular junction following denervation 
Analysis of the NMJ following denervation (representative images shown in Figure 
3.2b) showed a progressive breakdown of the pre-synaptic terminal (in green) starting 
almost immediately (1 day) following surgery and resulting in full muscle denervation 
from 7 days post-surgery. Fourteen days following denervation progressive enlargement 








Figure 3.1a.  Total body weights from control mice (non -
denervated) and mice at 1, 3,  7, 14 and 21 days post-
denervation. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).  
 
 
Figure 3.1b.  Tibialis Anterior muscle weights from control 
mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post -
denervation. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).  
** p<0.01 - *** p<0.001 compared with the control group.  



















































Figure 3.1c.  Fibre number in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 
days post-denervation. Histograms represent the mean and the 




Figure 3.1d.  Analysis of fibre CSA from Tibialis Anterior muscle in control mice (non -
denervated) and mice at 7, 14 and 21 days post -denervation.  
Histograms represent the mean  fibre percentage in each threshold  and the standard 
error of the mean for each experimental group (n=4) .  
* p<0.05 - ** p<0.01 - *** p<0.001 compared with the control group.  
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Figure 3.2a.  Transverse sections of Tibialis Anterior muscles visualized by H&E 





Figure 3.2b.  Represntative NMJs observed in whole EDL muscle from a control mice 
(non-denervated) and a mice at 1, 3,  7, 14 and 21 days post -denervation. Images 




3.3.3 Peroxide release from bundles of muscle fibres  
As shown in Figure 3.3a, data from the Amplex Red assay showed a statistically 
significant increase in peroxide production following denervation F(4,11)=44.354 
p<0.01. Peak peroxide production was at 7 days although levels remained significantly 
elevated up to 21 days. The addition of specific inhibitors Chlorgyline F(3,8)=4.902 
p<0.05, Pargyline χ2(3)=9.667 p<0.05, Apocynin F(3,8)=4.349 p<0.05 and 
AACOCF3 F(3,8)=8.347 p<0.01 reduced peroxide release to variable extents at 7, 14 
and 21 days post-denervation (Figure 3.3b). This decrease suggests that these 




Figure 3.3a.  State 1 H2O2 production in mitochondria in 
permeablised Tibialis Anterior fibre determined by oxidation of 
amplex red from control (non-denervated) mice and mice at 1, 3,  
7, 14 and 21 days post-denervation.  
Histograms represent the mean and standard error of the mean 
for each experimental group (n =4). *** p<0.001 compared with 
the control group.  
 
 
































































Figure 3.3b.  State 1 mitochondrial H 2O2  generation from permeabilised fibres of the 
Tibialis Anterior muscle in the presence of different enzyme inhibitors.  Chlorgyline 
(Monoamine Oxidase A -100µM), parglyline (Monoamine Oxidase B - 100µM), 
apocynin (NADPH oxidase -  0.5mM), AACOCF3 (PLA2 - 20µM) resulted in 
significantly reduced H 2O2 generation compared untreated fibre bundles at 14 and 
21 days post-denervation. Histograms represent the mean percentage of State 1 and 
standard error of the mean for each experimental group (n=4). * p<0.05 - ** p<0.01 
- *** p<0.001 compared with its state 1 (fibres not exposed to any inhibitor).  
 
 
3.3.4 Total glutathione and oxidised glutathione content 
The glutathione (GSH) and oxidised glutathione (GSSG) contents of denervated 
muscles are shown in Figure 3.4a and Figure 3.4b. Data show no statistically 
significant differences with time post-denervation in GSH F(5,16)=1.473 p>0.05 and 
GSSG F(5,15)=1.291 p>0.05. There was also no significant change in the percentages 
of glutathione that was oxidised F(5,15)=0.169 p>0.05. 
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Figure 3.4a.  Total glutathione (GSH) contents in Tibialis Anterior 
muscles from control (non-denervated) mice and mice at 1, 3,  7, 14 
and 21 days post-denervation.  
Histograms represent the mean and standard error of the mean for 




Figure 3.4b.  Oxidised glutathione (GSSG) contents in Tibialis 
Anterior muscles from control (non -denervated) mice and mice at 1, 
3, 7, 14 and 21 days post -denervation.  
Histograms represent the mean and standard error of the mean for 
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3.3.5 Protein oxidation in TA muscles following denervation 
Oxyblot analysis showed considerable variability within groups but no overall differences 
were seen with time. The Oxyblot (original blots presented in Appendix 2) revealed 6 
major bands of approximate molecular weight 95, 75, 65, 55, 35 and 25 kDa (Figure 
3.5). A comparison of the different time points with the control group demonstrated 
that only the band seen at approximately ~25 KDa, showed increased intensity at 7 











Figure 3.5.  Quantification of protein carbonyls by densitometric analysis of the 
protein bands at different molecular weights.  A representative lane of an Oxyblot 
for control muscle showing the bands detected with approximate molecular weights 
indicated (kDa). Histograms represent the mean and standard error of the mean for 
each experimental group (n=4). * p<0.05 compared with the control group.  
 




























































































































































































































































































































































3.3.6 Content of NADPH oxidase subunits in denervated muscle 
The proteins analysed were: NOX2/gp91 phosphorylated (NOX2/gp91 phox - Figure 
3.6a), p22 phosphorylated (p22phox - Figure 3.6.b), p40 phosphorylated (p40phox -, 
Figure 3.6c), p47 phosphorylated (p47phox - Figure 3.6d), p67 phosphorylated 
(p67phox - Figure 3.6e), Ras-related C3 botulinum toxin substrate 1 (Rac-1 - Figure 
3.6f) and NADPH Oxidase 4 (NOX4 - Figure 3.6g). The protein content of all the 
NOX2 subunits was increased significantly after denervation. However, this increase 
differed in terms of timing and magnitude of change. 
NOX2/gp91phox (F(5,14)=10.309, p<0.01), p22phox (χ2(5)=17.486 p<0.001) showed 
maximum protein content at 14 days post denervation. p47phox protein content 
reached a statistically significant value at 3 days post denervation (F(5,15)=7.390, 
p<0.01). p67phox protein content was increased at 14 days post denervation 
(F(5,17)=15.595, p<0.01) but changes were maintained significant up to 21 days after 
denervation. Rac-1 showed a statistically significant increase at 7 days (F(5,16)=3.829, 
p<0.01) post-denervation. Analysis of NOX4 protein content showed little change up 
to 14 days post-denervation, although a trend toward an increase was seen at 21 days 













Figure 3.6a .  Quantification of western blo ts of NOX2/gp91phox 
in Tibialis Anterior muscle from control mice (non-denervated) 
and mice at 1, 3, 7, 14 and 21 days post -denervation. Histograms 
represent the mean protein content and standard error of the 
mean for each experimental group (n=4).  




Figure 3.6b .  Quantification of western blo ts of p22phox in 
Tibialis Anterior muscle from control mice (non-denervated) and 
mice at 1, 3, 7, 14 and 21 days post -denervation. Histograms 
represent the mean protein content and standard error of the 
mean for each experimental group (n=4).  
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Figure 3.6c.  Representative western blots of p40phox in Tibialis Anterior muscle 
from control mice (non-denervated) and mice at 1, 3, 7,  14 and 21 days post -
denervation. As shown in the figure the control group was not detectable when 
analysed together with the 14 and 21 days group making impossible to accurately 
quantify the relative content of this  protein. Despite th is it is clear the progressive 





Figure 3.6d .  Quantification of western blo ts of p47phox in 
Tibialis Anterior muscle from control mice (non-denervated) and 
mice at 1, 3, 7, 14 and 21 days post -denervation. Histograms 
represent the mean protein content and standard error of the 
mean for each experimental group (n=4).  
*** p<0.001 compared with the control group.  
 
 































































Figure 3.6e.  Quantification of western blo ts of p67phox in 
Tibialis Anterior muscle from control mice (non -denervated) 
and mice at 1, 3, 7,  14 and 21 days post -denervation. Histograms 
represent the mean protein content and standard error of the 
mean for each experimental group (n=4).  




Figure 3.6f .  Quantification of western blo ts of Rac-1 in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 
1, 3, 7, 14 and 21 days post -denervation.  Histograms represent 
the mean protein content and standard error of the mean for each 
experimental group (n=4).  
* p<0.05 compared with the control group.  
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Figure 3.6g .  Quantification of western blo ts of NOX4 in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 
1, 3, 7, 14 and 21 days post -denervation.  Histograms represent 
the mean protein content and standard error of the mean for each 
experimental group (n=4).  
 
 
3.3.7 Muscle protein content of Prx6, cPLA2 and Monoamine Oxidase A in 
denervated muscle 
Prx6 was undetectable in the baseline (non-denervated) samples making impossible to 
accurately quantify the relative content of the protein at 14 and 21 days post-denervation. 
Therefore, example blots are presented (Figure 3.7a) where the significant increase of 
this protein is clear from 7 days following denervation. 
Calcium-dependent PLA2 content is shown in Figure 3.7b and indicate a statistically 
significant increase at 14 days post-denervation (F(5, 16)=98.569, p<0.01) and a 
further increase up to 21 days compared with the control group.  
Monoamine Oxidase A showed an increase in content in denervated muscle with a 




































































Figure 3.7a .  Representative western blots of Prx6 in Tibialis Anterior muscle 








Figure 3.7b .  Quantification of western blo ts of cPLA2  in 
Tibialis Anterior muscle from control mice (non-
denervated) and mice at 1, 3, 7, 14 and 21 days post -
denervation.  Histograms represent the mean protein 
content and standard error of the mean for each 
experimental group (n=4).  
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Figure 3.7c .  Quantification of western blo ts of Monoamine 
Oxidase A in Tibialis Anterior muscle from control mice 
(non-denervated) and mice at 1, 3,  7, 14 and 21 days post -
denervation.  Histograms represent the mean protein 
content and standard error of the mean for each 
experimental group (n=4).  
* p<0.05 - ** p<0.01 - *** p<0.001 compared with the 
control group.  
 
3.3.8 Muscle content of mitochondria-localised regulatory enzymes post-denervation 
Three major mitochondrial antioxidants enzymes were analysed: Manganese Super-oxide 
Dismutase (MnSOD - Figure 3.8a), Thioredoxin Reductase 2 (TrxR2 - Figure 3.8b) and 
Glutathione Peroxidase 1 (GPx1 - Figure 3.8c). 
MnSOD content in muscle did not change significantly following denervation 
(F(5,15)=3.829 p>0.05). In contrast, TrxR2 was statistically significantly increased at 3 
and 7 days post denervation (F(5,15)=10.899 p<0.01). GPX1 content showed an increased 








































































Figure 3.8a.  Quantification of western blo ts of MnSOD in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 
1, 3, 7, 14 and 21 days post -denervation.  
Histograms represent the mean protein content and standard 




Figure 3.8b .  Quantification of western blo ts of TrxR2 in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 
1, 3, 7, 14 and 21 days post -denervation.  Histograms represent 
the mean protein content and standard error of the mean for each 
experimental group (n=4).  
** p<0.01 - *** p<0.001 compared with the control group.  
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Figure 3.8c.  Quantification of western blo ts of GPx1 in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 
1, 3, 7, 14 and 21 days post -denervation.  
Histograms represent the mean protein content and standard 
error of the mean for each experimental group (n=4).  
* p<0.05 - ** p<0.01 compared with the control  group.  
 
3.3.9 Heat Shock Proteins content of denervated muscle fibres 
TA muscles from adult mice respond to denervation by a relatively slow increase in 
Hsp protein content. The Hsc70 content in denervated TA muscles was significantly 
increased at 14 and 21 days post-denervation (F(5, 15)=16.073 - Figure 3.9a). Hsp25 was 
significantly increased at 3, 7, 14 and 21 days following denervation (F(5, 16)=147.142, 
p<0.01 - Figure 3.9b).  Hsp70 was barely detectable at basal levels (non-denervated) 
making impossible to perform relative quantification of the protein content at 14 and 21 
days post-denervation. Therefore, only an example blot is presented (Figure 3.9c). 
However, in the representative blots presented in Figure 3.9c, it is clear that an 
increase of this protein occurs immediately following denervation which is maintained 
up to 21 days. 
 
































































Figure 3.9a .  Quantification of western blo ts of Hsc70 in 
Tibialis Anterior muscle from control mice (non-denervated) 
and mice at 1, 3, 7, 14 and 21 days post -denervation. 
Histograms represent the mean protein content and standard 
error of the mean for each experimental group (n=4).  




Figure 3.9b .  Quantification of western blo ts of Hsp25 in Tibialis 
Anterior muscle from control mice (non-denervated) and mice at 
1, 3, 7, 14 and 21 days post -denervation.  
Histograms represent the mean protein content and standard 
error of the mean for each experimental group (n=4).  

































































































1 0 0 0






























Figure 3.9c. Representative western blots of Hsp70 in Tibialis Anterior muscle from 
control mice (non-denervated) and mice at 1, 3, 7,  14 and 21 days post -denervation.  
As shown in the figure the control group was not detectable when analysed together 





3.4 Discussion  
It is well recognised that during ageing, alongside a significant loss of muscle mass, 
strength and power, there is a significant reduction of functional innervation of the 
skeletal muscles. Previous studies (Muller et al, 2007; Bhattacharya et al, 2009; 
Pollock et al, 2017) have investigated this phenomenon focusing their attention on the 
significant increase in peroxide release from mitochondria of denervated skeletal 
muscle fibres. During normal conditions, the ETC plays a central role in peroxide 
production and release; however other enzymes present within the mitochondria 
appear to play an important role in peroxide release in denervated muscle fibres 
(Pollock et al, 2017).  
In the present study, compared with previous works, we extended the time course of 
denervation up to 21 days to examine the long-term effects of peroxide release on those 
proteins that regulate redox homeostasis in muscle. To investigate the changes in 
peroxide release from denervated skeletal muscle fibres, we used a surgical procedure 
aimed at inducing full denervation on the TA and EDL muscles. Figure 3.2b shows 
the effectiveness of this denervation protocol in inducing a progressive loss of 
innervation from day 1 and full denervation between 3 and 7 days when traces of the 
nerve are not visible anymore. Furthermore, between 7 and 21 days the ACh receptors 
in denervated muscle fibres started to progressively breakdown. This loss of pre-
synaptic axonal input translates in a significant loss of muscle mass starting at 7 days 
following denervation which continues up to 21 days. Our results show that this loss 
of muscle mass was not due to a loss of muscle fibres but rather due to a significant 
muscle fibre atrophy. As shown in Figure 3.2a, a significant decrease in the number 
of large muscle fibres occurred following denervation accompanied by a significant 
increase of medium/small muscle fibres.  
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Previous work from our group (Pollock et al, 2017) demonstrated an increase in 
mitochondrial peroxide release at 7 days following denervation and addition of substrates 
and inhibitors of the ETC excluded the possibility that the increase in peroxide release 
resulted from the ETC activity (result not shown in detail). Our results showed that other 
enzymes such as the two isoforms of Monoamine oxidase (Monoamine oxidase A and 
Monoamine oxidase B), NADPH Oxidase and PLA2 may play a fundamental role in 
peroxide release (Figure 3.3b). 
Monoamine oxidase A and B share 70% of their sequences but present different 
substrate specificity (Duicu et al, 2016). Both isoforms are expressed in skeletal 
muscle and are normally located on the mitochondrial outer membrane (Billet, 2004; 
Manoli et al, 2005) where they play an important function in regulating neurotransmitter 
levels and in degrading amines that could function as false neurotransmitters (Cadenas 
and Davies, 2000). The addition of Chlorgyline (inhibitor of monoamine oxidase A) 
and Pargyline (inhibitor of Monoamine oxidase B) reduced the oxidation of Amplex 
red at 7, 14 and 21 days following denervation. In addition, while we failed to detect 
significant changes in Monoamine oxidase B content (result not shown in detail), we 
saw a significant increase of Monoamine oxidase A content at 7 days following 
denervation.  
In line with previous studies (Bhattacharya et al, 2009; Pollock et al, 2017), we showed 
a significant reduction of the Amplex Red signal following the addition of Apocynin 
(Figure 3.3b) suggesting a primary role played by NOX enzymes in the mitochondrial 
peroxide release following denervation. Given its subcellular localisation, NOX4 
could likely be an important contributor to mitochondrial peroxide release following 
denervation but our analysis of NOX4 content showed no significant changes throughout 
the time course. However, as the focus of the present work was to analyse NOX4 
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protein content and not activity, we cannot exclude the possibility that NOX4 activity 
is altered in response to denervation.    
Bhattacharya and colleagues (2009) suggested that mitochondria of denervated muscle 
fibres can also release lipid peroxide via PLA2 activity in addition to H2O2. Lipid 
peroxidation is a process that results in the deterioration of phospholipids via free-
radical propagated chain reactions leading to the formation of lipid radicals, lipid 
peroxyl radicals and lipid peroxides (Ayala et al, 2014). PLA2 generates arachidonic 
acid that, interacting with different phospholipids that compose the mitochondrial 
membrane, is able to produce large amounts of lipid peroxides (Balsinde et al, 2002). 
Our results suggested that PLA2 is also responsible for the significant increase in 
peroxide release in denervated skeletal muscle. In the present study, the addition of 
AACOCF3 (PLA2 inhibitor used in the present work – Figure 3.3b) to the Amplex 
Red assay resulted in the most significant drop in peroxide release suggesting that this 
enzyme plays a fundamental role in mitochondria of denervated muscle fibres. 
Furthermore we also saw a significant increase in protein content of the cytosolic 
isoform of this enzyme (cPLA2) which is able to stimulate the assembly and activation 
of NOX2 in the cytosol. Indeed, the arachidonic acid produced by cPLA2 is used by 
MAPK to induce phosphorylation of p40, p47 and p67 (3 important components of 
NOX2) allowing their translocation to the membrane (Chatterjee et al, 2011). 
NOX2 is a multimeric enzyme found mainly in the cytosol that catalyses the conversion 
of O2 to superoxide (Groemping and Rittinger, 2005; Ferreira and Laitano, 2016). This 
enzyme requires that its isoforms translocate to the membrane where this complex is 
assembled. Five different subunits compose this enzyme: p22phox and NOX2/gp91phox 
are membrane-bound while p40phox, p47phox and p67phox translocate to the membrane 
following activation through phosphorylation. In the present study we demonstrated that 
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there is a significant increase in the content of NOX2/gp91phox and p22phox 14 days 
following denervation, together with p67phox and p40phox (Figures 3.6a-e). Our data 
also showed that the protein contents of p47phox and Rac1 are significantly increased 
between 3 to 7 days post-denervation. Phosphorylation of p47 and activation of Rac1 
have previously been reported in skeletal muscle with these post-translational events 
leading to the activation of NOX2 (Ferreira and Laitano, 2016).  
The activation of this enzyme results in a significant production of superoxide in the 
extracellular space that, once converted onto H2O2 is able to translocate back into the 
muscle fibre where it plays different fundamental physiological roles. For instance, 
H2O2 generated by NOX2 plays an important role during muscle contraction (Ward et 
al, 2014) but is also able to interact with the angiotensin II system inducing insulin 
resistance or activating atrophy pathways involving the Proteasome 26S (Ferreira and 
Laitano, 2016). Furthermore, it has been suggested that, following denervation, the 
H2O2 produced by NOX2 may function as a signal aimed at stimulating and directing 
nerve sprouting in the attempt of restoring the connection between the ACh receptors 
and a motor neuron (Pollock et al, 2017). Despite the fact that we can only speculate 
about the physiological role played by the H2O2 produced by NOX2 in denervated 
skeletal muscle, the significant muscle atrophy observed could be explained by the 
activation of the ubiquitin proteasome pathway by the activity of NOX2.  
Another interest of this study was to determine the response of Prx6 following denervation 
as this atypical 1-Cys Prx can function either as antioxidant or as phospholipase (Fisher et 
al, 2011; Brandes et al, 2014). Prx6 is mainly a cytosolic enzyme but can translocate to 
the mitochondria where it binds and reduces phospholipid hydroperoxides (Eismann 
et al, 2009). Once in the mitochondrion, Prx6 can become over-oxidised and undergo 
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conformational changes that allow this protein to acquire PLA2 activity (Fisher et al, 
2011) producing arachidonic acid and lipid peroxides itself (Chatterjee et al, 2011). 
The protein content of Prx6 was undetectable in control samples but was increased 
from 3 days following denervation. Our data suggest that in response to denervation 
Prx6 translocates to the mitochondria where it may get over-oxidised starting to 
contribute to the peroxides release and the activation of NOX2 via the Prx6-PLA2-
mediated signalling pathway (Chatterje et al, 2011).  
A further objective of this study was to examine the response of the mitochondrial 
antioxidant system following the increase in peroxide release in denervated muscle 
fibres. The contents of 3 major mitochondrial antioxidant enzymes: MnSOD, TrxR2 
and GPx1 were analysed. While the content of MnSOD did not change following 
denervation, both TrxR2 and GPx1 contents were significantly increased at 3 and 7 
days (Figure 3.8b and Figure 3.8c). TrxR2, the mitochondrial isoform of thioredoxin 
reductase, catalyses the NADPH-dependent reduction of thioredoxin (Patenaude et al, 
2004). As GPx1 acts to prevent the harmful accumulation of H2O2 (Lubos et al, 2011), 
the initial response observed may reflect an adaptive response following the disruption 
of the NMJ in an attempt to maintain redox homeostasis in the muscle. Nevertheless, 
the increase content of Hsp proteins over long term suggests a disturbance of the redox 
homeostasis with significant increase in oxidative stress and protein degradation.  
It has previously been shown that exposure to elevated levels of H2O2 appears to 
promote protein degradation in skeletal muscle via the ubiquitin-proteasome pathway 
(Powers et al, 2011). An increase in H2O2 can induce activation of redox-sensitive 
genes that code for ubiquitin and regulatory E2 and E3 proteins; upregulation of these 
genes increases the rate of ubiquitin conjugation within skeletal muscle that accelerates 
the targeting of muscle proteins for degradation by the 26S proteasome (Li et al, 2003). 
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In this context Hsp70 is critical in maintaining terminally misfolded proteins in a 
soluble state for ubiquitin conjugation and proteasomal degradation (Shiber et al, 
2013). In this denervation model, the Hsp70 content was increased following 
denervation and remained increased up to 21 days (Figure 3.9c) suggesting that Hsp70 
may play a role in protein homeostasis in the denervated muscle fibres. Prolonged 
denervation also resulted in an increased content of Hsc70 (Figure 3.9a) which plays 
an important role during chaperone-mediated autophagy (CMA). Once Hsc70 
recognises and binds a targeted protein, it makes the protein available to the lysosome-
associated membrane protein 2 (LAMP-2A) that unfold and translocate the proteins 
into the lysosomal lumen for degradation (Cuervo and Wong, 2014; Zhou et al, 2017; 
Kaushik and Cuervo, 2015). CMA operates at basal conditions in most mammalian 
cells, but it is activated in response to stressors, such as oxidative stress (Xilouri and 
Stefanis, 2016). LAMP-2A was not measured in the current study but we speculate 
that the increased content of Hsc70 is linked to CMA although further studies are 
required to identify the precise mechanisms involved. 
Finally, we observed that the muscle Hsp25 content was also significantly increased 
from 3 days following denervation and remained increased until 21 days (Figure 3.9b). 
Previously it has been demonstrated that overexpression of Hsp25 in skeletal muscle 
cells resulted in dose-dependent protection against H2O2-induced damage that was 
associated with increased GSH levels and GPx1 activity (Escobedo et al, 2004). In our 
analysis there was no change in GSH concentration following denervation but a 
significant increase in Gpx1 content that is maintained up to 21 days. These data 
suggest that following denervation Hsp25 and Gpx1 may play a synergetic role in 
response to the increase of peroxide release from mitochondria. To our knowledge, no 
other studies have investigated eventual changes of GSH or GSSG levels in denervated 
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muscles. However, a previous study from Agostini and colleagues (2010) analysed 
changes in GSH levels using Gas chromatography–mass spectrometry finding that 
during muscle atrophy GSH content increases in response to an increase of ROS 
accumulation.  
In the present study, the lack of changes in GSH and GSSG levels may be related to a 
lack of sensitivity of the assay used. In future studies aimed to analyse the glutathione 
response in denervated fibres the use of relatively new and more reliable techniques 
such as Gas chromatography–mass spectrometry can potentially shed new light over 
the effects of denervation on GSH and GSSG levels.  
The carbonyl content of muscle soluble proteins following denervation was examined 
to verify whether the increased peroxide release resulted in significant changes in 
protein oxidation (Figure 3.5). Despite the high variability recorded, analysis of the 
bands at different molecular weights showed significant changes in the proteins around 
25 kDa, with a maximum increase around 7 days, which coincided with the maximal 
increase in peroxide release. Carbonylation is the most common type of alteration seen 
during oxidative stress where a carbonyl group is introduced into proteins by a metal-
catalysed oxidation of specific amino acids or indirectly by the reaction with species 
derived from lipid peroxidation (Lyons and Jenkins, 1997). The increased carbonylation 
seen at 7 days reinforce the possibility that over long term the denervation-induced 
release in peroxide leads to oxidative stress.  
Overall, our data suggest that following denervation, there is a significant increase in 
peroxide release that is maintained up to 21 days. This increase is associated with 
changes in content of Prx6 and the cytosolic isoform of PLA2 which, as suggested, play 
a primary role in NADPH oxidase 2 activation. The initial increase in the antioxidant 
enzymes TrxR2 and GPx1 content and the later increase in Hsps content suggests a 
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possible initial protection within the muscle bulk; however, long term exposure to 
peroxides together with the activation of cPLA2 and NOX2 is likely to activate 
















4.1 Introduction  
Mitochondria, known as “the power generators of the cell”, are rod-shaped organelles 
that play a pivotal role in cellular metabolism as they host important respiratory steps 
such as the citric acid cycle, β-Oxidation, oxidative phosphorylation while are also 
involved in calcium handling and heme biosynthesis (Mishra and Chan, 2016). 
Mitochondria perform these functions using nutrients such as glucose and through a 
series of chemical reactions in which components such as NADPH and O2 are used to 
generate ATP. The number of mitochondria in a cell depends on the metabolic requirements 
of that cell; indeed, the higher the mitochondria number, the higher is the amount of 
energy that can be produced (Mishra and Chan, 2016). Muscle fibres present a 
significantly high mitochondria density that varies according to fibre type. For example, 
the mitochondrial density in heart muscle cells is approximately 40% of total cell 
volume whereas slow twitch skeletal muscle fibres (Type I) present a density of 8-12% 
(which can increase up to 19% in highly trained endurance athletes); the percentage 
decreases in Type IIa (Intermediate fibres) with a density that variates between 5 to 
10% with a further decrease to 2% in Type IIx muscle fibres of highly trained strength 
athletes (Ortenblad et al, 2018).  
Maintaining skeletal muscle mitochondrial functions as well as content is important 
for sustained health throughout the lifespan. During ageing there is a significant 
reduction in mitochondria number accompanied by changes in ultrastructure and 
localisation. For instance, mitochondria in muscle fibres from older individuals show 
a more rounded appearance with vacuoles within the matrix and a shorter cristae when 
compared with mitochondria from muscles of younger subjects (Seo et al, 2016). These 
modifications are associated with impaired mitochondria metabolism, ATP production 
rate, protein synthesis and increased ROS production (Seo et al, 2016). In addition, with 
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age there is a significantly lower rate of mitochondrial biogenesis with reduced 
transcriptional regulation that results in significant alterations of cell homeostasis (Baker 
and Haynes, 2011). The increased production of ROS by impaired mitochondria has a 
significant impact on the redox homeostasis of skeletal muscle resulting in a greater 
oxidative damage to DNA, lipids and proteins (Nabben et al, 2011) with all these 
modifications associated with muscle wasting (Seo et al, 2016).  
Mitochondria are dynamic organelles as their turnover and morphology continually 
changes through the cell life cycle, changes that are driven by the combined action of 
fission, fusion and motility (Youle and van der Bliek, 2012). Cells are able to modify 
their number of mitochondria according to the physiological stimuli through a complex 
and well-coordinated process known as mitochondrial biogenesis. This process provides 
the cell with adequate mitochondrial turnover and adaptation to physiological stresses 
through growth and division of pre-existing mitochondria (Elguero et al, 2012). 
Another important process that plays a major role in maintaining a healthy pool of 
mitochondria is mitophagy. This phenomenon was firstly observed in 1962 by Ashford 
and Porter and describes the fission of damaged and superfluous mitochondria that are 
recycled by fusion with healthy mitochondria providing constant quality control and 
recycle of the mitochondria population (Youle and van der Bliek, 2012). As suggested 
by Palikaras and colleagues (2015), healthy cells have a correct balance between 
mitophagy and mitochondrial biogenesis. Imbalance, in either direction, can have a 
significant impact on mitochondria number, health and efficiency.  
Changes in the number and functionality of the mitochondria population has a severe 
impact on the survival of the cells and impairment of the mitochondria population is 
reported to be responsible of the initiation of sarcopenia (Alway et al, 2017). 
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In the previous chapter we described a significant increase in peroxide release from 
mitochondria of denervated skeletal muscle fibres that may trigger atrophy; however, 
the impact that this increase in peroxide release has on the functionality and stability 
of mitochondria is still unclear. In the current chapter the effects of skeletal muscle 
denervation on mitophagy, activation of apoptosis and mitochondrial number and 




4.2 Materials and Methods 
4.2.1 Mouse model 
Twelve wild type male C57BL/6 adult mice (8 to 10 months old) were purchased from 
The Charles Rivers Laboratory (Bar Harbor, ME, USA) and kept in the Biomedical 
Service Unit (BSU) facilities in accordance with the UK Home Office guidelines under 
the UK Animals (Scientific Procedures) Act 1986. 
4.2.2 Surgical denervation of the lower hind-limb 
Eight mice underwent a surgical procedure to remove a small section of the sciatic nerve 
to induce denervation (section 2.2). Mice were sacrificed 7 and 21 days following 
denervation by cervical dislocation and muscles from both legs were collected and 
prepared for further analysis. 
4.2.3 SDS-PAGE western Blot analysis 
For each analysis, 30μg of total protein from the TA muscle were added to 4μl of Blu-
mercaptoethanol (4x) and ddH2O to a final volume of 16μL. SDS-PAGE/Western Blot 
analysis was performed as previously described in section 2.5. Different primary 
antibodies (Table 2.3 for further details) were detected using near-infrared fluorescent 
IRDye secondary antibodies (Licor, Bad Homburg, Germany) and the membranes 
analysed on the Licory Odissey CLx (Licor, Bad Homburg, Germany).  
4.2.7 Citrate synthase assay 
This experiment was performed using the kit purchased from Cayman Scientific (Ann 
Arbor, MI, USA). An equal amount of proteins from the soleus muscle was diluted 
1:50 in the Buffer Assay provided with the kit and treated as presented in section 2.15. 
120 
 
4.2.8 Mitochondria membrane potential analysis  
Mitochondrial membrane potential was assessed in the EDL using TMRM as previously 
described in section 2.13. Images were collected using an inverted confocal microscope 
(Nikon, Kensington, UK) and changes in fluorescence overtime were analysed using 





4.3.1 Anthropometric measurements  
No significant differences in total body weight were seen between the groups (Figure 
4.1a). The Tibialis Anterior muscle showed a significant reduction in weight at 7 days 
following denervation progressing up to 21 days, F(2,9)= 17.765 p<0.01 (Figure 4.1b).  
The EDL showed a significant reduction in weight at 21 days following denervation 
F(2,9)= 6.909 p<0.05  (Figure 4.1c) while the soleus muscles F(2,9)= 6.412  p<0.05 
show a significant reduction in muscle mass at 7 and 21 days following denervation 




Figure 4.1a.  Total body weights from control mice 
(non-denervated) and mice at 7 and 21 days post -
denervation. Histograms represent the mean and the 
standard error of the mean for each experimental 










































Figure 4.1b.  Tibialis Anterior muscle weights from 
control mice (non-denervated) and mice at 7 and 21 
days post-denervation. Histograms represent the mean 
and the standard error of the mean for each 
experimental group (n=4).  





Figure 4.1c.  Extensor Digitorum Longus muscle weights 
from control mice (non-denervated) and mice at 7 and 
21 days post-denervation. Histograms represent the 
mean and the standard error of the mean for each 
experimental group (n=4).  
** p<0.01 compared with the contro l group.  
 
















































































Figure 4.1d.  Soleus muscle weights from control mice 
(non-denervated) and mice at 7 and 21 days post-
denervation. Histograms represent the mean and the 
standard error of the mean for each experimental 
group (n=4).  
* p<0.05 compared with the control group.  
 
 
4.3.2 Mitophagy markers 
Specific proteins involved in the mitophagy process were analysed through SDS-
PAGE western blot. The ratio of phosphorylated Dinamin-like Protein 1 
(pDrp1)/Dinamin-like Protein 1 (Drp1) showed a significant increase at  7 and 21 days 
compared with the control group F(2,9)=16.001 p<0.05 (Figure 4.2a). Analysis of Optic 
Atrophy 1 (OPA1) showed no significant differences between the 3 groups (Figure 
4.2b). Similarly, analysis of Mitofusin 2 (Mfn-2) showed no significant changes 
following denervation (Figure 4.2c). Analysis of p62 F(2,9)=13.722 p<0.05 instead 
revealed a significant increase in the content of this protein in skeletal muscle at 7 and 
21 days following denervation (Figure 4.2d).   
 
 














































Figure 4.2a.  Representative western blot and quantification of the ratio between 
phosphorylated Drp1 and Drp1 protein content used as a marker of mitochondria 
fission in Tibialis Anterior muscle from Control (non -denervated) and mice at 7 and 
21 days post-denervation. Histograms represent the mean protein content and 
standard error of the mean for each experimental group (n=4).  








Figure 4.2b.  Representative western blot and quantification of OPA1 protein content 
used as a marker of mitochondria fusion in Tibialis Anterior muscle from Control 
(non-denervated) and mice 7 and 21 days post -denervation. Histograms represent the 
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Figure 4.2c.  Representative western blot and quantification of Mfn-2 protein content 
used as a marker of mitochondria fusion in Tibialis Anterior muscle from Control 
(non-denervated) and mice 7 and 21 days post -denervation. Histograms represent the 









Figure 4.2d.  Representative western blot and quantification of p62 protein content 
used as a marker mitophagy in Tibialis Anterior muscle from Control (non -
denervated) and mice 7 and 21 days post -denervation. Histograms represent the mean 
protein content and standard error of the me an for each experimental group (n=4). 
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4.3.3 Apoptosis pathway activation 
The ratio between Bcl-2-associated X protein (BAX) and B-cell lymphoma 2 (Bcl-2) 
increased following denervation at both 7 and 21 days reaching significance only at 21 
days F(2,9)=11.210 p<0.05 (Figure 4.3a). Caspase-3 content was significantly increased 
7 and 21 days following denervation F(2,9)=132.152 p<0.05 (Figure 4.3b). Similarly, 
cleaved caspase-3 was also significantly increased 7 days and 21 days following 








Figure 4.3a.  Representative western blot and quantification of the ratio between BAX 
and Bcl-2 proteins content used as a marker of activation of apoptosis in Tibialis 
Anterior muscle from Control (non-denervated) and mice 7 and 21 days post -
denervation. Histograms represent the mean protein content a nd standard error of 
the mean for each experimental group (n=4).  





















































Figure 4.3b.  Representative western blot and quantification of caspase-3 protein 
content used as a marker of activation of apoptosis  in Tibialis Anterior muscle from 
Control (non-denervated) and mice 7 and 21 days post -denervation. Histograms 
represent the mean protein content and standard error of the mean for each 
experimental group (n=4).  








Figure 4.3c.  Representative western blot and quantification of cleaved caspase-3 
protein content used as a marker of activation of caspase-3 and apoptosis in Tibialis 
Anterior muscle from Control (non-denervated) and mice 7 and 21 days post -
denervation. Histograms represent the mean protein content and standard error of 
the mean for each experimental group (n=4).  
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4.3.4 Mitochondria content 
The citrate synthase assay showed a trend to a decrease activity reflecting a decrease 
in mitochondria content already at 7 days following denervation but the decrease in 
content became statistically significant at 21 days following denervation F(2,9)=7.924 
p<0.05 (Figure 4.4). 
 
 
Figure 4.4.  Citrate synthase activity expressed as mean 
µM/min/proteins and standard error of the mean for each 
experimental group (n=4). The assays were performed in 
duplicate for each sample. Histograms represent the mean 
activity and standard error of the mean for each experimental 
group (n=4).  
*** p<0.001 compared with the control group.  
 
 
4.3.5 Mitochondrial membrane potential 
The fluorescent signal generated by TMRM was recorded and plotted against time. 
Data are shown in Figure 4.5a together with 2 representative images showing an 
isolated muscle fibre in bright-field and the fluorescent image of the same fibre 
following loading of TMRM (Figure 4.5b). The analysis showed a very high variability 
and fluctuation of the fluorescent signal with no significant differences between groups 









Figure 4.5. A)  Measurement of ΔΨm in intact mitochondria of isolated EDL muscle 
fibres from control (non-denervated) and mice at 7 and 21 post-denervation, assessed 
by changes in TMRM (30nM) fluorescence in response to oligomycin (Olm, 2.5 μM) 
and FCCP (4 μM), added at the indicated time points. B)  Representative images of 
an isolated muscle fibres in bright-field and fluorescent image following loading with  





Mitochondria play fundamental roles within eukaryotic cells including: production of 
ATP, calcium handling, regulation of cell growth, cell death and cell signalling through 
the generation of ROS in response to alterations in cell homeostasis (Brand et al, 2013). 
Given the important roles played, the maintenance of a healthy pool of mitochondria 
is fundamental to the survival of the cell and mitochondrial abnormalities have been 
associated with several muscle wasting conditions such as sarcopenia, cachexia and 
muscular dystrophies (Vainshtein et al, 2015). A correct mitochondrial turnover is vital 
in the process of maintaining a healthy pool of mitochondria and it is usually controlled 
by a dynamic and tightly regulated process known as mitophagy (Stotland and Gottilieb, 
2015). 
Previous studies (Spendiff et al, 2016; Sonjak et al, 2019) have reported that denervated 
skeletal muscle fibres show a significant decrease in mitochondria number and functionality 
that is also typical of ageing muscles. A study from Dr. Nishimune’s group (Rogers et 
al, 2017) showed that the impairment of mitophagy plays a fundamental role in the 
disruption of the NMJ of mice affected by amyotrophic lateral sclerosis. In the previous 
chapter we observed a significant increase in peroxide release from mitochondria of 
denervated skeletal muscle. This significant increase was accompanied by an initial 
increase in GPx1 and TRxR2 content, proteins that play an important role in the 
reduction of H2O2. Over a longer term a significant increase in Hsp content at 14 and 
21 days was also seen suggesting the presence of oxidative stress in mitochondria from 
denervated muscle fibres and the activation of proteolysis processes. No previous 
studies appear to have investigated how the loss of innervation affects mitophagy in 
the denervated muscle fibre and the impact that denervation-induced alteration of 
mitophagy can have on the mitochondria population. In the present study, markers of 
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mitophagy and apoptosis together with changes in mitochondria number and mitochondria 
membrane potential were analysed to determine the impact that the accumulation of 
peroxide has on mitochondria and their functionality.  
Mitophagy is a fundamental process which involves the activity of several proteins. 
Two main steps are involved in mitophagy: fission and fusion. These processes are 
tightly regulated by proteolysis and post-translational modifications (Hoppins et al, 
2007). Fission and fusion divides and fuses the two lipid bilayers that enclose the 
mitochondria (the inner membrane and the outer membrane) (Youle and van der Bliek, 
2012). As the name suggest, fission is the process of mitochondrial breaking down 
which is able to generate new organelles (Youle and van der Bliek, 2012). This process 
is directed by a cytosolic protein belonging to the dynamin family, known as Drp1 
(Mishra and Chan, 2016) a cytosolic protein usually recruited by Mid49, Mid51 and 
Mitochondrial fission factor (Mff) (Friedman et al, 2011; Elgass et al, 2013). Drp1 is 
a protein found mainly in the cytosol in proximity of the endoplasmic reticulum (Hu 
et al, 2017). The activity of Mid49, Mid51 recruits Dpr1 while Mff is responsible of 
its phosphorylation (pDrp1). Once phosphorylated, Drp1 is activated and forms spirals 
around the mitochondria membrane inducing transection of both the outer and inner 
membrane (Hu et al, 2017). Previous studies have used the pDrp1/Drp1 ratio to 
determine the activation of Drp1 and an increase of fission. In the present study, as 
shown in Figure 4.2a we observed a significant increase in this ratio at 7 and 21 days 
following denervation suggesting increased fission.  
Fusion is the process where mitochondrial organelles are assembled together. Fusion is 
usually increased following several physiological stimuli such as increased oxidative 
phosphorylation and inhibition of protein synthesis (mainly through starvation and 
mTOR inhibition) (Youle and van der Bliek, 2012). In the mitochondria, 3 different 
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dynamin proteins (present at different levels) are involved in the fusion process where 
the inner and outer membrane get reunited (Youle and van der Bliek, 2012). Mfn1 and 
Mfn2 are membrane anchored proteins involved in the fusion of the mitochondrial 
outer membrane while OPA1 is involved in the fusion of the mitochondrial inner 
membrane (Youle and van der Bliek, 2012).  
Mfn-1 is found in different tissues including: heart, liver, pancreas, adrenal glands and 
testis.  Mfn-2 is more abundant in the heart, skeletal muscle, brain and brown adipose 
tissue while OPA1 is mostly expressed in the retina, brain, testis, liver, heart, and 
skeletal muscle (Zorzano et al, 2015). In the present study Mfn-2 and OPA-1 were 
examined as markers of mitochondrial fusion. As shown in Figure 4.2b and Figure 
4.2c no changes were observed in denervated skeletal muscle which may indicate a 
possible impairment of mitophagy. Fission and fusion play a major role in maintaining 
healthy mitochondria as mitochondria with mutated DNA can fuse with intact mitochondria 
potentially overcoming the problems induced by mitochondrial DNA modifications and 
maintaining the level of mutated mitochondria under 80-90% (Nakada et al, 2001). 
Defective mitochondria that cannot be recycled are removed from the network, 
engulfed by autophagosomes, delivered to the lysosome for proteolytic degradation 
(Vainshtein et al, 2015). Our results suggest a possible impairment of the mitophagy 
process since there was a significant mitochondria breakdown unaccompanied by an 
adequate fusion response. Malfunctioning of the mitophagy process may lead to a vicious 
cycle that results in the accumulation of dysfunctional mitochondria and the incorrect 
disposal of damage proteins with accumulation of p62. For this reason, an increase in 
p62 content has been reported to be a reliable marker for autophagy and mitophagy 
impairments (Liu et al, 2017). The accumulation of p62 in denervated muscle fibres 
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observed here fits with the hypothesis that the increased peroxide release reported in 
the previous chapter may led to breakdown of damaged mitochondria.  
Youle and van der Bliek (2012) suggested that following fission, uncoupled mitochondria 
accumulate debris within their structure and experience fluctuations of the membrane 
potential that they are unable to deal with. These authors also suggest that these 
fluctuations may function as a marker of mitochondrial damage and trigger their 
disposal (Youle and van der Bliek, 2012). Part of the aims of this study was to analyse 
the mitochondrial membrane potential using a fluorescent probe that is rapidly sequestered 
within the mitochondria and is capable of generating a signal which intensity is associated 
with mitochondria membrane potential (Perry et al, 2011). To quantify the mitochondria 
membrane potential we used a protocol previously used by our group (Sakellariou et 
al, 2016) employing a fluorescent probe (TMRM) and recording the fluorescent signal 
overtime following addition of Olygomicin and FCCP. Oligomycin is capable of 
blocking the ATP synthase complex at the level of the ETC inducing accumulation of 
protons in the mitochondrial intermembrane space (Perry et al, 2011). Its addition is 
associated with an increase in the mitochondria membrane potential. FCCP is a 
protonophore able to induce permeabilisation of the mitochondrial inner membrane 
inducing an increased proton flux and a drop of the mitochondrial potential associated 
with the disappearing of fluorescent signal. As suggested by Perry and colleagues 
(2011), this protocol allows a more accurate determination of mitochondrial membrane 
potential through the analysis of the area under the TMRM fluorescence trace. In the 
results reported here we observed great variability within the groups. Despite this 
variability, there was a suggestion of possible impairment of mitochondrial membrane 
potential (Figure 4.5a) but we did not proceed with the analysis of the results. 
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Another important focus of the present study was to assess mitochondria number as a 
reduction has been reported during ageing and disease (Sun et al, 2016). Analysis of 
citrate synthase activity suggested that, in accordance with previous findings, denervated 
muscle fibres experience a significant reduction in mitochondrial number. Our results 
therefore show that, following denervation, the significant increase in peroxide release 
reported in Chapter 3 has a tremendous impact on mitochondria, inducing a significant 
reduction in mitochondria number with impairment of mitophagy and increased fission.  
As previously discussed, mitochondria are involved in a series of different signalling 
functions that ensures the correct functioning and survival of the cell (McBride et al, 
2006). In the present study, it was speculated that the increase in peroxide release 
together with the inhibition of mitophagy may trigger activation of apoptosis. Therefore, 
we investigated the Bax/Bcl-2 ratio and the caspase-3 activation. The Bcl-2 family plays 
a fundamental role in the regulation of the mitochondria-mediated apoptotic signal 
transduction (Siu and Alway, 2005). In particular, among the Bcl-2 family, the pro-
apoptotic member BAX plays a central role in regulating the apoptotic machinery (Siu 
and Alway, 2005). 
In the present study an increase in the BAX/Bcl-2 ratio was found following denervation 
that is in line with the previous work of Siu and Alway (2005). The significant increase 
of the BAX/Bcl-2 ratio is associated with mitochondria membrane permeabilisation and 
release of cytochrome c which, interacting with apoptotic protease activating factor 1, 
induces the formation of the apoptosome responsible of the activation of different 
caspases including caspase-3, -6 and -7 which are all known as “executional” caspases 
(Slee et al, 2001; Sandri et al, 2001). The activation of these caspase usually triggers 
apoptosis through the cleavage of specific proteins (Slee et al, 2001). Dupont-Versteegden 
(2006) suggests that a close correlation exists between activation of apoptosis and skeletal 
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muscle atrophy. In the previous chapter we highlighted how skeletal muscle fibres in 
denervated muscles showed significant muscle fibre atrophy and the current results shed 
new light on one of the possible pathways responsible for this. Caspase-3 activation 
has previously been associated with skeletal muscle atrophy (Sandri et al, 2001) 
inducing protein degradation and enhancing proteasomal activity through the cleavage 
of Rpt2 and Rpt6 two specific 19S proteasome subunits (Wang et al, 2010). Together 
with the 20S proteasome, the 19S proteasome compose the 26S and 30S proteasomes of 
which it is the regulatory component (Tanaka, 2009). The 19S proteasome plays a 
fundamental role in recognising ubiquitinated proteins and, after unfolding them, 
translocate them into the core component of the proteasome where degradation takes 
place (Tanaka, 2009). Previous studies have investigated the role of Caspase-3 and 
proteasome activation both in denervated (Siu and Alway, 2005) and in ageing muscles 
(Baumann et al, 2016) suggesting that mitochondria play a fundamental role in driving 
muscle atrophy. In the present study we collected evidence that suggest that the 
increased peroxide release from mitochondria of denervated muscle fibres triggers a 
cascade of events that culminate with the possible activation of the proteasome system.  
It has been speculated that an increase in ROS production may be responsible for damaging 
mitochondria triggering a subsequent increase of mitochondrial fission (Jezek et al, 
2018), loss of mitochondria (Alway et al, 2017) and activation mitochondria-induced 
apoptosis (Siu and Always, 2005). Our results suggest that starting from 7 days 
following denervation, there is a significant impairment of mitophagy (determined 
through the analysis of p62) together with an increase in fission resulting in a significant 
reduction of the mitochondria population at 21 days following nerve transection. In 
addition, we investigated the hypothesis that mitochondria may play a pivotal role in 
muscle atrophy seen following denervation. Our results suggest that the increase in the 
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BAX/Bcl-2 ratio results in a significant increase in caspase-3 content and its cleavage. 
The significant increase in caspase-3 content may induce the activation of the 26S 
proteasome system which previous studies (Siu and Always, 2005; Bhattacharya et al, 
2009; Romanello et al, 2010; Hepple, 2014; Baumann et al, 2016) have indicated as 












Chapter 5. Metabolic changes induced by skeletal 





The use of Nuclear Magnetic Resonance spectroscopy for metabolic profiling is a developing 
and promising technique that allows scientists to obtain extensive quantitative information 
about a tissue, a fluid or an entire living organism (Emwans et al, 2019).  
Initially developed by Wilson and Burlingame back in 1974, this technique allows the 
analysis of a large array of metabolites in a reliable and reproducible way.  
NMR is based on the physics principle of the energy difference:  
𝐸 = ℎ𝜈 
Energy “E” (in Joules) is proportional to frequency “ν” (in Hertz) where “h” is Planck’s 
constant (6.62607004×10-34 m2kg/s). Every proton (1H) has a certain magnetic moment; 
when a magnetic field is applied to a certain proton this generates changes in the 
magnetisation (the 1H will be in resonance with the applied magnetic field). The 
differences between the original magnetic state and the applied magnetic state is 
defined as “frequency” and generates a radio wave in the electromagnetic spectrum 
(Tognarelli et al, 2015). 
Since NMR metabolomics generates a spectrum of all the resonances, each signal in 
the spectrum can be defined as a 1H resonance and the chemical shift can be then 
defined as the frequency of the resonance expressed with reference to a standard 
compound which is defined to be at 0 ppm (Tognarelli et al, 2015). 
Metabolites with multiple 1H environments will give rise to spectra with multiple 





Figure 5.1. Representative NMR metabolomics spectra and its component metabolites  
as presented by Soininen et al, (2009).  
 
One of the most key features of NMR metabolomics is that the results are highly 
reproducible and comparable independently of the magnetic field used during the 
experiment (Emwans et al, 2019). To allow this, every signal is reported as a fraction of 
the operating frequency of the spectrometer using a scale set in Parts Per Million (ppm) 
which is independent of the spectrometer frequency (Kemp, 1986). The chemical shift 
(the position in ppm where the signal generated by a specific metabolite is found 
compared to the reference chemical) is calculated by the following formula:  
 
δ=




For the protocol chosen for this project, selectively deuterated trimethylsilyl propionate 
(TSP) was used as a reference. This compound is used in NMR metabolomics for two 
reasons: it is soluble in aqueous buffers and all the 1H atoms in this molecule are 
equivalent and more shielded than almost all the organic compounds found in nature. 
This means that TSP generates a singlet with a chemical shift (δ) equal to 0. Therefore, 
this chemical can be used as a reference to identify other chemicals and to normalise 
the data generated (Dona et al, 2016).  
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The aim of the present study was to determine the metabolic changes induced in skeletal 




5.2 Materials and Methods 
5.2.1 Nuclear Magnetic Resonance Metabolomics of denervated gastrocnemius 
The gastrocnemius muscle from the mice used in Chapter 4 was used for NMR 
metabolomics analysis and treated as presented in section 2.16. The Spectra obtained 
were analysed with TopSpin 3.5 (Bruker, Coventry, United Kingdom), ChenomX 8.2 
(Edmonton, Alberta, Canada) and tameNMR on Galaxy.liv.ac.uk (github.com/PGB-
Liv/tameNMR) 
5.2.2 Metabolite identification  
A pattern file containing all the peaks predicted in mouse skeletal muscle was obtained 
using TopSpin 3.5 software. Using previously published data (Sparling et al, 1990; 
Soinnien et al, 2009), we identified some of the peaks present in our spectra as lipids. 
However, due to the limited information available we were not able to determine which 
specific lipids they were; hence these were labelled simply as “lipids”.  In addition, for 
those peaks where annotation was not available in the ChenomX database, the label 
“unknown” was applied. For all those annotated peaks, the KEGG compound code was 
applied for pathways analysis. These annotations were then converted to peak boundaries 
(pattern file) that defines “bins” that every peak should be divided into. This procedure called 
“binning” was then verified by uploading the pattern file to Galaxy.liv.ac.uk as suggested 
by Afgan and colleagues (2016) to exclude any risk of bin overlapping which may interfere 






5.3.1 Anthropometric measurements 
No significant differences in total body weight were seen between groups (Figure 4.1a 
- section 4.3.1). The Gastrocnemius muscle (Figure 5.2) showed a significant reduction 




Figure 5.2.  Gastrocnemius muscle weights from 
control mice (non-denervated) and mice at 7 and 21 
days post-denervation.  
Histograms represent the mean and the standard error 
of the mean for each experimental group (n=4).  
*** p<0.001 compared with the control group.  
 
5.3.2 NMR Metabolomics  
Analysis of the spectra obtained during the NMR analysis (presented in Figure 5.3), 
showed that denervation induces a series of very dramatic modifications in skeletal 
muscle. Differences between groups were highlighted by the Principal Component 
Analysis presented in Figure 5.4 with Principal Component 1 and 2 able to explain 
over 70% of variability within the samples.  









































Over 100 annotated peaks were significantly altered in response to denervation (Table 
5.1 for complete list). From the significant peaks we were able to identify 27 different 
metabolites. The heatmap presented in Figure 5.5 offers a better overview of the 
significant changes induced by denervation. In addition, to the heatmap, in Figures 
5.6-5.13 are presented the results of the post-hoc analysis of specific metabolites of 
interest in the context of this work. A MSEA analysis was also performed but failed to 
identify significant pathways altered in response to denervation (p>0.05); however the 
ranking, presented in Table 5.2, suggests that denervation may have induced insulin 
resistance, inhibition of glycolysis and increased activity of the purine metabolism.  
 
 
Figure 5.3.  1H 1D NMR spectra (700MHz) of murine gastrocnemius muscle tissue 
extract for Control (non-denervated),  7 day and 21 days post-denervation groups 
(n=4). Inset spectra (Blue squares) represent 4x magnification  of specific spectral 
regions: 10-7ppm (aromatic including NAD+ and ATP) and 2.8 -3.8ppm polar amino 
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Figure 5.4. A)  Results of the principal component analysis . Figure shows the first 5 
components able to explain more than 95% of the variance seen between the Control 
(Δ - non-denervated), 7 days post-denervation (+) and 21 days post-denervation (X) 
groups. B)  Results of the Principal Component Analysis of the first 2 Principal 
Components able to explain 75.5% of the variance seen between the control (Black - 
non-denervated, n=4), 7 days post-denervation (light grey, n=4) and 21 days post-
denervation (dark grey, n=4) groups. X and Y axis present the raw component score 
values derived from the formation of the principal components . These are arbitraty 




Table 5.1.  List of significant peaks identified using NMR Metabolomics. In the table 
are reported the metabolite(s) identified for a specific bin, the bin number, the 

















Figure 5.5.  Heatmap representing the results of the statistically significant 
metabolites (p<0.05) identified from NMR metabolomics (shown on the right of the 
figure). Groups are indicated at the top of the figure in black (Control), light grey (7 
days post-denervation) and dark grey (21 days post denervation). Individual samples 
IDs are indicated at the bottom of the figure while a reference to understand the fold 
changes of each sample compared to each peak √𝑆𝐷 is presented in the top right 







Figure 5.6.  Box plot presenting the mean-centered 
relative abundance of Glucose in control (non-
denervated), 7 days and 21 days post -denervation 
groups. Dots represent individual samples (n=4 per 
group) while asterisks show the statistical differences 
between 7 and 21 days post -denervation groups and the 
control group (non-denervated) as follows: *** 
p<0.001. Note: The mean-centred relative abundance is 
expressed in arbitrary units and is directly proportional 




Figure 5.7.  Box plot presenting the mean-centred 
relative abundance of NAD+ in control (non-
denervated), 7 days and 21 days post -denervation 
groups. Dots represent individual samples (n=4 per 
group) while asterisks show the statistical differences 
between 7 and 21 days post-denervation groups and the 
control group (non-denervated) as follows: ** p<0.01. 
Note: The mean-centred relative abundance is expressed 
in arbitrary units and is directly proportional to the 
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Figure 5.8.  Box plot presenting the mean-centred relative abundance of A)  Glucose 
6 phosphate, B)  Pyruvate and C)  Lactate in control (non-denervated),  7 days and 21 
days post-denervation groups. Dots represent individual samples (n=4 per group) 
while asterisks show the statistical differences between 7 and 21 days post -
denervation groups and the control group (non -denervated) as follows: * p<0.05 - 
*** p<0.001. Note: The mean-centred relative abundance is expressed in arbitrary 
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Figure 5.9.  Box plot presenting the mean-centred relative abundance of A)  GTP, B)  
IMP and C)  Xanthine in control (non-denervated),  7 days and 21 days post -
denervation groups. Dots represent individual samples (n=4 per group) while 
asterisks show the statistical differences between 7 and 21 days post -denervation 
groups and the control group (non-denervated) as follows: ** p<0.01 - *** p<0.001.  
Note: The mean-centred relative abundance is expressed in arbitrary units and is 
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Figure 5.10.  Box plot presenting the mean-centred relative abundance of A)  Valine, 
B)  Isoleucine and C)  Phenylalanine and D)  Glutamate in control (non-denervated),  
7 days and 21 days post-denervation groups. Dots represent individual samples (n=4 
per group) while asterisks show the statistical differences between 7 and 21 days 
post-denervation groups and the control group (non -denervated) as follows: ** 
p<0.01 - *** p<0.001. Note: The mean-centred relative abundance is expressed in 









Figure 5.11.  Box plot presenting the mean-centred 
relative abundance of Methionine in control (non-
denervated), 7 days and 21 days post -denervation 
groups. Dots represent individual samples (n=4 per 
group) while asterisks show the statistical differences 
between 7 and 21 days post -denervation groups and the 
control group (non-denervated) as follows: *** 
p<0.001. Note: The mean-centred relative abundance is 
expressed in arbitrary units and is directly proportional 




Figure 5.12.  Box plot presenting the mean-centred 
relative abundance of 3-Methylhistidine in control (non-
denervated), 7 days and 21 days post -denervation 
groups. Dots represent individual samples (n=4 per 
group) while asterisks show the statistical differences 
between 7 and 21 days post -denervation groups and the 
control group (non-denervated) as follows: *** 
p<0.001. Note: The mean-centred relative abundance is 
expressed in arbitrary units and is  directly proportional 






Figure 5.13.  Box plot presenting the mean-centred 
relative abundance of Acetylcholine in control (non-
denervated), 7 days and 21 days post -denervation 
groups. Dots represent individual samples (n=4 per 
group) while asterisks show the statistical differences 
between 7 and 21 days post -denervation groups and the 
control group (non-denervated) as follows: ** p<0.01 - 
*** p<0.001. Note: The mean-centred relative 
abundance is expressed in arbitrary units and is directly 




Table 5.2.  List of the pathways identified using MSEA in order from the most mapped 
to the least mapped.  The table shows the pathways, the pathways size, the number of 
metabolites mapped together with the raw p value, the adjusted p value and the 





5.4 Discussion  
The initial aim of the work described in this chapter was to perform NMR Metabolomics 
directly on mitochondria extracted from muscle. To do so, the isolation of mitochondria 
for NMR metabolomics required significant optimisation as the gold standard protocol 
for mitochondria isolation uses a sucrose gradient for isolation. Sucrose is a disaccharide 
(chemical structure shown in Figure A1.3 - Appendix 1) that, when analysed with NMR 
metabolomics, presents a very high “clarity x dynamic range” (the range of concentration 
that allows the visualisation of a metabolite) preventing the visualisation of several 
metabolites with a lower clarity x dynamic range (e.g. NAD+). An alternative buffer 
suggested in literature for mitochondria isolation (Corcelli et al, 2010) contains EDTA and 
MOPS (chemical structure shown in Figure A1.4 and Figure A1.5 - Appendix 1) that also 
have the potential to obscure the signal of other metabolites in a similar way (Figure A1.6 
- Appendix 1). Despite the mitochondrial isolation being successful (Figure A1.1 and 
Figure A1.2 - Appendix 1), the traces of buffers retained did not allow an accurate 
analysis and therefore it was decided to perform the analysis on the entire denervated 
skeletal muscle. By performing NMR metabolomics of the entire denervated muscle, 
we were able to obtain information regarding the metabolic changes induced by 
denervation in skeletal muscle. 
MSEA analysis (Table 5.2) indicates that denervated muscle shows insulin resistance, 
alteration of the glycolysis pathway and of purine metabolism with analysis of the 
single metabolites supporting this hypothesis. In the previous chapter it was reported 
that, in response to denervation, there was a significant increase in the content of NOX2 
subunits. It was speculated that the increase in content of these subunits corresponds to 
an increase of NOX2 activity and production of H2O2 able to drive different responses 
in skeletal muscle including mechanical contraction, activation of apoptotic pathways 
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(Kadoguchi et al, 2018) and insulin resistance (Ferreira and Laitano, 2016). Interfering 
with the Angiotensin II system (Sukumar et al, 2013) NOX2 induces the 
phosphorylation of insulin receptor substrate-1 (IRS1) and the activation of both 
Protein Kinase B (Akt) and NF-κB preventing the translocation of GLUT-4 to the fibre 
membrane (Wei et al, 2008). The significant decrease in glucose abundance observed 
(Figure 5.6) suggests that the H2O2 production by NOX2 at later stages following 
denervation may trigger a series of responses that prevent glucose uptake by the skeletal 
muscle. This significant decrease in glucose availability in the denervated muscle fibres 
would result in reduced glycolysis with lower concentrations of intermediate products 
such as glucose 6-phosphate (Figure 5.8a) and of the final products pyruvate (Figure 
5.8b) and lactate (Figure 5.8c).  
NMR metabolomics also revealed a significant decrease of NAD+ abundance at 21 
days following denervation (Figure 5.7). NAD is a coenzyme that can be found in two 
different forms: oxidised (NAD+) and reduced (NADH). NAD+ is a common product 
of Complex I of the ETC which uses NADH (normally produced during the citric acid 
cycle) as substrate. The reduction of NAD+ seen post-denervation suggests a possible 
reduction in NADH availability that may result in the substantial reduction of the ETC 
activity and ATP synthesis by ATP synthase.  
The MSEA analysis also highlighted possible denervation-induced changes in the purine 
metabolism pathway. Purine metabolism is responsible for the production and degradation 
of the purine nucleotides adenine and guanine producing different intermediates of the citric 
acid cycle as well as ATP and Guanosine Triphosphate (GTP) (Yin et al, 2018). The central 
component of this pathway is inosine-5’-Monophosphate (IMP) that, once synthetised from 
a ribose-phosphate, can be utilised for the production of ATP and GTP (Yin et al, 2018). 
IMP can directly be converted onto Adenosine Monophosphate (AMP) in a two-step 
156 
 
reaction that involves the enzymes adenylosuccinate synthase and adenylosuccinate lyase 
using the energy released from the hydrolysis of GTP (Armenta-Medina et al, 2014). Once 
formed, AMP can quickly be converted onto ADP and then converted onto ATP through 
oxidative phosphorylation (Schultheisz et al, 2008). IMP can also be converted into 
Xanthosine monophosphate (XMP) by IMP dehydrogenase that uses NAD+ as electron 
donor for this reaction (Sigel et al, 2009). The production of XMP is a necessary step 
for the generation of GTP which, in addition to serving as substrate for the generation 
of AMP, is also responsible of the activation of guanine nucleotide-binding proteins 
(G Proteins) (Yanamadala et al, 2009). G proteins are a family of proteins responsible 
for the signal transduction involved in different processes including apoptosis 
(Yanamadala et al, 2009). Several studies have shown that G proteins can stimulate 
apoptosis regulating numerous downstream effectors including the Bcl-2 family 
(Yanamadala et al, 2009). Furthermore, as previously mentioned (section 1.5.4.3), 
GTP is needed to activate Rac proteins therefore promoting the activation of NOX2 
enzyme and the subsequent H2O2 production observed in denervated muscles. Our data 
show an increase in GTP at 7 days post-denervation (Figure 5.19a) accompanied by a 
simultaneous significant reduction in IMP content (Figure 5.9b). The decrease in IMP 
and increase in GTP contents (together with the changes that we observed in NAD+ 
abundance) suggest that the activation of this pathway may result in the activation of 
G proteins and stimulation of apoptosis through the Bcl-2 family (which is in line with the 
findings presented in the previous chapter - section 4.3.3). A significant increase in xanthine 
was also seen (Figure 5.9c). This is an intermediate product resulting from the activity 
of xanthine oxidase. Xanthine oxidase is an enzyme involved in the production of uric 
acid and H2O2 from hypoxanthine (Cao et al, 2010), a natural derivate of purine 
metabolism resulting from the spontaneous deamination of adenine (Lee et al, 2009). 
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Independent studies demonstrated that xanthine oxidase plays a fundamental role in 
muscle atrophy in immobilised limb (Childs et al, 2003; Di Giovanni et al, 2004; Cao 
et al, 2010). The results of previous studies found that, following limb immobilisation, 
there is a 128% increase in p38 activation associated with a 38% decrease in muscle 
mass. 
Administration of allopurinol, an inhibitor of xanthine oxidase, was able to partially 
prevent muscle atrophy in rats (Cao et al, 2010). It is therefore possible that the 
increase in xanthine seen in our model is related to the activation of the atrophy 
pathways as described above.  
Increased proteolysis in skeletal muscle has been described also following fasting or 
prolonged exercise (Evans et al, 2017). During these conditions the body experiences 
significantly low levels of glucose availability that can induce an increase in protein 
catabolism in the muscle aimed to produce certain glucogenic amino acids. Glucogenic 
amino acids (such as valine or isoleucine) can be used by the muscle as intermediate 
substrates of the citric cycle or converted onto alanine that, once released onto the 
bloodstream, is used by the liver and converted into glucose that can be made available 
to the different tissues (Rui, 2014). Following denervation, we also observed a 
significant increase in valine (Figure 5.10a) and isoleucine (Figure 5.10b) that 
previous studies have reported to accumulate in muscles of diabetic patients (Lynch 
and Adams, 2014; Vendelbo et al, 2014) but also of phenylalanine (Figure 5.10c) and 
glutamate (Figure 5.10d). These latter two amino acids can be used to generate 
fumarate or α-ketoglutarate, two substrates that can be used by the citric acid cycle to 
generate NADH for the ETC. We speculated that the progressive accumulation of 
these amino acids in denervated skeletal muscles is the result of increased proteolysis 
but also due to a significant reduction of mitochondria number and functionality.   
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Another relevant change in the analysis is the significant reduction in methionine 
(Figure 5.11), an essential amino acid that plays a central role in protein biosynthesis 
and in oxidative resistance (Campbell et al, 2016). Methionine exerts its functions 
during oxidative resistance by inducing activation of enzymes such as methionine 
sulfoxide reductase A and biosynthesis of glutathione (Dos Santos et al, 2018). A 
previous study performed by Bianchi and colleagues (2000) showed that in plasma, 
the production of glutathione was directly proportional to the methionine load. To our 
knowledge this link between glutathione and methionine levels has not been investigated 
in skeletal muscle. Nevertheless, the low levels of methionine in denervated skeletal 
muscle may fit with the lack of response in glutathione previously reported (section 
3.3.3). Another interesting change observed is the significant reduction of 3-Methylhistidine. 
3-Methylhistidine is a metabolic product of actin and myosin methylation (Terman and 
Kashina, 2013). In a ground breaking study in 1973, Young and colleagues highlighted 
a negative correlation between 3-Methylhistidine and muscle protein catabolism. Our 
results show that following denervation, the concentration of this metabolite drops 
significantly (Figure 5.12) suggesting that the muscle fibre contractile proteins actin and 
myosin may remain unaffected and may still be functional.  
Following denervation there is also a significant increase in ACh levels in muscle fibres 
(Figure 5.13). This increase appears to be in line with the progressive breakdown of the 
post-synaptic receptors discussed earlier (section 3.3.1) and with a previous study from 
Stanley and Drachman (1981). Another interesting study from An and colleagues (2010) 
showed that the accumulation of ACh in embryonic muscle prevents the formation of 
NMJ limiting axonal branching and synapse formation. To our knowledge, no other 
studies have investigated the ACh localisation following denervation. Future studies 
using genetically encoded fluorescent indicators such as the one recently developed by 
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Borden and colleagues (2020) called iAChSnFR may help determine ACh localisation 
following denervation. Gathering information regarding ACh localisation following 
recpetors breakdown in denervated muscle fibres may help to understand if the Ach 
accumulation measured in this study using NMR metabolomics can prevent the 
formation of neuromuscular junctions as seen at embryonic level by An and colleagues 
(2010). 
NMR Metabolomics is an interesting and fast developing technique that, to our knowledge, 
has not been previously performed on denervated skeletal muscle. This technique provides 
a snapshot of the metabolic changes occurring in a tissue, shows high reproducibility 
and allows a fast and reliable analysis. However, compared to other techniques such 
as Liquid Chromatography – Mass Spectrometry, it has lower sensitivity (Edison et al, 
2016; Viant et al, 2017). In addition, due to the limited availability of metabolite libraries, 
we were unable to annotate several peaks that may contain important information. This is 
reflected in the MSEA analysis which, based on the Fisher’s exact test, highlighted only 
few pathways that were altered following denervation. Nevertheless, by analysing specific 
metabolites it was speculated that denervation is able to induce insulin resistance in 
denervated muscle fibres with inhibition of glycolysis, possibly limiting the ETC activity 






















Chapter 6. Age-related skeletal muscle denervation 





In normal physiology the neuromuscular system goes through continuous modifications 
and adaptations (Hepple and Rice, 2016). Among these series of adaptations, of 
particular relevance is the denervation-reinnervation cycle (Aare et al, 2016). The 
efficiency of this cycle is reduced with the advancing age with a major impact on muscle 
health and function (Jang and Van Remmen, 2011). In a study aimed to analyse the 
stability of NMJs in C57BL6 mice, Balice-Gordon and colleagues (1997) found that 
the stability of the NMJs tends to decrease around 12-18 months of age with a 
significant loss of motor terminal branches and a reduction of post-synaptic receptors 
in the muscles. These changes induce several physiological adaptive responses in the 
motor units affected by the lack of NMJ stability. For example, in order to compensate 
for the loss of synaptic contact, motor axons respond with nerve sprouting to create 
new junctions. However, this compensatory response is far from being efficient given 
that newly formed junctions are unstable, vulnerable and can be quickly lost, explaining 
the decrease in motor units seen during ageing (Balice-Gordon et al, 1997; Jang and Van 
Remmen, 2011). This decrease is also accompanied by a shift in protein metabolism 
from protein synthesis to protein degradation with loss of muscle mass and an increased 
proportion of connective tissue within the muscle (Park, 2015). These changes have a 
severe impact on health and quality of life of older people. Therefore, to consider the 
neuromuscular system in its entirety becomes mandatory for scientists wishing to 
understand the process that leads to sarcopenia (Vellas et al, 2018).  
The first aim of the present study was to evaluate the age-related changes in nerve-
muscle interactions at different time points during adulthood and ageing in mice, this 
in order to understand whether the age-related loss in the stability of the NMJs precedes 
skeletal muscle loss or vice versa. In the present study we also aimed to investigate whether 
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the redox-related changes observed in our denervation model also occur during skeletal 




6.2 Materials and Methods 
6.2.1 Mice strain 
In the present study 28 B6.Cg-Tg(Thy1-YFP)16Jrs/J(+/-) both male and female were bred 
within the Biomedical Service Unit at the University of Liverpool. Mice were divided in 
groups of 4 (2 males and 2 females) and sacrified at: 6, 12, 15, 18, 21, 24, 27 months of 
age. Experiments were performed in accordance with United Kingdom Home Office 
guidelines under the United Kingdom Animals (Scientific Procedures) Act 1986 as 
presented in section 2.1.  
6.2.2 Samples preparation for immunohistochemical analysis 
For immunohistochemical analysis, samples were prepared as described in section 2.3.4.  
6.2.3 WGA Staining 
Wheat germ agglutinin (Vector Lab, Burlingame, CA, USA) was used to stain the 
slides for cross sectional area analysis. The samples were treated as explained in 
section 2.10 and examined using a Zeiss LSM 800 confocal microscope (Zeiss, 
Oberkochen, Germany). 
6.2.4 Myosin Heavy Chain immunostaining 
Following defrosting (30 minutes at room temperature), sections were rehydrated in 
PBS for 10 minutes (2x5 minutes) and blocked in PBS containing M.O.M blocking 
(Vector Lab, Burlingame, CA,USA) with 5% goat serum for 1 hour at room 
temperature. Sections were then incubated with MyHC-IIa primary antibody (1:250, 
Developmental Studies Hybridoma Bank, Iowa, USA) overnight at 4⁰C. The following 
day, sections were washed with PBS-T20 3 times for 5 minutes each. Goat Anti-Mouse 
IgG1 secondary antibody conjugated with Alexa Fluor 647 (1:500 in PBS with 12% 
Goat Serum - Invitrogen, Paisley, United Kingdom) was added to each slide for 60 minutes 
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at room temperature. Sections were washed with PBS-T20 3 times for 5 minutes each 
and were then incubated overnight with MyHC-I antibody (Abcam, Cambridge, United 
Kingdom) conjugated with Alexa Fluor 408 using the Bio-Rad kit (Bio-Rad, Hercules, 
CA, USA). The following day, sections were washed with PBS-T20 as described before 
and the antibody for MyHC-IIb (1:250, Developmental Studies Hybridoma Bank, Iowa, 
USA) was added overnight. Following overnight incubation and washing, samples were 
incubated with the goat Anti-Mouse IgM secondary antibody conjugated with Alexa Fluor 
488 (1:500 in PBS with 12% Goat Serum - Invitrogen, Paisley, United Kingdom) for 1 hour 
at room temperature. At this point, sections were stained with Rhodamine WGA (1:1000 
Vector Lab, Burlingame, CA, USA) following the protocol previously described (Section 
2.11). Sections were visualised using confocal microscopy at 10x magnification and 
analysed using ImageJ software. 
6.2.5 SDS-PAGE and western blot analysis 
Thirty micrograms of total protein from the TA muscle were added to 4μL of Blu-
mercaptoethanol (4x) and ddH2O to reach a final volume of 16μL. SDS-PAGE and 
western blot analysis was performed as previously described (section 2.5). Ponceau 
red (Sigma-Aldrich, St. Louis, MI, USA) was used to verify the effectiveness of the 
transfer procedure and to normalise the results as described in Appendix 1. Densitometry 
analysis was performed using the ImageJ software following the protocol described by 
McLean (2011). 
6.2.6 Assessments of Neuromuscular junctions 
B6.Cg-Tg(Thy1-YFP)16Jrs/J(+/-) mice express a yellow fluorescent protein in their 
nervous system that allows detection and analysis via confocal fluorescent microscopy 
with excitation at 488nm. To fully examine the NMJ, the acetylcholine receptors were 
also stained with α-bungarotoxin conjugated with Alexa-642 as explained in section 
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2.11. Samples were analysed using a Nikon intravital confocal microscope (Nikon A1, 
Kingston, United Kingdom).  
6.2.7 Neuromuscular junction analysis with ImageJ 
Fifty to 100 NMJs from each group were analysed to determine different structural 
parameters that change with ageing including: area of synaptic contact, complexity, 
fragmentation, overlap of post-synaptic terminals. This analysis was performed on 
ImageJ using the BinaryConnectivity plugin developed by Landini (available at 
https://blog.bham.ac.uk) and following the protocol described by Jones and colleagues 
(2016) and summarised in Figure 6.1. Full and partial innervation cut points were 
determined as follow: Fully innervated (100-80% overlap), partially innervated (80-15% 
overlap) and denervated (<15%). Denervated post-synaptic receptors were analysed 





















Figure 6.1.  Schematic representation of the steps necessary to analyse the NMJ structure 






6.3.1 Anthropometric measurements  
No statistically significant changes in the body weight were observed with ageing (Figure 
6.2a). We observed a slight tendency to a decrease in the TA muscle mass starting at 18 
months that did not reach statistical significance (Figure 6.2b). Similarly, analysis of 
the EDL muscle weight, showed a tendency to a progressive decrease in the mean 
muscle mass starting around 18 months which did not reach statistical significance 
(Figure 6.2c). The analysis of the TA muscle fibre minimum Feret’s diameter showed 
a trend with a decrease in large muscle fibres (50-60.1 and 60+ thresholds) in favour 
of medium size fibres (40.1-50.1 threshold). However, these changes were not 




Figure 6.2a.  Total body weights from mice sacrified at 
different ages: 6, 12, 15, 18, 21, 24  and 27 months.  
Histograms represent the mean and the standard error 









































































Figure 6.2b.  Tibialis Anterior muscle weights from mice 
sacrified at different ages: 6, 12, 15, 18, 21, 24 and 27 
months. Histograms represent the mean and the standard 





Figure 6.2c.  Extensor Digitorum Longus muscle weights 
from mice sacrified at different ages: 6, 12, 15, 18, 21, 
24 and 27 months. Histograms represent the mean and 
the standard error of the mean for each experimental 
group (n=4).  
 













































































































































Figure 6.2d.  Muscle fibre minimum Feret’s diameter.  Histograms represent the mean 
and standard error of the mean of the percentage of fibres counted in each threshold 
(10-20, 20.1-30, 30.1-40, 40.1-50, 50.1-60, 60.1+) for each experimental group: 6, 
12, 15, 18, 21, 24 and 27 months.  
 
 
6.3.2 Age-related changes of the neuromuscular junction 
Although high variability was seen, significant changes occurred at the NMJ level. The 
BinaryConnectivity plugin allowed the analysis of several parameters related to the 
NMJ morphology. Analysis of the numbers of fully innervated, partially innervated and 
denervated post-synaptic terminals shows a progressive reduction in fully innervated 
post-synaptic terminals that was statistically significant at 24 and 27 months of age with 
a significant increase in denervated acetylcholine receptors at 27 months of age F(18,99) 
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Significant changes were also seen in average overlap between the pre- and post-synaptic 
terminals of the NMJ F(6,285)=5.393 p<0.05 (Figure 6.3b), area of synaptic contact 
F(6,285)=3.081 p<0.05 (Figure 6.3c), post-synaptic receptors area F(6,297)=5.401 p<0.05 
(Figure 6.3d) and diameter F(6,297)=10.376 p<0.05 (Figure 6.3e). With ageing there was 
also a progressive increase in nerve sprouting and “blebbing” and an example is presented 




Figure 6.3a.  Percentage of fully innervated (Black -  100-80% overlap), partially 
innervated (Light grey - 79-15% overlap) and denervated (Dark grey - <15% overlap) 
acetylcholine receptors together with representative NMJs. Histogram represent the 
percentage of overlap of the NMJs for each experimental group: 6, 12, 15, 18, 21, 24 
and 27 months.  






Figure 6.3b.  Average overlap between the motor neuron 
and the post-synaptic receptors from mice sacrified at 
different ages: 6, 12, 15, 18, 21, 24 and 27 months. 
Histograms represent the mean and the standard error 
of the mean for each experimental group (n=4).  
* p<0.05 - ** p<0.01 - *** p<0.001 compared with the 
6 months group.  
 
 
Figure 6.3c.  Analysis of the Area of synaptic contact 
between motor neurons and post-synaptic receptors from 
mice sacrified at different ages: 6, 12, 15, 18, 21, 24 and 
27 months. Histograms represent the mean and the 
standard error of the mean for each experimental grou p 
(n=4).  
* p<0.05 - ** p<0.01 compared with the 6 months group.  
 















































































































































Figure 6.3d.  Analysis of the post-synaptic receptors area  
from mice sacrified at different ages: 6, 12, 15, 18, 21, 24 
and 27 months. Histograms represent the mean and the 
standard error of the mean for each experimental group 
(n=4).  
* p<0.05 compared with the 6 months group.  
 
 
Figure 6.3e.  Analysis of the post-synaptic receptors  
diameter of acetylcholine receptors  from mice sacrified at 
different ages: 6, 12, 15, 18, 21, 24 and 27 months. 
Histograms represent the mean and the standard error of the 
mean for each experimental group (n=4).  
* p<0.05 compared with the 6 months group.  
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Figure 6.4.  Representative image of muscle innervation obtained from a 27 months 
old mouse. Axon branches (green), acetylcholine receptors  (red) and NMJs (yellow) 







6.3.3 Analysis of changes of muscle structure and composition  
Analysis of the MyHC isoforms present in the TA muscle showed significant changes 
associated with ageing F(18,43) =2.564, p <0.05; Wilk's Λ = 0.127, partial η2 =0.498 
(Figure 6.5). With the exception of few sporadic fibres, no fibres expressing the MyHC-I 
isoform in the TA muscle were seen. With ageing there was a significant reduction in the 
number of fibres expressing MyHC-IIa with advancing age (Figure 6.5). In contrast 
MyHC-IIb fibres showed a statistically significantly increase at 27 months of age. MyHC-




Figure 6.5.  Representative image of a TA muscle (scale bar 100μm) stained for the 
four myosin heavy chain isoforms present in murine muscle: MyHC-I (Blue),  MyHC-
IIa (Red), MyHC-IIb (Green) and MyHC-IIx (Black).  
Histograms represent the mean percentage of fibres expressing one of the 4 myosin 
heavy chain isoforms in tibialis anterior muscle and the standard error of the  mean 
for each experimental group: 6, 12, 15, 18, 21, 24 and 27 months.  
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6.3.4 Age-related changes in neuromuscular junction markers 
Analysis of the protein contents of Agrin (Figure 6.6a) and MuSK (Figure 6.6b) failed 
to show significant changes with ageing.  
 
 
Figure 6.6a.  Agrin protein content of Tibialis Anterior 
muscle from mice sacrified at 6, 12, 15, 18, 21, 24 and 27 
months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).  
 
 
Figure 6.6b.  MuSK protein content of Tibialis Anterior 
muscle from mice sacrified at 6, 12, 15, 18, 21, 24 and 27 
months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).  
 






















































































































































6.3.5 Age-related changes in protein content of antioxidant enzymes 
No changes in CuZnSOD (Figure 6.7a), MnSOD (Figure 6.7b), GPx1 (Figure 6.7c) 
and Catalase (Figure 6.7d) proteins content were observed during ageing.  
 
 
Figure 6.7a.  CuZnSOD protein content of Tibialis 
Anterior muscle from mice sacrified at 6, 12, 15, 18, 21, 
24 and 27 months. Histograms represent the mean and the 




Figure 6.7b.  MnSOD protein content of  Tibialis Anterior 
muscle from mice sacrified at 6, 12, 15, 18, 21, 24 and 27 
months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).  
 























































































































































Figure 6.7c.  GPx1 protein content of Tibialis Anterior 
muscle from mice sacrified at 6, 12, 15, 18, 21, 24 and 27 
months. Histograms represent the mean and the standard 
error of the mean for each experimental group (n=4).  
 
 
Figure 6.7d.  Catalase protein content of Tibialis Anterior 
muscle from mice sacrified at 6, 12, 15, 18, 21, 24 and 27 
months. Histograms represent the mean and the standard error 
of the mean for each experimental group (n=4).  
 






















































































































































6.3.6 Age-related changes in autophagy/mitophagy and apoptosis markers 
Analysis of p62 (Figure 6.8a) and of the BAX/Bcl-2 ratio (Figure 6.8b) did not show 

















Figure 6.8a.  p62 protein content  of  Tibialis Anterior muscle 
from mice sacrified at 6, 12, 15, 18, 21, 24 and 27 months. 
Histograms represent the mean and the standard error of the 
mean for each experimental group (n=4).   
 
 
Figure 6.8b.  BAX/Bcl-2 ratio of Tibialis Anterior muscle from 
mice sacrified at 6, 12, 15, 18, 21, 24 and 27 months. Histograms 
represent the mean and the standard error of the mean for each 


















































































































































Ageing is a multifactorial process that affects the majority of tissues in the body (Bulla 
and Shafwe, 2011). One of the tissues most affected by ageing is skeletal muscle that, in 
humans, after reaching a peak in muscle mass around the age of 24, experiences a 
progressive loss that from the age of 50 accelerates to up to 10% per decade (Lexell et 
al, 1988). Sarcopenia, the loss of muscle mass, strength and functionality has a tremendous 
impact on the health and quality of life of older adults (Baumann et al, 2016). To limit 
and prevent sarcopenia, a better understanding of this disease is essential but it is still 
unclear which factors play a primary role in inducing the loss of muscle mass and 
strength typically seen in sarcopenic patients.  
Previous reports have suggested that muscle fibre denervation may be one of the main 
factors responsible for the significant loss of muscle mass and functionality observed 
with ageing (Jang and Van Remmen, 2011; Aare et al, 2016; Hepple and Rice, 2016). 
During ageing, changes occurring at the level of the NMJ are known to trigger a series 
of consequences that can have a direct effect on the skeletal muscles (Jang and Van 
Remmen, 2011; Hepple and Rice, 2016). The process of denervation-reinnervation is 
a normal process that involves the NMJs and gives the skeletal muscle the plasticity 
necessary to continuously adapt to external stimuli (Hepple and Rice, 2016). Previous 
studies have reported that with ageing the efficiency of this process tends to decrease 
inducing decreased pre- and post-synaptic overlap at the NMJ level, altered distribution 
of laminin, post-synaptic receptors disruption and nerve sprouting (Balice‐Gordon, 
1997; Jang and Van Remmen, 2010; Samuel et al, 2012).  
In line with these previous studies the analyses presented here of the area of synaptic 
contact in young (6 months), adult (12-18 months) and old (21-27 months) mice showed 
a pattern that suggests an age-related impairment of the neuromuscular system with a 
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progressive reduction of the area of synaptic contact (Figure 6.3c) that was statistically 
significant at 24 months. Furthermore, there was also an age-related reduction in the average 
overlap between the pre- and post-synaptic terminals (Figure 6.3b). This progressive 
reduction of the average overlap suggests a progressive deterioration of the NMJ but may 
also lead to false conclusions. As suggested by Pennefather and Quastel (1981), only an 
overlap lower as 15% would significantly compromise the NMJ functionality preventing 
muscle fibre contraction. To provide a better understanding of the age-related changes 
occurring in the NMJs, data has been presented as percentages of post-synaptic terminals 
defined by the programme as fully innervated (100-80% overlap), partially innervated 
(79-15% overlap) and denervated (<15% overlap) (Figure 6.3a). The percentage of 
fully innervated post-synaptic terminals decreases with ageing and this is accompanied 
by an increase in denervated post-synaptic terminals that becomes significant at 27 months 
of age. Previous studies have also reported a progressive breakdown of post-synaptic 
receptors not appropriately connected with the nerve terminal (Hepple and Rice, 2016; 
Pollock et al, 2017). In the present study, the progressive reduction in the area of synaptic 
contact (Figure 6.3c) was accompanied by an age-related increase in both post-synaptic 
receptor area (Figure 6.3d) and diameter (Figure 6.3e) resulting from the progressive 
breakdown of denervated post-synaptic terminals.  
The content of important bio-markers that play a role in maintaining the NMJ stability 
was examined. Agrin is a large proteoglycan located in the basal lamina of the muscle 
cells and is responsible for the clustering and localisation of post-synaptic receptors 
on the muscle fibre surface (Samuel et al, 2012). During development, a specific agrin 
isoform (z-agrin) is secreted by the nerve inducing phosphorylation and activation of 
MuSK a high-affinity cell surface receptor that plays a fundamental role in the formation 
and maintenance of the NMJ. Upon activation of MuSK by z-agrin through the activity 
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of casein kinase 2, Dok-7 and rapsyn (Cheusova et al, 2006; Okada et al, 2006) the 
clustering and formation of the post-synaptic receptors is stimulated (Samuel et al, 
2012). A study focused on understanding the role of agrin in adult NMJs (Samuel et 
al, 2012) found that depletion of agrin induces several consequences such as:  
 Loss of acetylcholine receptors aggregates;  
 Depletion of important components of the post-synaptic membrane, rapsyn, and 
laminins α-4 and α-5; 
 Remodelling of the nerve terminal and eventual loss of the connection between 
the motoneuron and the post-synaptic terminal.  
These alterations resulted in a phenotype similar to the one seen in aged wild type mice 
supporting the speculation that agrin plays a fundamental role not only in the development 
of the NMJ but also in its maintenance. In the present study we observed no significant 
changes in agrin or MuSK protein contents despite the progressive disruption of the 
NMJ with ageing. Samuel and colleagues (2012) also failed to see such changes with 
ageing. These authors suggested that during ageing, it may be an alteration in the 
distribution of these proteins that potentially affects the stability of the NMJs rather 
than reduction of the protein contents and activities (Samuel et al, 2012).  
Loss of stability of the NMJ can trigger responses that allows a neighbouring axon to 
re-innervate the denervated post-synaptic receptors (Kung et al, 2014; Greising et al, 
2015). This phenomenon known as nerve sprouting (presented in Figure 6.4) is also 
accompanied by the appearance of NMJ “blebbing”. The origin, role and function of 
these protuberances are still poorly understood. Formation of these structures (presented 
in Figure 6.4) appears symptomatic of nerve deterioration and ineffectiveness in 
stabilising the NMJ, even when these overlap with an ACh receptor. In the context of 
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this study nerve sprouting and “blebbing” were observed starting around 12 months of 
age with a progressive increase in frequency up to 27 months of age.  
As suggested by Hepple and Rice (2016) and as briefly introduced earlier, nerve sprouting 
can be seen following the disruption of the NMJ as a nearby motoneuron attempts to 
restore the connection with an unoccupied post-synaptic terminal. However, even if this 
physiological attempt of restoring the NMJs succeeds in re-establishing a connection 
between the nerve and the muscle cell, these newly formed NMJs are very unstable 
and can be lost within few weeks from formation (Jang and Van Remmen, 2011; 
Hepple and Rice, 2016). When unstable NMJs are lost, some structural changes can also 
be observed at muscle fibre level. Denervated fibres quickly become more angular, 
atrophy and will eventually be lost over longer term (Hepple and Rice, 2016) reinforcing 
the hypothesis that impairments at the NMJs level may play a central role in sarcopenia 
(Kent-Braun et al, 2000; Lexell et al, 1988; Williams et al, 2002; Baumann et al, 2016). 
In the present study it was not possible to perform an accurate analysis of the muscle 
fibre number as some sections presented significant cryo-damage. Despite this 
limitation, we were able to analyse the muscle fibre Feret’s diameter observing high 
variability in our groups. Our results showed a trend towards a loss of large muscle fibres 
(50.1-60 and 60+ thresholds - Figure 6.2d) commencing at 18 months of age, however 
this loss did not reach statistical significance.  
When nerve sprouting is successful, it has the potential to restore the NMJ inducing 
alterations in the muscle fibre composition (fibre clustering) and changes in the muscle 
fibre contractile properties through the modification of the MyHC isoform of the 
reinnervated fibres (Maggs et al, 2008; Kung et al, 2014; Greising et al, 2015). Murine 
muscle fibre composition of specific muscles differs significantly from humans (Augusto et 
al, 2004). For instance, in the murine lower hind limb, the soleus muscle is the muscle 
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that presents a high percentage of MyHC-I fibres and, with around 40% percent of slow 
twitch muscle fibres (Augusto et al, 2004), is comparable to the human vastus lateralis 
(Staron et al, 2000). Tibialis Anterior in mice is composed of less than 1% of MyHC-
I type fibres and in the present analysis this isoform was not detected in the majority 
of the samples. To guarantee that the lack of detection of MyHC-I fibres in our samples 
was due to the absence of this isoform rather than an issue with the staining protocol, 
alongside the TA a soleus muscle was also stained as a control (result not shown in 
detail).  
With ageing we observed a decrease in fibres expressing MyHC-IIa at 24 and 27 months of 
age while the percentage of MyHC-IIx fibres remained stable until 27 months of age when 
a significant reduction was observed. The loss of MyHC-IIa and MyHC-IIx appeared to be 
in favour of MyHC-IIb which showed a statistically significant increase at 27 months of age. 
The mouse TA muscle mainly expresses the MyHC-IIb isoform with a high density of 
fast contracting motoneurons (Augusto et al, 2004) explaining the progressive switch 
from MyHC-IIa and MyHC-IIx fibres toward MyHC-IIb fibres. These modifications 
result in fibre clustering, a situation where two or more fibres of the same type present 
adjoining sarcolemma (Greising et al, 2015). Fibre clustering is a condition typical of 
ageing that, despite not having a direct impact on muscle functionality (Baumann et 
al, 2016) is symptomatic of sarcopenic muscles. This result reinforces the hypothesis 
that impairment at the NMJ level can have a direct effect on skeletal muscle structure 
and functionality.  
During ageing, alongside the progressive impairment of the neuromuscular system, there 
is also a significant increase in H2O2 accumulation resulting in oxidative stress (Stefanatos 
and Sanz, 2017; Staunton et al, 2019). As mentioned earlier in this chapter, one of the 
aims of the present work was to determine whether the adaptive response to the 
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significant increase in peroxide release that we observed in our denervation model, 
also occurs during ageing. Our work in full denervation model has demonstrated that 
in the first days (between day 1 and day 7) post-denervation, the antioxidant system 
responded by increasing the content of the antioxidant enzyme GPx1 (section 3.3.8) 
while we did not observe any significant change in MnSOD content. Similarly, in our 
ageing model we did not observe any significant change in MnSOD content and these 
results are in line with what previously reported by Brown and colleagues (2007) 
showing that during ageing the levels of MnSOD remain stable. Previous studies from 
our group (Palomero et al, 2013) have reported a significant increase in GPx1 activity 
in skeletal muscle during ageing. GPx1 is an enzyme mainly located in the cytosol and 
mitochondria and is able to catalyse the reduction of H2O2 into water also catalysing 
the reduction of lipid peroxides into alcohols (Brigelius-Flohé and Maiorino, 2013). In 
the present study we failed to show a similar increase in GPx1 protein content; 
however, activity was not measured and the possibility that this is increased during 
ageing cannot be excluded.  
The protein content of CuZnSOD and catalase, two proteins that have been proposed 
to play an important role during ageing were also examined. Previous studies showed 
that overexpression of CuZnSOD and catalase were capable of extending the lifespan 
of drosophila melanogaster (Orr and Sohal, 1994; Orr et al, 2003). However, these 
results were never replicated in mammalian models (Orr et al, 2003). Lack of CuZnSOD 
has been associated with an early and progressive modifications in muscle innervation 
including: fragmentation of the endplate, nerve sprouting and partial or no overlap 
between the motor neuron and the post-synaptic receptors in the NMJs (Sakellariou et al, 
2014b; Park, 2015). Models overexpressing catalase have shown protection of mitochondria 
with reduced oxidative stress, increased genomic stability resulting in a significant 
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maintenance of skeletal muscle structures and functions (Schriner et al, 2005; Umanskaya 
et al, 2014). Previous studies from our group showed that during ageing there is a 
significant increase in CuZnSOD and catalase enzymes activities (Vasilaki et al, 2006b; 
Palomero et al, 2013), but in the present study no significant age-related alterations in 
CuZnSOD and catalase contents were seen compared to the 6 months old group. 
Nevertheless, we cannot exclude the possibility that, despite the lack of changes 
observed in protein content, there may be an alteration of these enzymes activities 
similar to those previously reported by our group.  
In chapter 4 we described how mitochondria of denervated skeletal muscle fibres can 
play a fundamental role in driving muscle atrophy with an increase of the BAX/Bcl-2 
ratio resulting in a significant increase in activity of executional caspases, including 
caspase-3. When activated, this protein is able to induce protein degradation enhancing 
the activity of the 26S proteasome through the cleavage of Rpt2 and Rpt6 (Wang et al, 
2010). We previously speculated that the activation of this pathway is directly related 
to the significant increase in peroxide release from enzymes not involved in the ETC 
able to damage mitochondria and impair mitophagy. In contrast to the denervation 
models, we did not observe any accumulation of p62 suggesting that, in our ageing 
model, there may be correct recycle of damaged mitochondria and misfolded proteins 
with no activation of the 26S proteasome through the Bcl-2 family. This may be related 
to the lack of muscle atrophy observed in the present study as previous studies suggested 
that a close correlation exists between activation of apoptosis pathways and skeletal 
muscle atrophy (Dupont-Versteegden, 2006). 
In summary, our results suggest that with ageing there is a progressive impairment of 
the NMJ that induces nerve sprouting and progressive loss of pre- and post-synaptic 
overlap. These changes result in an increase in the number of non-occupied post-synaptic 
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terminals that tend to increase in diameter and eventually start to breakdown. These changes, 
were not associated with statistically significant changes in muscle mass or fibre Feret’s 
diameter that has been reported with ageing in previous studies (Palomero et al, 2013; 
Sakellariou et al, 2014b). Analysis of agrin and MuSK, two important proteins involved 
in the formation and stabilisation of the NMJ, also did not show significant age-related 
loss in protein content although we cannot exclude the possibility that changes in localisation 




















One of the major features of ageing is the loss of skeletal muscle mass and function 
known as sarcopenia with multiple factors contributing to its development and progression 
(Baumann et al, 2016). Several authors suggest that denervation of skeletal muscle fibres 
may play a prominent role in the age-related loss of muscle mass (Aare et al, 2006; Jang 
and Van Remmen, 2011; Hepple, 2014; Hepple and Rice, 2016; McDonagh et al, 2016; 
Spendiff et al, 2016; Pollock et al, 2017; Soniak et al, 2019). Furthermore, previous 
studies (Muller et al, 2007; Bhattacharya et al, 2009; Pollock et al, 2017) have also 
demonstrated a significant increase in mitochondrial peroxide release from denervated 
muscle fibres. Since the physiological roles of this peroxide release are still poorly 
understood, the aims of the present thesis were:  
 Examine the effects of prolonged denervation on peroxide release and proteins 
that regulate redox homeostasis in skeletal muscle.  
 Examine the effects of prolonged skeletal muscle denervation on mitochondria 
with a specific focus on: mitophagy, activation of apoptosis and mitochondrial 
number.  
 Determine the metabolic changes induced by skeletal muscle denervation.  
 Investigate whether the redox-related changes observed in our denervation model 
also occur during skeletal muscle ageing since muscle denervation appears to be a 
key characteristic of sarcopenia.  
 Evaluate the age-related changes occurring in the nerve-muscle interactions 
and examine whether the age-related loss in the stability of the NMJs results in 
skeletal muscle loss or vice versa.  
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7.1 Discussion of the main findings 
7.1.1 Mitochondrial peroxide release following denervation is driven by enzymes 
not involved in the ETC and induces activation of NOX2, PLA2 and Prx6 in the 
cytosolic environment 
Following denervation a significant increase in mitochondrial peroxide release occurred 
becoming significant 7 days following denervation and was sustained up to 21 days. 
In line with previous studies (Bhattacharya et al, 2009; Pollock et al, 2017), our results 
suggest that this increase is induced by enzymes not involved in the ETC but by other 
enzymes present in the mitochondrion such as NOX, Monoamine Oxidase A, Monoamine 
Oxidase B and PLA2. The significant decrease in peroxide release following the addition 
of AACOCF3 (a PLA2 inhibitor added to the Amplex Red assay) suggests that PLA2 
is active following denervation. This result indicates that, other than H2O2, mitochondria 
of denervated fibres also release other peroxides, including lipid peroxides.  
The increase in peroxide generation from mitochondria appears to trigger responses also 
in the cytosolic environment. Fourteen days following denervation an increase in Prx6 
content was seen. Prx6 is an enzyme that, when over-oxidised, can undergo conformational 
changes that allow the protein to acquire PLA2 activity. The significant increase in the 
NOX2 subunits between 7 and 14 days post-denervation suggests that an activation of 
this enzyme may have occurred. NOX2, using O2 and NADPH as substrates, is able to 
produce superoxide that is usually released in the extracellular matrix and, once converted 
into H2O2, is able to translocate into the cell exploiting aquaporins (Sies, 2017; Tamma 
et al, 2018). Peroxide released by NOX2 can participate in different functions including: 
mechanical contraction stimulating E-C coupling, (Kadoguchi et al, 2018) promoting 
insulin resistance through the interaction with the angiotensin-II system (Sukumar et 
al, 2013; Ferreira and Laitano, 2016) and activating pro-apoptotic pathways upregulating 
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the activity of the 26S proteasome (Li et al, 2003; Bodine et al, 2014; Delafontaine and 
Yoshida, 2016). Thus overall, our data support the hypothesis that post-denervation, 
muscle mitochondria increase peroxide release leading to activation of NOX2 possibly 
through the Prx6-cPLA2 signalling pathways. 
7.1.2 An initial adaptive response following denervation may be an attempt to protect 
mitochondria but is not sustained over long-term resulting in oxidative stress and 
possible activation of proteolytic pathways  
In the present study, 3 major mitochondrial antioxidant enzymes were analysed: MnSOD, 
TRxR2 and GPx1. While MnSOD content did not change following denervation, TrxR2 
and GPx1 contents were significantly increased between 3 and 7 days.  
The initial increase in the content of these mitochondrial antioxidant enzymes may 
reflect an adaptive response triggered by the loss of innervation in an attempt to 
maintain redox homeostasis in the muscle. In prolonged denervation, an increase in 
the content of different Hsp proteins was observed and remained increased up to 21 
days post-denervation. Activation of Hsc70, Hsp70 and Hsp25 may play a role in 
protein homeostasis and protection against H2O2-induced damage. Therefore, the data 
suggest that the increased peroxide release following denervation can stimulate adaptive 
responses against oxidative stress and repair mechanisms to protect the muscle from 
degeneration.  
7.1.3 Mitophagy is significantly inhibited following denervation with an increase 
in fission, activation of pro-apoptotic pathways and reduction in mitochondria 
population 
The effect of prolonged denervation on mitophagy and the mitochondria of denervated 
skeletal muscle fibres was examined. Mitophagy is a tightly regulated process that can be 
influenced and regulated by mitochondrial ROS (Forrester et al, 2018). It has been 
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previously demonstrated that oxidative stress is able to enhance Drp1 recruitment and 
activation (Giedt et al, 2012; Forrester et al, 2018). Results showed that 7 days 
following denervation, the significant increase in mitochondrial ROS production was 
associated with a significant activation of Drp1 resulting in fission of mitochondria. In 
contrast, the two different fusion markers analysed, OPA1 and Mfn-2, did not show 
any changes following denervation. Similar to fission, fusion activity can also be influenced 
by the production of mitochondrial ROS. For instance, as described by Forrester and 
colleagues (2018), an increase in mitochondrial ROS produced by NOX4, can prevent 
OPA1 and Mfn-2 accumulation and activity. Furthermore, a significant increase in p62 
content, which is indicative of a significant impairment of mitophagy, was seen. The 
increase in fission and the impairment of mitophagy was also associated with a progressive 
reduction of mitochondria numbers post-denervation.  
7.1.4 Activation of apoptosis in denervated skeletal muscle fibres  
Alongside the inhibition of mitophagy, results showed that 7 days following denervation 
there was an increase in the BAX/Bcl-2 ratio. Elevated BAX/Bcl-2 ratio is indicative of an 
increase in susceptibility of skeletal muscle fibres to apoptosis. Apoptosis is characterised 
by the permeabilisation of the mitochondrial membrane, release of cytochrome C, formation 
of the apoptosome and activation of the executional caspases -3, -6 and -7 (Slee et al, 
2001; Sandri et al, 2001). In the present study, together with the increase in BAX/Bcl-2 
ratio, an increase in caspase-3 content and cleavage was seen. The activation of caspase-3 
has been previously reported to induce protein degradation enhancing proteasomal 
activity through the cleavage of Rpt2 and Rpt6 two specific subunits of the 26S 
proteasome (Wang et al, 2010).  
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7.1.5 Denervation triggers significant metabolic changes in skeletal muscle 
Following denervation several metabolic changes were seen by NMR metabolomics 
including insulin resistance accompanied by inhibition of glycolysis. In addition, increased 
activity of the purine metabolism was seen. The latter is an important source of GTP 
and an alternative source of ATP. GTP can induce activation of a family of proteins 
known as G Proteins able to function as signal transducers and involved in the 
activation of several pathways including apoptosis through the Bcl-2 family 
(Yanamadala et al, 2009). Furthermore, GTP is a fundamental substrate of Rac-1, a 
protein necessary for NOX2 activation. NMR metabolomics also suggested that post-
denervation there is a significant increase in proteolysis with a progressive accumulation 
of amino acids such as valine, isoleucine, phenylalanine and glutamate. These amino 
acids are usually released from the breakdown of proteins during extreme conditions 
such as fasting or prolonged exercise where they can function as intermediate products 
of the citric acid cycle or to generate alanine (Lynch and Adams, 2014; Vandelbo et al, 
2014). The accumulation of these amino acids resulting from an acceleration in proteolysis 
can also be associated with an impairment of mitochondria, unable to use these 
substrates to generate ATP.  
 7.1.6 During ageing there is a progressive instability of the NMJ, accompanied 
by nerve sprouting and post-synaptic receptor breakdown. These changes were 
accompanied by mild structural changes at muscular level 
One of the focuses of the present thesis was to evaluate the age-related changes in 
nerve-muscle interaction at different time points during adulthood and ageing in order 
to better understand whether the age-related loss in the stability of the NMJs induces 
skeletal muscle loss or vice versa. Previous studies in humans and murine models 
showed that during ageing there are significant changes of the NMJs that compromise 
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its stability and functionality (Hepple and Rice, 2016). Instability of the NMJs triggers 
a cascade of events able to induce: nerve sprouting, fibre type grouping (Lexell and 
Taylor, 1991) and motor unit loss (McNeil et al, 2005) resulting in myofibre atrophy 
(Hepple and Rice, 2016). In the current study a progressive instability of the NMJ 
starting around 18 months of age was seen together with an increase in nerve sprouting 
and “blebbing” and other structural post-synaptic terminal changes resulting in a progressive 
increase in denervation.    
Nerve sprouting is a physiological response to the loss of NMJs as adjacent motor neurons 
spread in an attempt to re-innervate denervated post-synaptic receptors (Pestronk et al, 
1980; Jang and Van Remmen, 2011; Kung et al, 2014; Greising et al, 2015 Hepple and 
Rice, 2016). When successful, nerve sprouting has the potential to alter the activity of 
the genes regulating the MyHC fibre phenotype by imposing a different electrical 
activity to the fibre (Maggs et al, 2008). A switch from MyHC-IIa and MyHC-IIx fibres 
towards MyHC-IIb fibres was seen with ageing. This progressive switch reinforce the 
possibility that denervation plays a fundamental role in inducing age-related structural 
changes of the skeletal muscle. In the present work, a trend (not statistically significant) 
indicating a loss of large muscle fibres occurred in concomitance with the impairment of 
the NMJs.  
Another focus of the present work was to investigate whether the redox-related changes 
observed in the full denervation model also occur during skeletal muscle ageing since 
muscle denervation appears to be a key characteristic of sarcopenia. Previous studies from 
our group (Vasilaki et al, 2006b; Palomero et al, 2013) have reported a significant increase 
in the activity of different antioxidant enzymes during ageing. Surprisingly, our analysis 
failed to show similar changes in catalase, CuZnSOD and GPx1 contents. The discrepancy 
between previous results from our group and the results presented in this work could be 
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due to the high variability observed in the present study. Furthermore, the current study 
investigated protein content and hence cannot exclude age-related changes in the activity 
of these antioxidant enzymes. The lack of changes in p62 content and BAX/Bcl-2 ratio 
with ageing also suggest correct functioning of the autophagy and mitophagy machineries 
without the apparent activation of pro-apoptotic pathways as seen in our denervation 
models. 
7.2 Future perspectives 
7.2.1 Alternative methods for ROS detection 
Direct and quantitative measurement of ROS production continue to represent a 
challenge due to the reactive nature of ROS as well as methodological shortcomings 
(He et al, 2016). In addition to the the Amplex Red assay other methods such as 
Electron Paramagnetic Resonance (EPR) or fluorescent probes can be used for the 
detection of ROS production, their primary source and localisation. EPR is considered 
the gold standard for the analysis of oxygen centered free radicals such as superoxide, 
both in vivo and in vitro, using a “spin trap” such as DMPO (a nitrogen spin trap) 
(Griendling et al, 2016). Alternatively, probes similar to TMRM such as MitoSOX or 
the cell-permeant 2',7'-dichlorodihydrofluorescein diacetate allow researchers to 
determine the source and localisation of ROS both in cells and isolated muscle fibres. 
7.2.2 Analysis of the H2O2/lipid peroxide ratio 
The Amplex Red assay is unable to distinguish between lipid peroxides and H2O2 as 
both are able to induce oxidation of the Amplex Red reagent to the same extent. Future 
studies to determine the lipid peroxides produced during prolonged denervation will provide 
clearer information regarding the physiological impact of the peroxide released from 
denervated muscle fibres. Different methodologies are available to determine the extent 
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of lipid peroxidation including: measuring the losses of unsaturated fatty acids and 
measuring primary peroxidation products. The most widely used method to detect lipid 
peroxidation (although non-specific) is the thiobarbituric acid assay that analyses the 
formation of a pink chromogen that can be detected at 532nm wavelength and that is 
formed by the interaction of one molecule of malondialehyde and two molecules of 
thiobarbituric acid (Gutteridge and Halliwell, 1990). 
7.2.3 Activity of the 26 proteasome in denervated muscle fibres 
Following denervation a significant muscle fibre atrophy was seen. These results suggest 
activation of different pathways able to drive muscle fibre atrophy through apoptosis. 
In particular, the significant increase in content of NOX2 subunits and cleaved 
caspase-3 suggests the activation of the 26S proteasome system. Analysis of the 
activity of this molecular complex would allow to determine its actual role in 
denervated skeletal muscle fibres.  
7.2.4 ATP production during oxidative phosphorylation in denervated skeletal 
muscle fibres 
In the present work a progressive accumulation of amino acids that can function as 
intermediate substrates for the citric acid cycle was seen. This accumulation may be 
related to an impairment of the mitochondrial network with mitochondria unable to 
generate ATP. NMR was unable to identify changes in ATP abundance and changes 
may have been obscured by metabolites with higher clarity x dynamic range. 
Analysing mitochondrial respiration in denervated muscle fibres would allow the 
determination of whether denervation significantly impairs mitochondria functions and 
ATP production via oxidative phosphorylation. 
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7.2.5 Muscle fibres contractility post-denervation 
Despite the significant proteolysis and activation of pro-apoptotic pathways, NMR 
metabolomics showed a significant decrease in 3-methylhistidine abundance. As this 
metabolite is usually produced by the breakdown of actin and myosin, this result may 
indicate a preservation of the contractile structures of the muscle. In future studies, 
performing ex-vivo muscle contractions of denervated muscles will allow the determination 
of whether the contractile apparatus is still functional.  
7.2.6 Redox proteomics 
New developments in the field of mass spectrometry allow investigation of the 
reversible and irreversible post-translational modifications induced by the activity of 
ROS (McDonagh, 2017). In future studies, redox mass spectrometry may allow integration 
of the results obtained from NMR metabolomics analysis to obtain a more complete 
picture of the impact that prolonged denervation has on skeletal muscle fibres. 
7.2.7 Alternative mitophagy markers 
In the present study we used the accumulation of p62 as a marker of mitophagy 
impairment. An alternative method to verify an eventual impairment of mitophagy 
using immunoblotting is by measuring the rate of conversion of Microtubule 
associated protein light chain 3 (LC3) (Mizushima and Yoshimori, 2007). LC3 is 
ubiquitously expressed in mammalian tissues. During the formation of 
autophagosomal membranes, LC3-I (the cytosolic form of LC3) is conjugated to 
phosphatidylethanolamine to form LC3-phosphatidylethanolamine conjugate (LC3-II) 
and this is then recruited to autophagosomal membranes (Tanida et al, 2008). An 







In conclusion, sarcopenia is a serious threat to the health of older adults, increased 
understanding of this disease will significantly help in reducing its incidence and its 
consequences. Future studies to implement the findings of the present work will contribute 
to provide a better picture of the role that ROS and denervation play in the age-related 
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Figure A1.1.  Representative membrane stained with Ponceau. Each lane represents  
a different sample (S1-12) together with a protein ladder (PL)  used as molecular 
weight reference and 2 extra samples (SOa-b) used to verify the specificity of the 
secondary antibody. The representative orange box shows the area used for the 
densitometry analysis of each lane.  
 
 
Table A1.1.  In the table are presented the raw values obtained from the  ImageJ 
analysis of the ponceau staining as shown in Figure A1.1 and the ratio obtained 











Figure A1.2.  Representative membrane blotted for Mfn2. Each lane represents a 
sample (S1-12), together with a protein ladder (PL) and 2 extra samples (SOa -b) 
used to verify the specificity of the secondary antibody. The representative orange 
box shows the area used for the densitomet ry analysis of each lane.  The lack of signal 






Table A1.2.  In the table are presented the raw values obtained from the densitometry 
analysis of the Mfn2 bands shown in Figure A1.2 (DRV) and the normalised valued  
obtained dividing DRV by the S1 ratio of the corresponding lane obtained analysing 
the ponceau S (Table A1.1). The normalised results are expressed in arbitrary units 
































Figure A2.1  Original oxyblots analysed to generate the data presented in section 
3.3.5. The nature of the protocol did not allow the use of any normalisation method 
(i.e. Ponceau S, GADPH or β-Actin) therefore it  was impossible to normalise the 






















Appendix 3. Mitochondria isolation and NMR 








Figure A3.1.  Representative blots of  GADPH and COXIV in 
mitochondrial (Mito) and cytosolic (Cyto) extracts obtained 





Figure A3.2.  Representative blots of GADPH and COXIV in 
mitochondrial (Mito) and cytosolic (Cyto) extracts obtained 













Figure A3.3.  Chemical structure of Sucrose. The presence of 
two aromatic rings generate a series of peaks in the NMR 
metabolomics spectra with the potential to obscure the signal 




Figure A3.4.  Chemical structure of EDTA. Although not 
presenting an aromatic ring in its structure this chemical, 
similar to Sucrose,  generates a series of peaks in the NMR 
metabolomics spectra with the potential to obscure the 




Figure A3.5.  Chemical structure of MOPS. This N-substituted 
amino sulfonic acid, similarly to Sucrose,  generates a series 
of peaks in the NMR metabolomics spectra with t he potential 
to obscure the signal of other metabolites.  
 
 







Figure A3.6.  1H 1D NMR spectra (700MHz) of mitochondria extracted from mouse 
gastrocnemius using KCl or Sucrose buffers and of the extract  from C2C12 cells 
using a standard extraction buffer for NMR metabolomics containing 50% HPLC 
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A B S T R A C T
Previous studies have shown a significant increase in the mitochondrial generation of hydrogen peroxide (H2O2)
and other peroxides in recently denervated muscle fibers. The mechanisms for generation of these peroxides and
how the muscle responds to these peroxides are not fully established. The aim of this work was to determine the
effect of denervation on the muscle content of proteins that may contribute to mitochondrial peroxide release
and the muscle responses to this generation. Denervation of the tibialis anterior (TA) and extensor digitorum
longus (EDL) muscles in mice was achieved by surgical removal of a small section of the peroneal nerve prior to
its entry into the muscle. An increase in mitochondrial peroxide generation has been observed from 7 days and
sustained up to 21 days following denervation in the TA muscle fibers. This increased peroxide generation was
reduced by incubation of skinned fibers with inhibitors of monoamine oxidases, NADPH oxidases or phospho-
lipase A2 enzymes and the muscle content of these enzymes together with peroxiredoxin 6 were increased
following denervation. Denervated muscle also showed significant adaptations in the content of several enzymes
involved in the protection of cells against oxidative damage. Morphological analyses indicated a progressive
significant loss of muscle mass in the TA muscle from 7 days up to 21 days following denervation due to fiber
atrophy but without fiber loss. These results support the possibility that, at least initially, the increase in per-
oxide production may stimulate adaptations in an attempt to protect the muscle fibers, but that these processes
are insufficient and the increased peroxide generation over the longer term may activate degenerative and
atrophic processes in the denervated muscle fibers.
1. Introduction
Loss of muscle mass occurs during aging and is known as sarco-
penia. This has a significant impact on health and is caused by several
factors, among which impairment of the neuromuscular system appears
to play a primary role. The neuromuscular system shows great plasticity
and muscle fibers undergo a process of denervation and re-innervation
repeatedly throughout life. With advancing age, the efficiency of this
cycle appears to decline with a characteristic loss of neuromuscular
junction (NMJ) structure (the synapse between a motor neuron and
muscle fiber), motor units (the unit consisting of a single motor neuron
and the muscle fibers it innervates), muscle mass (due to both the loss
of motor units and individual muscle fiber atrophy) and together with
an increase in neuronal axon sprouting with preferential re-innervation
of slow-twitch muscle fibers [1–4]. Denervated fibers atrophy and, on
average, they are 35–50% smaller in comparison with innervated fibers
in muscles of old rats [1]. However, the reasons for the age-related
changes in muscle fiber denervation and disrupted NMJ innervation
and function are not currently known.
A characteristic of aging is an increase of reactive oxygen species
(ROS) activities that, if not adequately counteracted, can result in
oxidative stress with decreased mitochondrial efficiency and cellular
damage. Although numerous studies have highlighted the degenerative
roles played by chronic increases in ROS [5], others have highlighted
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the signalling role played by ROS in response to alterations in redox
homeostasis [2]. Thus, oxidants can activate and inactivate transcrip-
tion factors, membrane channels and metabolic enzymes in addition to
modulating calcium-dependent and phosphorylation signalling path-
ways [6].
Nerve transection models have been extensively used to investigate
the mechanisms leading to rapid decline in muscle mass and function
following the loss of innervation. Studies using this denervation model
in rodents also point to a role of mitochondrial oxidative stress in the
mechanisms of denervation-induced muscle atrophy [7]; Bhattacharya
et al., 2008, [10].
Hydrogen peroxide (H2O2) plays a key role in cell signalling and is
usually formed within the mitochondria by dismutation of superoxide
generated from the electron transport chain. Beside the mitochondrial
electron transport chain, up to 31 other enzymes have been implicated
in the generation of H2O2 in skeletal muscle [9]. Studies performed by
Muller et al. [7] indicated that H2O2 and other peroxides are produced
in high amounts by muscle mitochondria [10] following short-term
denervation and recent data published by our group show that this
increased H2O2 may be generated by sources other than the electron
transport chain within mitochondria [8].
The aim of the present study was to determine the effect of pro-
longed denervation on peroxide release and proteins that regulate
redox homeostasis in muscle fibers.
2. Materials and methods
2.1. Mice
8–10 month old male C57BL/6 WT and B6. Cg-Tg (Thy1-YFP) mice
were used for this study, with 4 mice used per time point (unless
otherwise stated). The C57BL/6 WT mice were used for biochemical
analyses whereas the B6. Cg-Tg (Thy1-YFP) mice were used for histo-
logical analyses and NMJ visualization as previously described [8].
Mice were fed ad libitum on a standard laboratory diet, subjected to a
12-h light/dark cycle and maintained under SPF conditions. All ex-
periments were performed in accordance with UK Home Office guide-
lines under the UK Animals (Scientific Procedures) Act 1986 and re-
ceived ethical approval from the University of Liverpool Animal
Welfare Ethical Review Body (AWERB).
2.2. Surgical denervation of the tibialis anterior (TA) and extensor
digitorum longus (EDL) muscles
Mice underwent surgical denervation of the tibialis anterior (TA)
and extensor digitorum longus (EDL) muscles as described by Pollock
et al. [8]. Briefly, mice were anesthetized with Isoflurane 0.2% (ISO)
while Buprenorphine (analgesic; 1 mg/kg, SC 0.1 ml) was administered
before surgery. To induce denervation of the TA and EDL muscles, a
small section of the peroneal nerve was removed. The external wound
was sutured and mice were maintained under close observation until
recovery from anesthetic. Mice were then sacrificed at different time
points after denervation (1, 3, 7, 14, 21 days) through cervical dis-
location and TA and EDL muscles were immediately removed.
2.3. Assessment of morphological changes in muscle and nerve
TA muscles were mounted directly on a cork disk, surrounded with
O·C.T. mounting medium (Thermo Fisher Scientific, Waltham, MA,
USA), frozen rapidly in isopentane cooled in liquid nitrogen and sec-
tioned (12 μm) using a cryostat (Leica CM1850, Leica, Wetzlar,
Germany) as described by Vasilaki et al., [11]. To assess fiber cross-
sectional area (CSA) transverse sections were fixed onto slides in ice-
cold methanol and stained with Alexa Fluor 488 nm conjugated wheat
germ agglutinin (WGA-488) (5 μM) (Vectorlabs, Burlingame, CA, USA).
Multiple images were collected by confocal microscopy (Nikon,
Kingston, UK) using ×20 objective to capture the section in its entirety.
The images were collated into a montage and analyzed using ImageJ
software (U.S. National Institutes of Health, USA). Separate transverse
sections of TA muscle were stained with hematoxylin and eosin (H&E)
using a standard protocol [12]. Each slide was examined using a Nikon
Ci microscope (Nikon Kingston, UK) equipped with ×4 and ×20 ob-
jectives.
In order to assess the loss of innervation at different time points the
EDL muscle from Thy1-YFP mice was pinned onto sylgard plates
(Fernell, Preston, UK) and fixed in 10% neutral buffered formalin.
Whole EDL muscles were incubated (30min) with bungarotoxin con-
jugated with Alexa Fluor-532nm (10 μg/ml) and Dapi (1:500)
(Invitrogen, Paisley, United Kingdom). Nerves were visible due to the
expression of YFP. Muscles were imaged via confocal microscopy
(Nikon A1, Kingston, UK) using a water immersion lens.
2.4. Analysis of mitochondrial peroxide generation
Analysis of the mitochondrial release of H2O2 (and other peroxides)
from the TA muscle was performed by following the oxidation of am-
plex red as described by Pollock et al. [8]. Small bundles of muscle
fibers were placed into 200 μM saponin (Sigma Aldrich, UK) in relax
solution (containing 4.5 mM MgATP, 1mM Free Mg, 10mM Imidazole,
2 mM EGTA and 100mM KCl, pH 7.0) to permeabilize the fibers. Sa-
ponin was washed from the tissue through 3 cycles of fresh relax so-
lution with gentle agitation prior to placing the bundles into amplex red
solution (containing 37.5U/ml SOD, 19.44mM Amplex red, 5U/ml
Horse radish Peroxidase (HRP) in ROS buffer (125mM KCL, 10mM
Hepes, 5 mM MgCl2, 2 mM K2HPO4) in black 96 well plates (Corning,
Wiesbaden, Germany). Bundles were then incubated at 37 °C with
amplex red solution without added substrates to assess state 1 peroxide
production, or in the presence of specific enzyme inhibitors: (20 μM
AACOCF3 - phospholipase A2 inhibitor; 0.5 mM apocynin – a non
specific NADPH oxidase inhibitor; 100 μM chlorgyline - monoamine
oxidase A inhibitor; 100 μM pargyline - monoamine oxidase B inhibitor)
as described in Pollock et al. [8]. The fluorescent signal was recorded at
590 nm using a fluorimeter (Fluorstar, BMG Labteck, Germany).
2.5. Muscle content of total and oxidized glutathione
TA muscles were ground under liquid nitrogen and the resulting
powder was added to 1% sulfosalicylic acid. Following homogeniza-
tion, samples were centrifuged for 10min at 14,000g and the super-
natant was collected for total and oxidized glutathione analyses as
described by Vasilaki et al. [13]; whilst the pellet was re-suspended in
0.5 M Tris/HCl buffer (pH 7.6) for total protein content determination
[14]. The automated glutathione recycling method described by An-
derson [15] was used to assess the total glutathione content using a 96-
well plate reader (SPECTROstar Nano, BMG labtech, Ortenberg, Ger-
many). To determine the oxidized glutathione content, samples were
firstly derivatized with 2-Vinylpyridine and analyzed as above.
2.6. SDS-PAGE and immunoblotting
Denervated and control TA muscles were ground in liquid nitrogen.
The resulting powder was added to 1% SDS (Sigma-Aldrich Ltd,
Gillingham, Dorset, United Kingdom) containing protease inhibitors
(Thermo Fisher Scientific, Waltham, MA, USA) and homogenized for
30–60 s. Samples were centrifuged for 10min at 13,000g, the super-
natant collected and protein content analyzed using a BCA assay kit
(Thermo Fisher Scientific, Waltham, MA, USA). Thirty micrograms of
total protein was applied to a 12% polyacrylamide gel with a 4%
stacking gel. The separated proteins were transferred onto ni-
trocellulose membranes by western blotting as previously described by
Sakellariou et al. [16]. Ponceau red (Sigma-Aldrich, St. Louis, MI, USA)
was used to verify the effectiveness of transfer procedure and to
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normalize the results as described by Romero-Calvo et al. [17]. The
membranes were analyzed using antibodies against; Nox2/gp91 phos-
phorylated (Nox2/gp91phox), Nox4, p22 phosphorylated (p22phox), p40
phosphorylated (p40phox), p47 phosphorylated (p47phox) and p67
phosphorylated (p67phox), Ras-related C3 botulinum toxin substrate 1
(Rac-1), peroxiredoxin 6 (Prx6), cytosolic phospholipase A2 isoform
(cPLA2), monoamine oxidase A (MAO-A), thioredoxin reductase 2
(TrxR2), glutathione peroxidase 1 (GPx1), manganese superoxide dis-
mutase (MnSOD; SOD2) and Heat Shock Proteins (HSPs) Hsp25, Hsc70
and Hsp70 (Tables 1 and 2). Chemiluminescence was detected using the
ChemiDocTM imaging system (Bio-Rad, Hercules, CA, USA) following
addition of ECL (Bio-Rad, Hercules, CA, USA). Densitometry analysis
was performed using ImageJ software according to the protocol de-
scribed by McLean [18].
2.7. Analysis of protein carbonylation
Denervated and control TA muscles from C57/Bl6 mice were
homogenized in Hepes buffer and analyzed using the OxyBlot protein
oxidation detection kit (Merk, Darmstadt, Germany). Samples were
separated on 12% polyacrylamide gels, transferred on a PVDF mem-
brane (GE Healthcare Bio-Sciences, Pittsburgh, USA) and analyzed as
specified. Densitometry analysis of the bands at different molecular
weights was performed using ImageJ software.
2.8. Statistical analysis
Statistical analysis was performed using IBM SPSS statistic version
22 software (IBM analytics, New York, USA). All tests have been carried
out with a 95% confidence interval and the level of significance was set
at 0.05. Normal distribution was verified using the Shapiro-Wilk test
and the data were expressed as the mean ± standard error mean. One-
way ANOVA was performed using Bonferroni's correction to identify
significant differences between the control group and the other time
points. For those variables where the assumption of normal distribution
was violated, differences within and between groups were determined
by Kruskal-Wallis test followed by Mann-Whitney U test for post hoc
analysis applying Bonferroni's correction.
3. Results
3.1. Morphological and structural changes following denervation
No significant difference in body weights of mice were observed
between the control and the denervated groups (Fig. 1A). Analyses
indicated a progressive and significant loss of mass in the TA muscle
from 7 days up to 21 days following denervation (F (5,19)= 33.204
p < 0.01) (Fig. 1B) which was not associated with any loss of fiber
number (F (5,10)= 0.316 p > 0.05) (Fig. 1C) but appeared entirely
due to fiber atrophy (Fig. 1D). Analysis of the distribution of fiber CSA
indicated that denervation induced a decrease in the number of larger
fibers at 7, 14 and 21 days post-nerve transection with an increase in
the number of smaller fibers compared with control muscle (Fig. 1D).
While the decline in fiber size reported in Fig. 1 was clearly evident,
histological examination revealed no structural abnormalities within
muscles (i.e. presence of necrotic or regenerating fibers; Fig. 2A). No
significant infiltration of the muscle by immune or other mononuclear
cells was apparent following denervation with hematoxylin and eosin
staining (Fig. 2A). Since this was not within the scope of the study,
specific staining for potential invading cells was not performed and
therefore, it is not possible to entirely rule out the possibility that in-
creased numbers of immune cells were present at some time points.
Examination of the EDL muscles confirmed that neuronal input to
the NMJs was lost by 3 days post-nerve transection [8]. There was no
evidence of re-innervation at 14 or 21 days and acetylcholine receptors
(stained using α-bungarotoxin) remained present in characteristic
clusters. Further bungarotoxin-staining distant from NMJs was also
apparent along the length of the muscle fibers by 21 days post-de-
nervation (Fig. 2B).
3.2. Peroxide production by mitochondria in bundles of TA muscle fibers in
state 1
A statistically significant increase in the rate of oxidation of amplex
red was observed from bundles of permeabilized TA fibers following
denervation (F (4,11)= 44.354 p < 0.001) (Fig. 3A). Peak mi-
tochondrial peroxide production in state 1 was seen at 7 days following
denervation although levels remained elevated up to 21 days after
denervation (Fig. 3A).
3.3. Total and oxidized glutathione content of muscle
The total glutathione (GSH) and oxidized glutathione (GSSG) con-
tents of denervated TA muscles are shown in Fig. 3B. Data show no
significant differences in total GSH (F (5,16)= 1.473 p > 0.05) or
GSSG (F (5,15)= 1.291 p > 0.05) content following denervation.
3.4. Protein oxidation in TA muscles following denervation
Analysis of protein carbonylation has been widely used as a measure
of oxidative damage to proteins. The OxyBlot approach is relatively
non-specific and semi-quantitative but potentially provides insight into
the molecular mass of oxidized protein targets. Soluble proteins from
denervated and control TA muscles were separated by SDS-PAGE and
were analyzed for carbonyl content following western blotting. An il-
lustrative blot of the pattern of bands is shown in Fig. 3C. Six major
bands of approximate molecular weight 95, 75, 65, 55, 35, and 25 kDa
were quantified by band densitometry (Fig. 3D). Densitometry analysis
revealed no major differences in the carbonyl content between control
and denervated muscles except from the band seen at approximately
∼25 KDa, which showed increased intensity at 7 days following de-
nervation (F (5,17)= 3.616 p < 0.05) (Fig. 3D) when the significant
increase in mitochondrial peroxide generation from the denervated
Table 1
List of the antibodies utilized for SDS-PAGE Western blot analysis.
Target Company Code Clonal Host
species
Dilution
GPx1 Abcam ab22604 Polyclonal Rabbit 1:1000
Hsp25 ENZO 801d Polyclonal Rabbit 1:1000
Hsp70 Abcam ab31010 Polyclonal Rabbit 1:1000
Hsc70 Stress Gen SPA815 Monoclonal Rat 1:750
MAO-A Abcam ab126751 Monoclonal Rabbit 1:1000
Nox4 Abcam ab133303 Monoclonal Rabbit 1:1000
Nox2/gp91phox Abcam ab43801 Polyclonal Mouse 1:500
P22 phox SCBT sc271968 Monoclonal Mouse 1:500
P40 phox SCBT sc48388 Monoclonal Mouse 1:500
P47 phox SCBT sc17845 Monoclonal Mouse 1:500
P67 phox BD Bioscience 610913 Monoclonal Mouse 1:500
cPLA2 CST 2832S Polyclonal Rabbit 1:1000
Prx6 Abcam ab133348 Monoclonal Rabbit 1:1000
Rac-1 Abcam ab33186 Monoclonal Mouse 1:500
MnSOD CST 13194S Monoclonal Rabbit 1:1000
TRxR2 CST 12029S Monoclonal Mouse 1:1000
Table 2
List of the secondary antibodies utilized for SDS-PAGE Western Blot analysis.
Secondary Antibody Company Code Dilution
Anti-mouse IgG, HRP-linked CST 7076S 1:5000
Anti-rabbit IgG, HRP-linked CST 7074S 1:5000
Anti-rat IgG, HRP-linked CST 7077S 1:5000
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muscle fibers was also evident (Fig. 3A).
3.5. Potential sources of H2O2 in TA muscle following denervation
In order to determine potential sources of H2O2 production in TA
muscles in state 1 following denervation, permeabilized muscle fiber
bundles were incubated with specific enzyme inhibitors during analysis
of peroxide generation as previously described [8]. All inhibitors re-
duced peroxide release to variable extents at the different time points
examined (7, 14 and 21 days post-denervation) (Fig. 4A).
Functionally active NADPH oxidase 2 (Nox2) is a multimeric en-
zyme composed of various subunits: Nox2/gp91phox and p22phox com-
prise the membrane-bounded part of the enzyme whereas, p47phox,
p67phox, p40phox, and Rac-1 subunits organize and assemble the func-
tional complex and regulate its activity [19–21]. The muscle content of
all of the Nox2 subunits examined increased after denervation, al-
though the relative increases differed between subunits in terms of
timing and magnitude of change. While most of the subunits showed
changes that could be quantified by densitometry within the dynamic
range of western blots, some of the regulatory subunits were un-
detectable, or barely detectable in the baseline (non-denervated) sam-
ples and in these cases only example blots are shown in the supple-
mentary data to provide examples of the changes observed. Nox2/
gp91phox content (F (5,14)= 10.309, p < 0.01, Fig. 4B) increased with
time to an apparent peak at 14 days post-denervation and p67phox
protein content showed a significant increase compared to control at 14
days after denervation which increased further at 21 days post de-
nervation (F (5,17)= 15.595, p < 0.01).
Example blots showing the increased p40phox content are presented
in Supplementary data 1A. The p22phox content was significantly in-
creased at 7, 14 and 21 days post-denervation whereas p47phox protein
content was significantly increased at 3 days following denervation (F
(5,15)= 7.390, p < 0.01; Supplementary data 1B). Rac-1 is reported
to trigger activation of the NADPH oxidase complex and Rac-1 content
showed a statistically significant increase at 7 days (F (5,16)= 3.829,
p < 0.01) post-denervation (Supplementary data 1B).
The muscle content of NADPH oxidase 4 (Nox4) showed little
change up to 14 days post-denervation compared with control and al-
though a trend towards an increase was seen at 21 days, this did not
reach statistical significance when compared with the control group
(Fig. 4B).
The protein levels of three other proteins that might potentially be
involved in generation of fatty acid peroxides or H2O2 were examined.
The muscle content of cPLA2 increased post-denervation and was sig-
nificantly higher than control at 14 and 21 days (F (5, 16)= 98.569,
p < 0.01) (Fig. 4C). Monoamine oxidase A protein content was sig-
nificantly increased at 1 day following denervation and remained in-
creased up to 14 days following denervation (F (5, 16)= 10.986,
p < 0.01) (Fig. 4C). Prx6 is a peroxiredoxin that may also have PLA2
activity under some conditions and although this protein was un-
detectable in control muscle samples, a clear increase was seen in
muscle up to 21 days post-denervation (Supplementary data 2A).
Fig. 1. (A) Total body weights (B) TA muscle weights (C) fiber number and (D) fiber CSA from control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days
post-denervation. Histograms represent the mean and the standard error of the mean for each experimental group (n = 4). *p < 0.05 - **p < 0.01 - ***p < 0.001
compared with the control group.
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3.6. Muscle content of mitochondria-localized regulatory enzymes following
denervation
The content of three major mitochondrial enzymes involved in
redox regulation were analyzed: The MnSOD content in muscle did not
change significantly following denervation (Fig. 5A), but TrxR2 was
significantly increased at 3 and 7 days post denervation and then de-
clined over the following time points (F (5,15)= 10.899 p < 0.01),
while the GPx1 content was significantly increased at 3, 7 and 21 days
following denervation (Fig. 5A).
3.7. HSP content of TA muscles following denervation
Data in Fig. 5B show that skeletal muscles from adult mice also
responded to denervation by an increase in the content of some HSPs.
Hsp25 was significantly increased at 3 days and continued to increase
at 7, 14 and 21 days following denervation ( F (5, 16)= 147.142,
p < 0.01). The Hsc70 content of denervated TA muscles was sig-
nificantly increased at 14 and 21 days post-denervation ( F (5,
15)= 16.073, p < 0.01). Hsp70 was undetectable in some control
muscle samples but appeared to increase at 14 and 21 days post-de-
nervation (Supplementary data 2B).
4. Discussion
It is now well established that during aging a number of muscle
fibers lose functional innervation, leading to significant fiber degen-
eration and atrophy [1,3] and studies using nerve transection models in
rodents have indicated a role for mitochondrial oxidative stress in the
mechanism of denervation-induced muscle atrophy [7,8,10]. Specifi-
cally, previous work from our group and others has shown that de-
nervation of muscle leads to a large increase in the release of H2O2 and
lipid peroxides from muscle mitochondria over a short time course
[7,8,10]. In this study, we extended the time course of denervation in
order to examine the longer-term effect of muscle denervation on per-
oxide release and proteins that regulate redox homeostasis in muscle
fibers.
Full denervation of the TA muscle was achieved by surgically re-
moving a small section of the peroneal nerve prior to entry into the
muscle. Morphological analyses of the TA muscle indicated a
Fig. 2. (A) Cross-sections of TA muscles visualized by H&E staining and (B) NMJs observed in whole mount EDL muscles from control mice (non-denervated) and
mice at 1, 3, 7, 14 and 21 days post-denervation. Images show the peripheral nerves (green) and acetylcholine receptors (red). (For interpretation of the references to
colour in this figure legend, the reader is referred to the Web version of this article.)
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progressive significant loss of muscle mass from 7 days up to 21 days
post-denervation. This occurred without loss of fibers (Fig. 1C) and
hence was due to fiber atrophy (Fig. 1D). Our previous published data
have demonstrated that by 7 days following denervation there was
complete loss of pre-synaptic axonal input at the NMJs [8] and our
current data confirm this (Fig. 2B) and demonstrate the longer-term
effects on muscle fiber atrophy (Fig. 1).
The extended time course of mitochondrial peroxide generation
reported here showed a significant increase in H2O2 generation from
fiber bundles by 7 days post-denervation, which was sustained up to 21
days (Fig. 3A). Pollock et al. [8] previously demonstrated by addition of
substrates and inhibitors of the electron transport chain that the
Fig. 3. (A) State 1 H2O2 production in mitochondria from permeabilized fibers from the TA muscles determined by oxidation of amplex red. (B) Total glutathione
(GSH) and oxidized glutathione (GSSG) contents in TA muscles from control (non-denervated) mice and mice at 1, 3, 7, 14 and 21 days post-denervation. (C) A
representative lane of an OxyBlot for control muscle showing the bands detected with approximate molecular weights (MW) indicated. (D) Quantification of protein
carbonyls by densitometric analysis of the protein bands at different molecular weights. Histograms represent the mean and standard error of the mean for each
experimental group (n = 4). *p < 0.05 - **p < 0.01 - ***p < 0.001 compared with the control group.
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increased peroxide generation by muscle mitochondria post-denerva-
tion did not derive from the electron transport chain but indicated that
alternative sources of peroxides were likely to be involved. Skeletal
muscle mitochondria contain several other potential sources of ROS
including monoamine oxidases [22]), NADPH oxidase [16] and phos-
pholipases [23] and inhibitor studies have suggested that all of these
proteins may be involved in the denervation-induced increase in mi-
tochondrial ROS ([8] and Fig. 4A).
Monoamine oxidases are flavoenzymes that are present in the mi-
tochondrial outer membrane [24] and exist in two isoforms, mono-
amine oxidase A and B that share approximately 70% of sequence
identities but are distinguished by different substrate specificity [25].
Both monoamine oxidase A and B play a primary function in regulating
neurotransmitter levels and the degradation of amines [24]. Skeletal
muscle has been reported to contain both monoamine oxidase A [26]
and B [27] and addition of chlorgyline (monoamine oxidase A) and
pargyline (monoamine oxidase B) inhibitors reduced the oxidation of
amplex red by permeabilized muscle fibers. Monoamine oxidase A
protein content was also found to be increased prior to the increase in
mitochondrial peroxide release (Fig. 4C) whereas monoamine oxidase B
protein content was unchanged (data not shown).
Previous studies have shown that, following denervation, lipid
peroxides are also released from mitochondria and can oxidize amplex
red [8,10]. Our current inhibitor data supports this possibility since
Fig. 4. (A) State 1 mitochondrial H2O2 generation from permeabilized fibers of the TA muscle in the presence of different enzyme inhibitors. Addition of each
inhibitor (chlorgyline (monoamine oxidase A), parglyline (monoamine oxidase B), apocynin (NADPH oxidase), AACOCF3 (PLA2) resulted in significantly reduced
H2O2 generation compared to untreated fiber bundles at 14 and 21 days post-denervation. Histograms represent the mean and standard error of the mean for each
experimental group (n = 4). *p < 0.05 - **p < 0.01 - ***p < 0.001 compared with its state 1. (B) Quantification of western blots of NADPH oxidase 2 subunits
(Nox2/gp91phox and p67phox) and NADPH oxidase 4 (mitochondrial isoform) and (C) of cPLA2 and monoamine oxidase A content in TA muscle from control mice
(non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. Histograms represent the mean protein content and standard error of the mean for each
experimental group (n = 4). *p < 0.05 - **p < 0.01 - ***p < 0.001 compared with the control group.
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addition of the cPLA2 inhibitor, AACOCF3, reduced mitochondrial
peroxide production (Fig. 4A) and muscle levels of cPLA2 were also
increased post-denervation (Fig. 4C and [8]).
Other studies have demonstrated that skeletal muscles contain dif-
ferent isoforms of NADPH oxidase [16,28]. Addition of apocynin (a
non-specific NADPH oxidase inhibitor) significantly reduced the de-
nervation-induced mitochondrial amplex red oxidation at all time
points following denervation (Fig. 4A), but the cPLA2 inhibitor AA-
COCF3 and the monoamine oxidase inhibitors also caused a marked
reduction of peroxide release. These apparently conflicting pieces of
data may potentially be explained by a lack of specificity of the in-
hibitors used or by involvement of complex interacting pathways, such
as for instance, a potential direct role for PLA2 in the production of
peroxide together with a role for PLA2 in activation of NADPH oxidase
[29,30].
In the present study, we examined two NADPH oxidase isoforms
that are reported to be present in skeletal muscle, Nox4, present within
mitochondria, and Nox2 which is found mainly in the cytosolic en-
vironment [28]. Due to the reported sub-cellular location of the two
isoforms, only Nox4 could likely contribute to the post-denervation
increase in mitochondrial peroxide generation, but the muscle content
of Nox4 showed no significant changes throughout the time course
(Fig. 4B). However, our study focused on measuring protein content
and not activity, therefore we cannot rule out altered activity of Nox4.
In contrast, significant post-denervation increases in muscle were
seen in the content of components of the Nox2 complex. All Nox2-re-
lated subunits were seen to increase to some extent after denervation
(Fig. 4B and Supplementary data 1). The interaction of Nox2/gp91phox
with p22phox is a necessary step for the assembly of the Nox2 complex
and the content data presented suggest that this would be maximal from
14 days following denervation. The protein content of p47phox and Rac-
1 were significantly increased between 3 and 7 days post-denervation
(Supplementary data 1). Phosphorylation of p47phox and Rac-1 activa-
tion have previously been reported in skeletal muscle and these post-
translational events lead to translocation and binding of cytosolic
subunits to the cell membrane and Nox2 and p22phox to form a func-
tionally active complex [21]. The content of p67phox and p40phox sub-
units was also increased at 14 days post-denervation. These are re-
ported to be mainly cytosolic and translocate to the cell membrane
upon Nox2 activation [21].
NADPH oxidases can be activated by different stimuli and different
pathways can induce their assembly. It has previously been shown that
PLA2 activity can activate NADPH oxidases [29] and can promote ROS
generation in muscle mitochondria [31] and cytosol [32]. PLA2 is
mainly involved in the hydrolysis of sn-2 fatty acyl chains of phos-
pholipids generating fatty acids such as arachidonic acid which are
important substrates for cyclooxygenases (COX) and lipoxygenases
(LOX) and involved in the activation of NADPH oxidase and generation
of ROS [33]. In the present study, an increase in cPLA2 content was
seen at 14 days following denervation which would be compatible with
a potential role for this enzyme in Nox2 activation. Previously pub-
lished data has shown that cPLA2 is a negative regulator of growth,
specifically of striated muscle and deletion of cPLA2 promotes striated
muscle growth [34]. Our data demonstrated that the cPLA2 content was
significantly increased in muscle at 14 days post-denervation and re-
mained increased thereafter (Fig. 4C) when muscle fiber atrophy was
evident.
Prx6 protein content was also increased in muscle at 3 days post-
denervation (Supplementary data 2A). This protein is an atypical per-
oxiredoxin, which has potential PLA2 activity [35]. It is a 1-Cys per-
oxiredoxin with unique bi-functional characteristics and can translocate
into the mitochondria during stress conditions where it plays a primary
role in binding and reducing phospholipid hydroperoxides [36]). This
protein also acquires PLA2 activity if it is over-oxidized [37]. This
Fig. 5. (A) Quantification of western blots for mitochondrial antioxidant enzymes (GPx1, TRxR2, MnSOD) and (B) HSP (Hsp25, Hsc70) content in TA muscle from
control mice (non-denervated) and mice at 1, 3, 7, 14 and 21 days post-denervation. Histograms represent the mean protein content and standard error of the mean
for each experimental group (n = 4). *p < 0.05 - **p < 0.01 - ***p < 0.001 compared with the control group.
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suggests the possibility that the increased peroxide release from mi-
tochondria may induce the translocation of Prx6 into mitochondria
where it becomes over-oxidized and undergoes conformational changes
acquiring PLA2 properties. These conformational changes allow Prx6 to
produce fatty acids, including arachidonic acid that have been reported
to induce the phosphorylation of p40phox, p47phox and p67phox and their
subsequent translocation to the plasma membrane allowing the as-
sembly of Nox2 [38].
Thus, overall, the data obtained are compatible with the hypothesis
that, following denervation, muscle mitochondria increase peroxide
release and this leads to an adaptive increase in Nox2 content and that
this enzyme may be activated via Prx6-PLA2-mediated signalling
pathways. It is important to note that the increases in muscle content of
Nox2 protein and its regulatory sub-units are unlikely to have con-
tributed to the observed increase in mitochondrial peroxide generation
post-denervation. Previous studies have not identified Nox2 in muscle
mitochondria [16]. Rather these changes are likely to reflect an addi-
tional adaptation of the muscle to denervation. We have previously
speculated that a key role of the increased mitochondrial peroxide
generation following denervation may be to stimulate axonal sprouting
and regrowth [8] and the increase in Nox2 may also reflect a similar
adaptive response. Nox2 has been shown to play a role in axonal growth
cone dynamics and modulation of cytoskeletal proteins [39] and since
this enzyme predominantly generates superoxide to the external face of
the plasma or T-tubule membrane it is tempting to speculate that may
play a role in muscle-nerve communication to modulate axonal re-
growth or guidance [39].
To examine the effect of denervation on the antioxidant system
response in skeletal muscle mitochondria, the contents of 3 major mi-
tochondrial antioxidant enzymes, MnSOD, TRxR2 and GPx1 were
analyzed. The MnSOD content in muscle did not change following de-
nervation but our study focused on measuring protein content and not
activity, therefore we cannot rule out altered activity. In contrast, both
TrxR2 and GPx1 contents were significantly increased at 3 and 7 days
post-denervation (Fig. 5A). The rapid increase in the content of these
mitochondrial antioxidant enzymes may therefore also reflect an
adaptive response following loss of innervation in an attempt to
maintain redox homeostasis in the muscle.
We also hypothesized that the increased peroxide production fol-
lowing denervation would stimulate adaptive responses against oxida-
tive damage and repair processes in an attempt to protect the muscle
from degeneration. We observed that the Hsp70 content was increased
following denervation and remained increased up to 21 days post-de-
nervation (Supplementary data 2B) which is compatible with the pos-
sibility that the increased Hsp70 may play a role in protein homeostasis
in the denervated muscle. Prolonged denervation of muscle also re-
sulted in the increase content of Hsc70 (Fig. 5B).
Finally, we observed that the muscle Hsp25 content was also sig-
nificantly increased from 3 days following denervation and remained
increased until 21 days post-denervation (Fig. 5B). It has previously
been shown that overexpression of Hsp25 in skeletal muscle cells pro-
duced dose-dependent protection against H2O2-induced damage that
was associated with increased glutathione levels and GPx1 activity
[40]. We did not observe any significant differences with time post-
denervation in glutathione levels (Fig. 3B) but found a significant in-
crease in the content of GPx1 which was maintained up to 21 days post
denervation. Thus, the data are in accord with the possibility that the
increased Hsp25 together with the changes in GPx1 are important in
enhancing resistance to H2O2 damage in skeletal muscle fibers fol-
lowing denervation.
In summary, data indicate that following denervation, increased
mitochondrial peroxide generation is evident at 7 days post-denerva-
tion and maintained up to 21 days post-denervation and that this in-
crease is associated with a significant increase in the muscle content of
various proteins involved in the potential generation of peroxides in-
cluding Prx6 and cPLA2 which may be involved in the activation of
NADPH oxidase. A significant increase was also seen in the content of
several antioxidant enzymes and HSPs involved in the protection
against oxidative damage, maintenance of redox homeostasis and pro-
teostasis. These results support the possibility that, at least initially, the
increase in peroxide production following denervation may stimulate
adaptations to protect the muscle fibers; however sustained increased
peroxide generation over the longer-term is likely to activate degen-
erative processes that lead to degeneration and muscle atrophy.
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